data_2mts_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mts _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 . . . . . 0 N--CA 1.457 -0.075 0 CA-C-O 120.834 0.35 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.559 ' C ' ' H ' ' A' ' 6' ' ' VAL . 6.1 m-20 -69.03 -56.64 7.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.558 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.511 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 4.0 mm? -53.0 -6.41 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.561 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.559 ' H ' ' C ' ' A' ' 4' ' ' ASN . 40.1 t -91.44 -51.92 10.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.567 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.6 p -81.45 -23.36 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.529 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -46.66 88.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.556 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.4 ' ND2' ' O ' ' A' ' 5' ' ' LEU . 23.8 m-80 -64.02 -46.7 83.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.567 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.82 -36.87 73.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.566 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.45 -44.06 76.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.563 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.5 p -62.21 -41.75 98.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.556 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.9 t -68.94 -43.37 82.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.55 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.87 -52.47 63.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.575 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.27 -81.63 0.35 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.65 -67.48 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.822 0.344 . . . . 0.0 110.578 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -51.9 -19.42 1.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.632 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.33 -54.01 6.45 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 21.2 pt -68.84 -22.82 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 0.0 110.547 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -69.48 -41.91 75.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.54 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.3 m -63.74 -28.77 70.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.557 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.44 ' O ' ' N ' ' A' ' 25' ' ' PHE . 5.1 m-85 -64.31 -11.47 32.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.572 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.4 tp -41.31 -39.64 1.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.545 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.8 t -71.03 -39.68 75.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.568 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.44 ' N ' ' O ' ' A' ' 22' ' ' PHE . 84.9 t80 -74.82 -27.78 60.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.625 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.58 -42.78 77.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.55 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.0 m -46.2 -42.74 14.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.568 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.69 -36.24 57.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.538 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.412 ' O ' ' CG2' ' A' ' 32' ' ' ILE . . . -58.01 -39.68 78.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.561 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -69.34 -33.7 73.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.553 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -60.81 -22.12 63.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.608 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.548 ' CG2' ' N ' ' A' ' 33' ' ' LYS . 10.6 tp -48.04 -50.06 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.563 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.548 ' N ' ' CG2' ' A' ' 32' ' ' ILE . 4.7 tppt? -64.52 -50.56 66.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.515 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.9 43.13 6.87 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.762 ' O ' ' N ' ' A' ' 37' ' ' ALA . 15.4 ptm180 -145.5 -5.06 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.744 0.306 . . . . 0.0 110.523 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.699 ' C ' ' O ' ' A' ' 35' ' ' ARG . 32.2 tp -6.33 71.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.563 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.762 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -21.1 91.9 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.625 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.532 ' N ' ' O ' ' A' ' 36' ' ' LEU . 48.0 Cg_exo -53.62 150.74 27.11 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.843 2.362 . . . . 0.0 112.169 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.17 -75.51 0.42 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.5 ' C ' ' H ' ' A' ' 42' ' ' TYR . . . -87.77 -72.51 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.763 0.316 . . . . 0.0 110.575 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.12 -13.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.59 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.5 ' H ' ' C ' ' A' ' 40' ' ' ALA . 30.7 t80 -86.62 -49.39 7.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.551 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.35 -36.22 82.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.622 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.545 ' C ' ' H ' ' A' ' 46' ' ' GLY . 4.3 m-85 -44.61 -39.59 5.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.589 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -49.01 -10.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.62 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 44' ' ' PHE . . . -62.78 -35.47 91.99 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.0 m -148.62 23.91 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.85 0.357 . . . . 0.0 110.581 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.627 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -80.79 -42.99 1.25 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.513 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 15.1 Cg_exo -68.01 -15.09 42.77 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.806 2.337 . . . . 0.0 112.181 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.16 -33.96 75.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.521 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 tp -61.71 -7.56 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.611 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.1 mt -62.81 -49.55 74.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.609 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.468 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -85.2 -14.33 47.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.577 -178.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.414 ' CD1' ' C ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -76.96 -58.31 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.578 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.487 ' O ' ' C ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -75.84 -38.72 57.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.616 -178.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 55' ' ' LEU . . . -34.11 -52.47 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.572 -177.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.75 ' CD1' ' N ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -111.57 155.7 42.56 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.548 178.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -78.27 163.44 27.61 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.843 2.362 . . . . 0.0 112.126 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.546 ' C ' ' H ' ' A' ' 61' ' ' ALA . 54.5 Cg_exo -47.93 -42.23 31.72 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.744 2.296 . . . . 0.0 112.121 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -68.16 42.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.621 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.546 ' H ' ' C ' ' A' ' 59' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.602 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.441 ' CG ' ' H ' ' A' ' 4' ' ' ASN . 17.4 tp10 . . . . . 0 CA--C 1.528 0.099 0 CA-C-O 120.745 0.307 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.441 ' H ' ' CG ' ' A' ' 3' ' ' GLU . 75.0 m-20 -112.08 -35.05 5.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.568 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.475 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 4.1 mm? -48.27 -104.73 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.773 0.32 . . . . 0.0 111.446 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.0 t -44.03 -31.05 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.883 0.373 . . . . 0.0 110.72 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.8 t -62.32 -42.52 95.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.717 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.5 tp -62.21 -43.28 99.18 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.051 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -75.64 -34.88 60.54 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.048 0.451 . . . . 0.0 110.797 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 12' ' ' SER . . . -72.24 -77.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.787 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -43.16 -15.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.342 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -57.74 -38.8 75.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.363 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.3 p -94.85 -37.57 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.562 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.63 -37.78 8.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.609 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.38 -21.6 28.33 Favored Glycine 0 N--CA 1.465 0.588 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.41 -50.59 71.18 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.522 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -101.15 12.41 37.64 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.961 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.78 -48.48 55.14 Favored Glycine 0 N--CA 1.462 0.425 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 8.6 tt -67.49 -34.02 65.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.841 0.353 . . . . 0.0 110.495 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.13 -25.87 47.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.69 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.0 t -59.04 -43.16 91.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.913 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -62.22 -31.27 71.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.916 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tt -48.76 -39.38 24.81 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.391 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.8 p -63.21 -33.24 59.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.91 0.386 . . . . 0.0 110.255 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -63.94 -37.37 87.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.011 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -56.35 -43.85 79.53 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.754 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -44.59 -45.26 9.4 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.506 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.53 -39.24 22.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.843 0.354 . . . . 0.0 110.96 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.7 -36.07 24.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.253 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -59.22 -33.45 71.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.129 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -66.37 -44.9 81.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.542 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.5 mt -59.78 -44.42 93.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.949 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.677 ' C ' ' H ' ' A' ' 35' ' ' ARG . 84.7 tttt -69.32 -60.45 2.33 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.284 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.544 ' C ' ' H ' ' A' ' 36' ' ' LEU . . . 56.47 -12.22 0.01 OUTLIER Glycine 0 CA--C 1.536 1.361 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.677 ' H ' ' C ' ' A' ' 33' ' ' LYS . 2.0 mmp_? -72.19 20.75 0.06 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.026 0.441 . . . . 0.0 110.922 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.544 ' H ' ' C ' ' A' ' 34' ' ' GLY . 46.8 tp -130.97 123.68 29.36 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.067 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.79 159.76 66.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.81 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.587 ' O ' ' N ' ' A' ' 40' ' ' ALA . 36.7 Cg_endo -65.4 -91.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.502 2.135 . . . . 0.0 111.47 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 49.88 -79.31 0.01 OUTLIER Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' A' ' 38' ' ' PRO . . . -68.1 -25.22 65.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.37 . . . . 0.0 110.39 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.43 -10.51 59.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.406 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -64.45 -71.23 0.18 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.367 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -79.18 -77.7 0.17 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.838 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.469 ' C ' ' O ' ' A' ' 43' ' ' ALA . 80.6 t80 -23.17 -89.7 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.622 0.576 . . . . 0.0 111.94 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -52.87 -29.34 27.57 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.257 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -45.29 -14.51 0.06 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.512 ' N ' ' O ' ' A' ' 45' ' ' TYR . 10.5 m -102.25 59.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.976 0.417 . . . . 0.0 110.648 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.493 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -66.79 -56.41 14.41 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.748 179.295 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 48' ' ' TRP . 27.6 Cg_endo -61.44 -16.74 49.34 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.61 2.206 . . . . 0.0 112.36 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.32 -45.51 7.11 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.819 0.342 . . . . 0.0 110.412 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 53' ' ' LEU . 26.9 tp -60.66 -24.34 65.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.467 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -69.36 4.13 1.91 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.557 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.404 ' H ' ' C ' ' A' ' 51' ' ' LEU . 3.2 pp -68.24 -35.69 78.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.041 0.448 . . . . 0.0 110.678 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.2 pp -70.06 -1.26 9.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.871 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.4 -56.5 1.31 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.336 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.02 -19.88 50.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.191 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.0 tp -119.93 65.9 10.4 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.467 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.68 164.11 22.3 Favored 'Trans proline' 0 N--CA 1.501 1.915 0 C-N-CA 122.734 2.289 . . . . 0.0 111.872 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.51 -60.91 0.34 Allowed 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.764 2.309 . . . . 0.0 112.119 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.27 -75.56 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.673 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.276 -179.781 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.423 ' O ' ' CB ' ' A' ' 4' ' ' ASN . 18.6 pt-20 . . . . . 0 N--CA 1.466 0.343 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.606 ' C ' ' H ' ' A' ' 6' ' ' VAL . 55.4 t30 82.16 -123.02 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.612 0.57 . . . . 0.0 110.988 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tp -56.31 7.95 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.606 ' H ' ' C ' ' A' ' 4' ' ' ASN . 5.6 p -67.61 -46.49 82.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.974 0.416 . . . . 0.0 111.068 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.504 ' N ' ' CG1' ' A' ' 6' ' ' VAL . 13.5 p -64.84 -41.12 91.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.965 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.9 tp -46.07 -70.74 0.09 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.191 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -66.43 -46.94 74.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.519 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.51 -47.79 69.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.704 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.37 -42.84 92.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.82 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.4 m -63.44 -44.33 94.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.009 0.433 . . . . 0.0 110.534 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.1 t -68.95 -42.72 82.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.678 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -44.34 -57.04 3.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.594 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.71 -90.45 0.34 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 18' ' ' GLY . . . -59.87 -40.77 89.81 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.709 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -55.14 -3.82 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.75 0.309 . . . . 0.0 110.777 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.553 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -75.15 -51.05 7.85 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.4 tt -45.75 -17.64 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.761 0.315 . . . . 0.0 110.636 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.46 ' H ' ' C ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER -64.74 -42.79 94.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.857 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.9 p -70.6 -41.54 72.16 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.385 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -65.66 -16.59 63.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.684 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.413 ' O ' ' OG ' ' A' ' 27' ' ' SER . 5.6 tp -50.74 -36.19 35.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.514 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.407 ' CG2' ' N ' ' A' ' 25' ' ' PHE . 3.3 m -72.78 -39.82 60.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.914 0.388 . . . . 0.0 110.501 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.407 ' N ' ' CG2' ' A' ' 24' ' ' VAL . 28.5 m-85 -63.57 -45.41 90.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.718 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -67.04 -42.72 84.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 0.0 110.607 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 23' ' ' LEU . 43.6 m -53.8 -43.8 69.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.502 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.34 -40.57 62.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.424 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.91 -51.48 69.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -52.64 -27.23 16.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.603 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.74 -16.83 61.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.662 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.527 ' CG2' ' N ' ' A' ' 33' ' ' LYS . 18.8 tt -53.06 -50.05 47.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.703 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.527 ' N ' ' CG2' ' A' ' 32' ' ' ILE . 3.0 ptpp? -62.54 -46.87 86.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.295 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.96 11.14 47.22 Favored Glycine 0 N--CA 1.464 0.519 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.496 ' C ' ' H ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -79.06 -15.1 58.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.889 0.376 . . . . 0.0 110.312 179.378 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 37' ' ' ALA . 3.4 tp -73.63 13.36 0.49 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.225 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 35' ' ' ARG . . . -47.43 -179.8 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.4 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' A' ' 37' ' ' ALA . 37.2 Cg_exo -59.95 148.17 89.86 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.089 1.859 . . . . 0.0 111.634 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.31 -128.81 2.68 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.2 -10.18 28.71 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.727 0.299 . . . . 0.0 110.941 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.406 ' C ' ' N ' ' A' ' 43' ' ' ALA . . . -82.96 -72.47 0.45 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.057 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -47.1 -20.75 0.18 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.286 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.406 ' N ' ' C ' ' A' ' 41' ' ' ALA . . . -57.67 -88.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.779 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -64.62 -45.35 87.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.206 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.538 ' C ' ' H ' ' A' ' 47' ' ' VAL . 14.3 t80 -59.13 -16.08 17.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.528 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.08 20.36 0.92 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.538 ' H ' ' C ' ' A' ' 45' ' ' TYR . 12.7 p -99.05 71.79 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.104 0.478 . . . . 0.0 110.649 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.608 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 3.0 m0 -100.78 -34.04 0.23 Allowed Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.638 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 57.9 Cg_endo -77.59 -24.8 8.6 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.662 1.574 . . . . 0.0 112.575 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.7 -46.31 38.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.934 0.397 . . . . 0.0 110.441 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.07 -47.14 72.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.3 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.8 mt -52.75 -30.15 31.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.142 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.4 tp -67.21 -44.04 80.55 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' LEU . 55.8 tp -62.45 -44.96 95.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.758 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.0 tp -69.99 -37.76 75.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.811 0.339 . . . . 0.0 110.662 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.07 -30.9 60.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.137 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -155.28 148.03 17.95 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.626 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.432 ' HG3' ' H ' ' A' ' 4' ' ' ASN . 35.1 Cg_endo -65.53 171.66 9.12 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.346 2.031 . . . . 0.0 112.534 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' A' ' 61' ' ' ALA . 31.2 Cg_exo -59.47 -17.12 39.24 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 122.329 2.02 . . . . 0.0 112.163 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.491 ' O ' ' C ' ' A' ' 61' ' ' ALA . 58.6 mtm180 44.85 -91.15 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.422 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 59' ' ' PRO . . . . . . . . 0 N--CA 1.476 0.83 0 O-C-N 123.764 0.665 . . . . 0.0 111.961 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 110.386 -0.228 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.1 m120 72.82 -60.75 0.52 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.43 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.3 pp -70.66 -29.83 66.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.488 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 10' ' ' ALA . 28.7 m -56.79 -46.22 83.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.64 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.9 t -46.25 -29.69 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.829 0.347 . . . . 0.0 110.541 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.8 tp -94.23 -56.41 2.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.591 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -66.43 -55.61 14.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.434 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 6' ' ' VAL . . . -55.74 -54.26 46.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 110.644 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.15 -41.45 68.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.58 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 t -63.57 -45.49 90.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.542 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.5 t -74.15 -58.03 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.195 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.49 -58.03 9.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.774 0.321 . . . . 0.0 110.91 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.9 -32.45 6.82 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.557 ' C ' ' H ' ' A' ' 18' ' ' GLY . . . -69.91 -57.85 4.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.926 0.393 . . . . 0.0 110.322 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -50.75 -8.03 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.773 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -66.13 -58.06 9.53 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.2 pt -56.0 -24.05 16.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.424 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -72.67 -40.73 66.08 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.3 t -64.8 -43.46 93.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.631 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -78.91 -18.19 54.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.993 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.2 tp -48.9 -34.03 11.93 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.4 t -77.86 -36.64 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.693 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -61.0 -47.36 86.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.169 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -59.52 -26.82 65.64 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.515 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.7 t -51.12 -42.01 60.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.044 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.12 -37.89 53.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.383 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.08 -54.12 50.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.081 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 9.1 m0 -57.01 -23.79 48.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.702 0.287 . . . . 0.0 110.956 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.45 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 41.0 t80 -73.02 -14.99 61.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.688 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 33' ' ' LYS . 15.3 tt -62.09 -44.7 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.216 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.476 ' N ' ' CG2' ' A' ' 32' ' ' ILE . 1.5 tptm -70.84 -56.99 5.08 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.376 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.97 24.63 3.55 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -80.49 60.92 4.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.769 0.318 . . . . 0.0 110.283 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.9 mt -134.41 124.88 26.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.258 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -164.15 168.5 9.28 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.194 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -47.63 106.4 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.092 1.861 . . . . 0.0 112.074 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 133.82 -48.71 0.94 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.69 -60.77 2.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.822 0.344 . . . . 0.0 110.762 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.92 -5.82 14.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.52 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -72.96 -62.22 1.54 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.924 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.68 92.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.183 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.493 ' C ' ' H ' ' A' ' 46' ' ' GLY . 4.5 m-85 -63.1 -83.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.349 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -53.65 -8.76 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.699 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 44' ' ' PHE . . . -65.85 -52.58 36.8 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.7 m -135.7 11.09 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.871 0.367 . . . . 0.0 110.675 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.525 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 13.1 t90 -61.64 -51.76 74.22 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 48' ' ' TRP . 11.1 Cg_endo -51.85 -16.4 4.09 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.807 1.672 . . . . 0.0 112.288 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.8 tp -76.06 -33.6 59.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.979 0.418 . . . . 0.0 110.1 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 72.6 mt -78.18 2.49 17.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.507 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.4 tt -85.21 -32.14 22.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.9 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.436 ' N ' ' CD1' ' A' ' 53' ' ' LEU . 10.2 mp -63.6 -32.43 73.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.389 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.3 tp -54.91 -46.0 74.82 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 tt -62.78 -40.08 96.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.855 0.359 . . . . 0.0 110.257 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.02 -11.44 59.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.698 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.7 mt -134.58 66.94 71.03 Favored Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.361 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.543 ' O ' ' N ' ' A' ' 60' ' ' ARG . 59.6 Cg_endo -77.74 163.63 28.78 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.709 2.273 . . . . 0.0 112.335 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -43.67 -11.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.698 2.265 . . . . 0.0 112.588 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 58' ' ' PRO . 9.3 tmm_? -70.68 -60.22 2.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.373 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.291 179.863 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.704 0.288 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -105.9 38.12 2.09 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.872 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.3 tp -112.52 -70.86 0.78 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.381 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.432 ' CG1' ' N ' ' A' ' 7' ' ' VAL . 11.5 p -60.34 -47.33 92.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.428 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.432 ' N ' ' CG1' ' A' ' 6' ' ' VAL . 12.7 p -64.64 -40.96 90.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.462 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.5 tp -61.71 -44.74 96.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.409 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -63.95 -45.67 88.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.95 0.405 . . . . 0.0 110.577 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.94 -26.49 64.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.343 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.64 -17.81 59.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.554 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.6 t -64.38 -50.97 65.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.318 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.5 p -91.79 -21.0 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.181 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.16 -77.84 0.44 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.592 0.234 . . . . 0.0 110.995 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.04 -164.5 0.74 Allowed Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.245 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 18' ' ' GLY . . . -90.94 -1.78 57.79 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -41.66 -19.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.139 -0.225 . . . . 0.0 111.299 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -67.37 -49.6 50.53 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 15.1 tt -49.24 -28.26 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.83 0.348 . . . . 0.0 110.679 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.442 ' C ' ' CD1' ' A' ' 20' ' ' LEU . 3.2 tm? -65.97 -45.02 83.21 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.496 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.8 m -59.65 -43.76 93.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.779 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -61.69 -39.82 92.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.666 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.32 -39.23 89.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.816 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.1 t -68.18 -42.85 85.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.007 0.432 . . . . 0.0 110.036 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -63.12 -44.24 96.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.59 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.62 -41.8 99.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.182 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.0 m -54.35 -41.47 69.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.343 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.69 -43.06 39.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.494 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.5 -38.39 89.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.411 ' C ' ' N ' ' A' ' 32' ' ' ILE . 58.0 t-105 -59.89 -30.39 68.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.148 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -52.03 -15.04 0.48 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.138 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.411 ' N ' ' C ' ' A' ' 30' ' ' TRP . 3.5 tp -67.65 -19.28 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.504 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.664 ' C ' ' H ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -42.15 -58.01 2.29 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 58.47 -14.75 0.02 OUTLIER Glycine 0 CA--C 1.534 1.274 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.021 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.664 ' H ' ' C ' ' A' ' 33' ' ' LYS . 85.0 mtm-85 -128.36 70.35 1.37 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.038 0.419 . . . . 0.0 111.097 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.61 118.97 5.57 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.91 158.13 73.11 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-O 120.766 0.317 . . . . 0.0 110.484 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -63.88 -177.89 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.533 2.155 . . . . 0.0 111.783 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.91 -72.42 0.35 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.537 ' C ' ' H ' ' A' ' 42' ' ' TYR . . . -56.72 -34.94 67.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.766 0.317 . . . . 0.0 110.665 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.47 21.19 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.82 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.537 ' H ' ' C ' ' A' ' 40' ' ' ALA . 81.3 t80 -56.52 -42.96 79.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.443 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.14 -42.2 90.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.325 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -55.67 -47.62 76.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.792 0.329 . . . . 0.0 110.338 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.432 ' O ' ' O ' ' A' ' 46' ' ' GLY . 31.4 m-85 -75.98 -35.64 59.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.28 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 45' ' ' TYR . . . -42.26 -97.99 0.01 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -144.46 36.24 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.702 0.287 . . . . 0.0 111.074 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.536 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 20.2 t-105 -60.95 -46.59 96.74 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.877 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 48' ' ' TRP . 30.4 Cg_endo -61.99 -13.65 32.57 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 121.765 1.643 . . . . 0.0 112.522 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.7 tp -77.33 -38.8 49.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.752 0.311 . . . . 0.0 110.922 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.461 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 4.0 mm? -62.44 -40.18 95.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.579 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.0 mt -49.06 -19.04 0.37 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.442 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.0 tt -66.44 -43.43 85.65 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.299 0.571 . . . . 0.0 110.062 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.5 mt -74.05 -19.15 60.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.403 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.2 mp -93.99 -41.94 9.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.937 0.399 . . . . 0.0 110.233 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.3 -34.06 75.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.79 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.3 mp -110.79 95.27 22.96 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -47.08 175.37 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.457 2.105 . . . . 0.0 112.266 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.77 -38.85 78.23 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.399 2.066 . . . . 0.0 112.392 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -50.67 72.06 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.0 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.639 179.629 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.542 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 8.5 pm0 . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.713 0.292 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.23 -46.42 3.3 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.861 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.5 mt -78.3 -48.61 15.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.148 0.499 . . . . 0.0 110.633 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.415 ' CG1' ' N ' ' A' ' 7' ' ' VAL . 13.1 p -64.23 -44.08 97.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.552 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.415 ' N ' ' CG1' ' A' ' 6' ' ' VAL . 55.9 t -62.06 -50.02 81.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.825 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.437 ' O ' ' OG ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -65.97 -42.67 89.57 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.035 -179.528 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -60.92 -44.2 97.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.401 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 12' ' ' SER . . . -78.5 -68.31 0.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -41.22 -25.84 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.109 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 8' ' ' LEU . 3.1 m -60.85 -43.83 97.79 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.538 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.3 t -96.18 -34.64 5.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.852 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.73 -46.81 67.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.253 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.73 -11.04 23.29 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.89 -43.06 94.99 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.049 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -101.07 10.41 41.03 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.902 0.382 . . . . 0.0 110.336 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.29 -52.58 45.95 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.5 tp -66.28 -31.55 54.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.782 0.325 . . . . 0.0 110.774 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.6 mt -70.37 -39.11 74.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.231 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.1 t -62.26 -43.06 99.68 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.795 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -64.46 -35.45 80.97 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.474 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.8 tp -58.8 -36.53 74.61 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.396 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.441 ' O ' ' OG ' ' A' ' 27' ' ' SER . 38.8 t -76.82 -45.16 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.023 0.439 . . . . 0.0 110.413 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -66.41 -43.28 86.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.949 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -67.02 -24.55 66.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.971 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 24' ' ' VAL . 53.5 p -57.22 -32.77 66.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.915 0.388 . . . . 0.0 110.151 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.04 -28.91 70.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.42 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.96 -47.91 70.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.716 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -56.37 -37.8 70.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.831 0.348 . . . . 0.0 110.626 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -68.37 -44.38 75.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.534 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.77 -44.25 99.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.728 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -62.53 -43.92 97.62 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.467 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.55 74.57 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.86 -5.02 48.97 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.991 0.424 . . . . 0.0 110.175 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.01 158.45 28.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.636 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -167.82 174.46 2.35 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.481 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.86 139.45 90.37 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.198 1.932 . . . . 0.0 111.682 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.93 -99.27 0.29 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.46 -39.16 88.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.657 0.265 . . . . 0.0 110.95 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 44' ' ' PHE . . . -47.79 -85.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.723 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.438 ' C ' ' O ' ' A' ' 41' ' ' ALA . 72.3 m-85 -30.05 -44.06 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.749 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.13 -47.07 69.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.838 0.351 . . . . 0.0 110.824 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 41' ' ' ALA . 84.1 t80 -87.99 -70.47 0.63 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.27 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.47 ' O ' ' N ' ' A' ' 47' ' ' VAL . 3.5 m-85 -48.94 -39.95 28.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.7 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -41.12 -24.58 0.1 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 45' ' ' TYR . 42.8 t -81.45 76.11 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.923 0.392 . . . . 0.0 110.38 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.596 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -98.67 -39.32 0.24 Allowed Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.707 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 51.5 Cg_exo -53.19 -55.51 3.6 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.088 1.859 . . . . 0.0 112.213 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.445 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 10.1 mp -67.44 -29.54 69.04 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.998 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -44.69 95.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.92 0.39 . . . . 0.0 110.421 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.74 -33.03 53.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.202 0.525 . . . . 0.0 110.406 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.453 ' C ' ' H ' ' A' ' 55' ' ' LEU . 12.5 tp -66.54 -64.17 0.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.388 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.7 tp -53.9 -9.99 0.28 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.592 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -75.73 -73.3 0.27 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.791 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.95 3.15 52.2 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.627 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -127.45 81.12 70.71 Favored Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -75.99 165.07 30.51 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.378 2.052 . . . . 0.0 112.055 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -43.33 -35.81 5.83 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.361 2.04 . . . . 0.0 111.875 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.9 mtt-85 -49.03 -42.52 38.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.359 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 120.756 0.312 . . . . 0.0 110.432 179.776 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.588 0.232 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -115.04 -3.38 12.62 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.763 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.8 mp -106.82 -73.53 0.68 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.633 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.3 p -46.48 -33.89 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.907 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 11' ' ' ALA . 13.0 m -67.04 -41.11 86.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.759 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.99 -53.42 57.43 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.671 -0.412 . . . . 0.0 109.916 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -63.24 -45.11 93.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.311 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.75 -34.03 77.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.262 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -64.21 -37.44 87.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.454 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.9 t -49.56 -30.72 9.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.267 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.7 t -89.73 -50.16 13.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.454 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.1 -50.66 67.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.748 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 116.42 -2.74 20.35 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.959 -0.857 . . . . 0.0 110.959 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.548 ' C ' ' H ' ' A' ' 18' ' ' GLY . . . -61.1 -110.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.336 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.587 ' HE2' ' CA ' ' A' ' 58' ' ' PRO . 46.8 m80 -44.79 -13.12 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.813 0.34 . . . . 0.0 111.031 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.548 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -68.33 -45.51 69.09 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.1 tt -47.1 -24.22 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.371 . . . . 0.0 110.448 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.446 ' C ' ' CD1' ' A' ' 20' ' ' LEU . 3.0 tm? -64.73 -44.53 89.85 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.043 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.9 t -51.79 -42.86 62.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.439 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -64.17 -47.0 81.52 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.315 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.83 -46.07 74.56 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -177.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.1 p -69.21 -40.26 80.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.67 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -65.65 -38.58 89.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.34 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -75.79 -48.83 20.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.721 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.4 m -56.75 -42.07 78.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.389 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.66 -39.6 80.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.178 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.62 -40.07 90.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.565 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 9.7 t-105 -49.84 -32.34 14.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.968 0.413 . . . . 0.0 110.105 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -58.93 -26.22 64.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.198 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.2 tt -64.43 -33.78 65.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.938 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -68.92 -54.7 14.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.469 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.96 11.44 18.71 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 50.3 ttm-85 -76.88 -15.25 59.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.848 0.356 . . . . 0.0 110.575 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.4 tp -70.32 49.67 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.437 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.32 162.22 73.77 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.186 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.29 171.09 13.34 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.793 2.328 . . . . 0.0 111.796 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.83 -88.33 0.5 Allowed Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.23 -47.17 11.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 110.819 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.36 3.21 11.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.62 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -89.41 -45.59 9.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.607 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 45' ' ' TYR . . . -64.82 -74.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.174 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 46' ' ' GLY . 17.3 m-85 -65.34 6.1 0.33 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.686 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.519 ' H ' ' C ' ' A' ' 43' ' ' ALA . 58.5 t80 -40.95 -24.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.925 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 44' ' ' PHE . . . -92.36 31.26 6.16 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.433 ' N ' ' O ' ' A' ' 44' ' ' PHE . 7.4 p -110.93 -24.94 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 120.895 0.379 . . . . 0.0 110.581 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.639 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 19.0 p-90 -83.2 -29.5 0.45 Allowed Pre-proline 0 CA--C 1.549 0.92 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.702 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 60.4 Cg_endo -87.38 -19.32 2.41 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.951 2.434 . . . . 0.0 112.682 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.5 tp -77.1 -48.97 16.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.98 0.419 . . . . 0.0 110.663 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.6 mt -67.73 -2.21 6.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.323 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.9 tt -65.75 -39.01 90.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.8 mt -94.58 -48.2 6.2 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.805 0.336 . . . . 0.0 111.071 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.8 tp -41.8 -59.61 1.63 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.077 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.495 ' C ' ' H ' ' A' ' 57' ' ' LEU . 10.5 mp -62.01 -41.4 98.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.52 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.82 1.0 0.45 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.429 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.495 ' H ' ' C ' ' A' ' 55' ' ' LEU . 64.5 mt -130.79 146.65 62.89 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.656 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.587 ' CA ' ' HE2' ' A' ' 17' ' ' HIS . 38.9 Cg_endo -67.86 138.65 45.23 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.456 2.104 . . . . 0.0 112.45 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -45.06 -20.68 0.44 Allowed 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.351 2.034 . . . . 0.0 112.021 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 72.8 ttt-85 -63.63 -44.1 94.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.273 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.248 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.569 -179.959 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.413 ' HA ' HH22 ' A' ' 60' ' ' ARG . 33.8 tt0 . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.874 0.368 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -100.59 -64.88 1.01 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.431 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 53.8 mt -49.12 -33.41 11.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.681 0.277 . . . . 0.0 111.284 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' A' ' 7' ' ' VAL . 14.8 p -62.22 -48.42 88.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.739 0.304 . . . . 0.0 110.806 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.463 ' N ' ' CG1' ' A' ' 6' ' ' VAL . 7.2 p -85.62 -29.86 6.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.99 0.424 . . . . 0.0 111.288 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.414 ' O ' ' OG ' ' A' ' 12' ' ' SER . 3.0 tt -58.32 -74.24 0.06 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.257 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.426 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 28.5 m120 -57.26 -26.62 61.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.498 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.41 -82.3 0.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.848 0.356 . . . . 0.0 111.294 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . -53.42 -62.45 1.65 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.024 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 8' ' ' LEU . 1.4 m -38.24 -48.46 1.29 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.743 0.306 . . . . 0.0 110.819 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 9' ' ' ASN . 78.3 t -65.3 -42.73 94.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.945 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . -63.43 -19.26 64.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.537 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 16' ' ' ALA . . . 106.27 -28.79 12.46 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.618 ' C ' ' H ' ' A' ' 18' ' ' GLY . . . -50.79 -98.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.427 ' H ' ' HB3' ' A' ' 11' ' ' ALA . 68.3 t60 -47.48 -5.12 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.618 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -66.49 -51.92 38.92 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.1 tt -68.84 -31.77 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.678 0.275 . . . . 0.0 111.245 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.49 -42.35 87.54 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.449 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.4 m -65.83 -35.96 82.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.128 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -76.44 -21.63 55.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.762 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.1 tp -63.28 -40.76 98.29 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.652 0.263 . . . . 0.0 111.326 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.406 ' O ' ' OG ' ' A' ' 27' ' ' SER . 2.0 p -70.19 -28.81 37.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.166 0.508 . . . . 0.0 109.965 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -71.34 -41.02 70.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.604 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.5 ' O ' ' N ' ' A' ' 29' ' ' ALA . 16.2 t80 -65.85 -38.34 88.61 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.554 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 24' ' ' VAL . 85.3 p -45.62 -39.1 7.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.18 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.83 -29.03 70.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.144 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . -57.49 -38.13 74.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.642 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.432 ' CD1' ' N ' ' A' ' 30' ' ' TRP . 40.3 m0 -57.2 -41.0 78.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.495 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -65.01 -44.02 90.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.42 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.1 mt -66.57 -43.5 90.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.935 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -70.7 -54.31 12.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.838 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.34 28.2 68.38 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -100.06 9.88 42.16 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.729 0.3 . . . . 0.0 110.65 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.7 mt -110.07 173.65 6.23 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.64 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.561 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -157.08 173.26 5.16 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.312 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.42 72.83 0.02 OUTLIER 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 122.71 2.273 . . . . 0.0 112.28 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . -112.86 -129.76 5.19 Favored Glycine 0 N--CA 1.466 0.695 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.0 -40.2 14.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.697 0.284 . . . . 0.0 110.76 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.69 -10.32 59.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.803 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.22 -51.53 6.22 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.804 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.2 -49.21 78.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.18 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.465 ' O ' ' N ' ' A' ' 46' ' ' GLY . 62.0 t80 -62.43 -44.67 95.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.155 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.446 ' CD1' ' C ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -40.82 -25.24 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.269 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 44' ' ' PHE . . . -62.65 -62.58 5.41 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.112 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.2 p -83.5 10.66 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.897 0.349 . . . . 0.0 111.63 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.554 ' C ' ' H ' ' A' ' 50' ' ' LEU . 1.3 t90 -44.08 -44.67 18.08 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.225 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 32.0 Cg_exo -57.98 13.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.509 2.383 0 C-N-CA 122.533 2.156 . . . . 0.0 113.336 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.554 ' H ' ' C ' ' A' ' 48' ' ' TRP . 3.9 tt -104.0 -50.47 3.37 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.082 0.468 . . . . 0.0 110.125 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.1 tp -60.41 -38.91 85.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.463 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.493 ' CD2' ' N ' ' A' ' 52' ' ' LEU . 3.9 mm? -59.33 -73.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.436 ' N ' ' CD1' ' A' ' 53' ' ' LEU . 9.7 mp -46.37 -33.04 3.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.783 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.1 tp -63.29 -69.56 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.876 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.3 mt -68.31 -39.37 82.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.717 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.94 -16.48 6.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.789 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 43.2 mt -123.99 90.36 50.77 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.474 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.63 -178.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.072 0 C-N-CA 123.069 2.513 . . . . 0.0 112.724 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.58 ' C ' ' H ' ' A' ' 61' ' ' ALA . 32.0 Cg_exo -57.32 -39.65 88.08 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.941 2.427 . . . . 0.0 112.501 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.413 HH22 ' HA ' ' A' ' 3' ' ' GLU . 4.7 ptm180 -63.79 8.42 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.58 ' H ' ' C ' ' A' ' 59' ' ' PRO . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.257 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.493 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 58.6 mp0 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.838 0.352 . . . . 0.0 110.534 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -65.28 -144.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.74 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.498 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 3.8 mm? -82.91 -8.24 59.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.351 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 70.5 t -60.42 -46.27 95.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.093 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.407 HG23 ' H ' ' A' ' 8' ' ' LEU . 2.2 m -64.12 -47.56 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.293 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.407 ' H ' HG23 ' A' ' 7' ' ' VAL . 58.5 tp -61.52 -43.84 98.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.111 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.444 ' O ' ' OG ' ' A' ' 12' ' ' SER . 20.5 m120 -60.96 -46.39 90.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.285 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.95 -37.43 72.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.424 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.99 -36.18 83.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.974 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 9' ' ' ASN . 58.9 p -61.33 -34.13 74.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.969 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.5 m -100.25 -13.65 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.898 0.38 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.34 -57.64 5.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.481 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.93 -71.12 0.51 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.04 -50.07 71.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.663 0.268 . . . . 0.0 110.619 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -49.11 -19.1 0.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.619 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.86 -63.33 4.7 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.2 mm -54.16 -23.85 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.802 0.335 . . . . 0.0 110.414 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 mt -79.16 -31.87 44.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.21 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 m -71.4 -44.79 64.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.17 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -72.65 -14.49 61.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.547 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.411 ' CD2' ' HE1' ' A' ' 48' ' ' TRP . 4.6 tt -67.54 -31.42 71.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.952 0.406 . . . . 0.0 111.132 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.3 p -64.49 -21.55 29.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.925 0.393 . . . . 0.0 111.342 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -63.16 -38.72 92.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -60.78 -43.81 97.6 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.556 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.7 t -45.31 -46.65 12.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.129 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.51 -39.66 24.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.567 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.414 ' O ' ' CG ' ' A' ' 33' ' ' LYS . . . -55.35 -28.12 51.74 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.763 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -64.91 -28.37 69.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.788 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -77.6 -52.17 9.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.346 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.411 ' CG1' ' N ' ' A' ' 33' ' ' LYS . 3.1 pt -65.49 -39.35 84.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.527 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.414 ' CG ' ' O ' ' A' ' 29' ' ' ALA . 16.7 mmmt -59.28 -34.44 72.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.469 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.06 -5.36 71.79 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -87.42 63.13 7.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.736 0.303 . . . . 0.0 110.456 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.38 112.86 10.67 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.041 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.19 174.34 3.76 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.53 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.18 134.84 58.02 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.724 2.283 . . . . 0.0 111.909 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.69 -124.98 1.2 Allowed Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.53 ' C ' ' H ' ' A' ' 42' ' ' TYR . . . -97.31 -5.11 37.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.77 0.319 . . . . 0.0 110.657 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.81 -3.27 0.07 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.959 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.53 ' H ' ' C ' ' A' ' 40' ' ' ALA . 27.9 m-85 -65.94 -41.32 91.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.927 0.394 . . . . 0.0 110.552 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.79 -53.04 62.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.614 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -61.76 -69.65 0.23 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.439 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -59.22 -14.55 11.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.512 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -44.64 -79.87 0.05 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.3 m -123.19 48.09 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.721 0.296 . . . . 0.0 110.664 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.622 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 1.1 t90 -67.56 -41.94 33.78 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.269 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 30.7 Cg_exo -61.5 -27.66 82.44 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.901 2.401 . . . . 0.0 112.131 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 tt -74.61 -27.32 60.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.783 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 tp -95.85 10.05 38.47 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.807 0.337 . . . . 0.0 111.071 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.526 ' C ' ' H ' ' A' ' 54' ' ' LEU . 6.5 tt -78.72 -42.21 28.91 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.074 0.464 . . . . 0.0 111.897 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.55 ' N ' ' CD1' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -48.89 -9.23 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.119 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.526 ' H ' ' C ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -59.14 -54.33 48.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.769 0.319 . . . . 0.0 110.684 -178.075 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.5 tt -68.47 -52.04 36.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.837 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.34 -27.64 68.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.923 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 53' ' ' LEU . 2.8 mp -145.97 98.74 4.39 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.823 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.409 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 50.1 Cg_exo -48.29 -175.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 123.062 2.508 . . . . 0.0 112.554 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 61' ' ' ALA . 51.3 Cg_exo -54.42 -27.28 48.4 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.046 2.497 . . . . 0.0 111.995 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -42.98 -23.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.317 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 59' ' ' PRO . . . . . . . . 0 N--CA 1.463 0.184 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.33 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.454 ' HG2' ' H ' ' A' ' 4' ' ' ASN . 23.4 tt0 . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.454 ' H ' ' HG2' ' A' ' 3' ' ' GLU . 39.6 t30 -87.5 3.53 46.99 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.845 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.2 tp -69.2 -85.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.984 0.421 . . . . 0.0 111.039 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.474 ' O ' ' OD1' ' A' ' 9' ' ' ASN . 95.3 t -40.62 -50.99 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.981 0.42 . . . . 0.0 111.002 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.424 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 0.7 OUTLIER -40.36 -30.14 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.965 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.98 -70.45 0.12 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.121 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.474 ' OD1' ' O ' ' A' ' 6' ' ' VAL . 21.8 p-10 -69.8 -34.78 74.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.616 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.44 -50.24 72.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.396 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 7' ' ' VAL . . . -64.22 -39.4 93.9 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.925 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.0 t -62.66 -47.29 84.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.563 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.3 t -75.03 -45.33 42.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.95 -58.34 7.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.786 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.84 -5.85 84.2 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.79 -37.27 87.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.856 0.36 . . . . 0.0 110.734 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -86.01 14.78 5.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.188 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.68 -51.28 55.26 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.6 mm -67.43 -40.46 84.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.163 0.506 . . . . 0.0 110.178 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.9 mp -67.61 -42.53 82.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.08 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.1 p -64.39 -44.68 90.56 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.625 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -67.31 -25.59 66.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.529 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.2 tp -61.44 -40.49 94.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.479 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.27 -34.97 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.991 0.424 . . . . 0.0 110.097 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -67.52 -46.19 73.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.485 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -56.23 -29.12 60.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.279 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.0 m -57.72 -35.87 71.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.014 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.15 -39.71 86.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.408 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.42 -34.95 26.36 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-O 121.015 0.436 . . . . 0.0 110.355 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.485 ' N ' ' CD1' ' A' ' 30' ' ' TRP . 19.2 m0 -78.09 -35.08 49.82 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.098 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -63.58 -45.99 87.9 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.55 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.4 tt -69.72 -40.84 79.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.545 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -64.24 -46.91 81.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.23 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.25 7.91 63.37 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.603 ' C ' ' H ' ' A' ' 37' ' ' ALA . 10.2 tpt85 -74.19 -19.67 60.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 110.224 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 37' ' ' ALA . 1.9 pp -52.82 -1.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.172 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.603 ' H ' ' C ' ' A' ' 35' ' ' ARG . . . -39.74 164.87 0.06 OUTLIER Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 120.694 0.283 . . . . 0.0 110.459 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -40.95 125.95 2.36 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.407 2.071 . . . . 0.0 111.702 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 168.0 -120.5 0.9 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.58 -13.45 24.38 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.701 0.286 . . . . 0.0 110.726 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.63 -10.09 24.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.619 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -62.97 -37.66 87.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.651 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.5 -43.34 84.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.848 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.407 ' C ' ' N ' ' A' ' 46' ' ' GLY . 71.1 m-85 -63.17 -69.04 0.29 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.648 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -47.21 -20.19 0.17 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.281 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' A' ' 44' ' ' PHE . . . -65.33 -32.6 84.19 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 t -146.56 78.77 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 120.588 0.232 . . . . 0.0 110.677 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.63 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -82.98 -39.9 0.81 Allowed Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.548 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 38.4 Cg_exo -59.58 2.85 0.24 Allowed 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.836 2.357 . . . . 0.0 112.119 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.512 ' H ' ' C ' ' A' ' 48' ' ' TRP . 54.5 tp -69.99 -43.15 72.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.575 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.531 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 3.7 mm? -85.0 -20.75 30.02 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.527 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 tt -67.61 -55.36 13.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.704 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.411 HD21 ' H ' ' A' ' 54' ' ' LEU . 0.9 OUTLIER -73.11 -37.74 66.6 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.964 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.411 ' H ' HD21 ' A' ' 53' ' ' LEU . 50.0 tp -64.57 -45.26 87.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.087 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.88 -34.28 66.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.714 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -46.1 -34.57 4.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.556 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.42 153.92 26.01 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.825 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.35 163.97 32.44 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.59 2.193 . . . . 0.0 112.283 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -47.03 -27.17 5.71 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.706 2.271 . . . . 0.0 112.086 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 83.2 mtt85 -56.9 -72.44 0.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.882 0.372 . . . . 0.0 110.443 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.31 179.822 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.6 mt -72.77 146.3 46.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.536 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -108.4 -166.49 1.13 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.528 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.559 ' C ' ' H ' ' A' ' 6' ' ' VAL . 6.1 m-20 -69.03 -56.64 7.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.558 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.511 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 4.0 mm? -53.0 -6.41 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.561 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.559 ' H ' ' C ' ' A' ' 4' ' ' ASN . 40.1 t -91.44 -51.92 10.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.567 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.6 p -81.45 -23.36 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.529 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -46.66 88.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.556 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.4 ' ND2' ' O ' ' A' ' 5' ' ' LEU . 23.8 m-80 -64.02 -46.7 83.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.567 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.82 -36.87 73.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.566 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.45 -44.06 76.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.563 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.5 p -62.21 -41.75 98.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.556 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.9 t -68.94 -43.37 82.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.55 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.87 -52.47 63.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.575 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.27 -81.63 0.35 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.65 -67.48 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.822 0.344 . . . . 0.0 110.578 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -51.9 -19.42 1.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.632 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.33 -54.01 6.45 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 21.2 pt -68.84 -22.82 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 0.0 110.547 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -69.48 -41.91 75.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.54 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.3 m -63.74 -28.77 70.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.557 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.44 ' O ' ' N ' ' A' ' 25' ' ' PHE . 5.1 m-85 -64.31 -11.47 32.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.572 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.4 tp -41.31 -39.64 1.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.545 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.8 t -71.03 -39.68 75.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.568 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.44 ' N ' ' O ' ' A' ' 22' ' ' PHE . 84.9 t80 -74.82 -27.78 60.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.625 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.58 -42.78 77.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.55 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.0 m -46.2 -42.74 14.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.568 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.69 -36.24 57.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.538 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.412 ' O ' ' CG2' ' A' ' 32' ' ' ILE . . . -58.01 -39.68 78.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.561 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -69.34 -33.7 73.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.553 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -60.81 -22.12 63.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.608 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.548 ' CG2' ' N ' ' A' ' 33' ' ' LYS . 10.6 tp -48.04 -50.06 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.563 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.548 ' N ' ' CG2' ' A' ' 32' ' ' ILE . 4.7 tppt? -64.52 -50.56 66.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.515 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.9 43.13 6.87 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.762 ' O ' ' N ' ' A' ' 37' ' ' ALA . 15.4 ptm180 -145.5 -5.06 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.744 0.306 . . . . 0.0 110.523 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.699 ' C ' ' O ' ' A' ' 35' ' ' ARG . 32.2 tp -6.33 71.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.563 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.762 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -21.1 91.9 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.625 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.532 ' N ' ' O ' ' A' ' 36' ' ' LEU . 48.0 Cg_exo -53.62 150.74 27.11 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.843 2.362 . . . . 0.0 112.169 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.17 -75.51 0.42 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.5 ' C ' ' H ' ' A' ' 42' ' ' TYR . . . -87.77 -72.51 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.763 0.316 . . . . 0.0 110.575 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.12 -13.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.59 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.5 ' H ' ' C ' ' A' ' 40' ' ' ALA . 30.7 t80 -86.62 -49.39 7.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.551 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.35 -36.22 82.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.622 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.545 ' C ' ' H ' ' A' ' 46' ' ' GLY . 4.3 m-85 -44.61 -39.59 5.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.589 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -49.01 -10.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.62 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 44' ' ' PHE . . . -62.78 -35.47 91.99 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.0 m -148.62 23.91 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.85 0.357 . . . . 0.0 110.581 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.627 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -80.79 -42.99 1.25 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.513 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 15.1 Cg_exo -68.01 -15.09 42.77 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.806 2.337 . . . . 0.0 112.181 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.16 -33.96 75.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.521 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 tp -61.71 -7.56 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.611 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.1 mt -62.81 -49.55 74.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.609 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.468 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -85.2 -14.33 47.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.577 -178.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.414 ' CD1' ' C ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -76.96 -58.31 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.578 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.487 ' O ' ' C ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -75.84 -38.72 57.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.616 -178.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 55' ' ' LEU . . . -34.11 -52.47 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.572 -177.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.75 ' CD1' ' N ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -111.57 155.7 42.56 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.548 178.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -78.27 163.44 27.61 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.843 2.362 . . . . 0.0 112.126 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.546 ' C ' ' H ' ' A' ' 61' ' ' ALA . 54.5 Cg_exo -47.93 -42.23 31.72 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.744 2.296 . . . . 0.0 112.121 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -68.16 42.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.621 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.546 ' H ' ' C ' ' A' ' 59' ' ' PRO . . . -124.08 130.75 53.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.602 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -68.63 -3.46 11.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.581 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.551 179.959 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.39 -99.6 0.07 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.441 ' CG ' ' H ' ' A' ' 4' ' ' ASN . 17.4 tp10 -76.99 -138.18 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.745 0.307 . . . . 0.0 110.513 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.441 ' H ' ' CG ' ' A' ' 3' ' ' GLU . 75.0 m-20 -112.08 -35.05 5.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.568 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.475 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 4.1 mm? -48.27 -104.73 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.773 0.32 . . . . 0.0 111.446 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.0 t -44.03 -31.05 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.883 0.373 . . . . 0.0 110.72 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.8 t -62.32 -42.52 95.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.717 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.5 tp -62.21 -43.28 99.18 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.051 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -75.64 -34.88 60.54 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.048 0.451 . . . . 0.0 110.797 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 12' ' ' SER . . . -72.24 -77.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.787 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -43.16 -15.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.342 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -57.74 -38.8 75.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.363 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.3 p -94.85 -37.57 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.562 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.63 -37.78 8.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.609 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.38 -21.6 28.33 Favored Glycine 0 N--CA 1.465 0.588 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.41 -50.59 71.18 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.522 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -101.15 12.41 37.64 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.961 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.78 -48.48 55.14 Favored Glycine 0 N--CA 1.462 0.425 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 8.6 tt -67.49 -34.02 65.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.841 0.353 . . . . 0.0 110.495 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.13 -25.87 47.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.69 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.0 t -59.04 -43.16 91.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.913 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -62.22 -31.27 71.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.916 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tt -48.76 -39.38 24.81 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.391 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.8 p -63.21 -33.24 59.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.91 0.386 . . . . 0.0 110.255 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -63.94 -37.37 87.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.011 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -56.35 -43.85 79.53 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.754 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -44.59 -45.26 9.4 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.506 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.53 -39.24 22.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.843 0.354 . . . . 0.0 110.96 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.7 -36.07 24.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.253 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -59.22 -33.45 71.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.129 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -66.37 -44.9 81.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.542 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.5 mt -59.78 -44.42 93.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.949 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.677 ' C ' ' H ' ' A' ' 35' ' ' ARG . 84.7 tttt -69.32 -60.45 2.33 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.284 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.544 ' C ' ' H ' ' A' ' 36' ' ' LEU . . . 56.47 -12.22 0.01 OUTLIER Glycine 0 CA--C 1.536 1.361 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.677 ' H ' ' C ' ' A' ' 33' ' ' LYS . 2.0 mmp_? -72.19 20.75 0.06 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.026 0.441 . . . . 0.0 110.922 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.544 ' H ' ' C ' ' A' ' 34' ' ' GLY . 46.8 tp -130.97 123.68 29.36 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.067 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.79 159.76 66.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.81 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.587 ' O ' ' N ' ' A' ' 40' ' ' ALA . 36.7 Cg_endo -65.4 -91.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.502 2.135 . . . . 0.0 111.47 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 49.88 -79.31 0.01 OUTLIER Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' A' ' 38' ' ' PRO . . . -68.1 -25.22 65.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.37 . . . . 0.0 110.39 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.43 -10.51 59.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.406 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -64.45 -71.23 0.18 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.367 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -79.18 -77.7 0.17 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.838 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.469 ' C ' ' O ' ' A' ' 43' ' ' ALA . 80.6 t80 -23.17 -89.7 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.622 0.576 . . . . 0.0 111.94 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -52.87 -29.34 27.57 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.257 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -45.29 -14.51 0.06 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.512 ' N ' ' O ' ' A' ' 45' ' ' TYR . 10.5 m -102.25 59.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.976 0.417 . . . . 0.0 110.648 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.493 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -66.79 -56.41 14.41 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.748 179.295 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 48' ' ' TRP . 27.6 Cg_endo -61.44 -16.74 49.34 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.61 2.206 . . . . 0.0 112.36 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.32 -45.51 7.11 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.819 0.342 . . . . 0.0 110.412 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 53' ' ' LEU . 26.9 tp -60.66 -24.34 65.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.467 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -69.36 4.13 1.91 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.557 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.404 ' H ' ' C ' ' A' ' 51' ' ' LEU . 3.2 pp -68.24 -35.69 78.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.041 0.448 . . . . 0.0 110.678 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.2 pp -70.06 -1.26 9.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.871 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.4 -56.5 1.31 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.336 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.02 -19.88 50.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.191 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.0 tp -119.93 65.9 10.4 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.467 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.68 164.11 22.3 Favored 'Trans proline' 0 N--CA 1.501 1.915 0 C-N-CA 122.734 2.289 . . . . 0.0 111.872 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.51 -60.91 0.34 Allowed 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.764 2.309 . . . . 0.0 112.119 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.27 -75.56 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.673 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.75 -177.25 3.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.276 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 62' ' ' TYR . 48.3 p90 -162.91 122.97 2.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.459 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.462 179.996 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.531 ' N ' ' CD2' ' A' ' 2' ' ' LEU . 3.7 mm? -88.09 98.91 11.8 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.361 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.423 ' O ' ' CB ' ' A' ' 4' ' ' ASN . 18.6 pt-20 -124.24 168.9 12.33 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.14 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.606 ' C ' ' H ' ' A' ' 6' ' ' VAL . 55.4 t30 82.16 -123.02 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.612 0.57 . . . . 0.0 110.988 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tp -56.31 7.95 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.606 ' H ' ' C ' ' A' ' 4' ' ' ASN . 5.6 p -67.61 -46.49 82.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.974 0.416 . . . . 0.0 111.068 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.504 ' N ' ' CG1' ' A' ' 6' ' ' VAL . 13.5 p -64.84 -41.12 91.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.965 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.9 tp -46.07 -70.74 0.09 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.191 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -66.43 -46.94 74.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.519 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.51 -47.79 69.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.704 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.37 -42.84 92.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.82 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.4 m -63.44 -44.33 94.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.009 0.433 . . . . 0.0 110.534 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.1 t -68.95 -42.72 82.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.678 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -44.34 -57.04 3.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.594 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.71 -90.45 0.34 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 18' ' ' GLY . . . -59.87 -40.77 89.81 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.709 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -55.14 -3.82 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.75 0.309 . . . . 0.0 110.777 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.553 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -75.15 -51.05 7.85 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.4 tt -45.75 -17.64 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.761 0.315 . . . . 0.0 110.636 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.46 ' H ' ' C ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER -64.74 -42.79 94.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.857 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.9 p -70.6 -41.54 72.16 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.385 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -65.66 -16.59 63.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.684 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.413 ' O ' ' OG ' ' A' ' 27' ' ' SER . 5.6 tp -50.74 -36.19 35.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.514 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.407 ' CG2' ' N ' ' A' ' 25' ' ' PHE . 3.3 m -72.78 -39.82 60.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.914 0.388 . . . . 0.0 110.501 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.407 ' N ' ' CG2' ' A' ' 24' ' ' VAL . 28.5 m-85 -63.57 -45.41 90.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.718 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -67.04 -42.72 84.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 0.0 110.607 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 23' ' ' LEU . 43.6 m -53.8 -43.8 69.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.502 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.34 -40.57 62.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.424 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.91 -51.48 69.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -52.64 -27.23 16.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.603 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.74 -16.83 61.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.662 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.527 ' CG2' ' N ' ' A' ' 33' ' ' LYS . 18.8 tt -53.06 -50.05 47.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.703 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.527 ' N ' ' CG2' ' A' ' 32' ' ' ILE . 3.0 ptpp? -62.54 -46.87 86.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.295 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.96 11.14 47.22 Favored Glycine 0 N--CA 1.464 0.519 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.496 ' C ' ' H ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -79.06 -15.1 58.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.889 0.376 . . . . 0.0 110.312 179.378 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 37' ' ' ALA . 3.4 tp -73.63 13.36 0.49 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.225 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 35' ' ' ARG . . . -47.43 -179.8 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.4 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' A' ' 37' ' ' ALA . 37.2 Cg_exo -59.95 148.17 89.86 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.089 1.859 . . . . 0.0 111.634 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.31 -128.81 2.68 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.2 -10.18 28.71 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.727 0.299 . . . . 0.0 110.941 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.406 ' C ' ' N ' ' A' ' 43' ' ' ALA . . . -82.96 -72.47 0.45 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.057 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -47.1 -20.75 0.18 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.286 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.406 ' N ' ' C ' ' A' ' 41' ' ' ALA . . . -57.67 -88.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.779 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -64.62 -45.35 87.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.206 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.538 ' C ' ' H ' ' A' ' 47' ' ' VAL . 14.3 t80 -59.13 -16.08 17.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.528 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.08 20.36 0.92 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.538 ' H ' ' C ' ' A' ' 45' ' ' TYR . 12.7 p -99.05 71.79 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.104 0.478 . . . . 0.0 110.649 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.608 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 3.0 m0 -100.78 -34.04 0.23 Allowed Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.638 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 57.9 Cg_endo -77.59 -24.8 8.6 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.662 1.574 . . . . 0.0 112.575 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.7 -46.31 38.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.934 0.397 . . . . 0.0 110.441 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.07 -47.14 72.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.3 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.8 mt -52.75 -30.15 31.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.142 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.4 tp -67.21 -44.04 80.55 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' LEU . 55.8 tp -62.45 -44.96 95.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.758 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.0 tp -69.99 -37.76 75.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.811 0.339 . . . . 0.0 110.662 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.07 -30.9 60.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.137 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -155.28 148.03 17.95 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.626 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.432 ' HG3' ' H ' ' A' ' 4' ' ' ASN . 35.1 Cg_endo -65.53 171.66 9.12 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.346 2.031 . . . . 0.0 112.534 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' A' ' 61' ' ' ALA . 31.2 Cg_exo -59.47 -17.12 39.24 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 122.329 2.02 . . . . 0.0 112.163 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.534 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 58.6 mtm180 44.85 -91.15 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.422 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 59' ' ' PRO . . . -19.7 91.06 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.764 0.665 . . . . 0.0 111.961 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.534 ' CD2' ' O ' ' A' ' 60' ' ' ARG . 46.9 m-85 -92.17 85.72 5.55 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.812 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.536 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.348 179.475 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.621 ' N ' ' NH1' ' A' ' 60' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.453 ' C ' ' NH2' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -107.61 86.48 2.31 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.127 -179.656 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -102.24 -165.89 1.23 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.386 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.1 m120 72.82 -60.75 0.52 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.43 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.3 pp -70.66 -29.83 66.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.488 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 10' ' ' ALA . 28.7 m -56.79 -46.22 83.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.64 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.9 t -46.25 -29.69 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.829 0.347 . . . . 0.0 110.541 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.8 tp -94.23 -56.41 2.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.591 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -66.43 -55.61 14.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.434 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 6' ' ' VAL . . . -55.74 -54.26 46.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 110.644 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.15 -41.45 68.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.58 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 t -63.57 -45.49 90.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.542 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.5 t -74.15 -58.03 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.195 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.49 -58.03 9.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.774 0.321 . . . . 0.0 110.91 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.9 -32.45 6.82 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.557 ' C ' ' H ' ' A' ' 18' ' ' GLY . . . -69.91 -57.85 4.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.926 0.393 . . . . 0.0 110.322 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -50.75 -8.03 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.773 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -66.13 -58.06 9.53 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.2 pt -56.0 -24.05 16.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.424 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -72.67 -40.73 66.08 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.3 t -64.8 -43.46 93.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.631 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -78.91 -18.19 54.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.993 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.2 tp -48.9 -34.03 11.93 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.4 t -77.86 -36.64 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.693 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -61.0 -47.36 86.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.169 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -59.52 -26.82 65.64 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.515 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.7 t -51.12 -42.01 60.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.044 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.12 -37.89 53.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.383 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.08 -54.12 50.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.081 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 9.1 m0 -57.01 -23.79 48.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.702 0.287 . . . . 0.0 110.956 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.45 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 41.0 t80 -73.02 -14.99 61.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.688 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 33' ' ' LYS . 15.3 tt -62.09 -44.7 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.216 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.476 ' N ' ' CG2' ' A' ' 32' ' ' ILE . 1.5 tptm -70.84 -56.99 5.08 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.376 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.97 24.63 3.55 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -80.49 60.92 4.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.769 0.318 . . . . 0.0 110.283 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.9 mt -134.41 124.88 26.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.258 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -164.15 168.5 9.28 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.194 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -47.63 106.4 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.092 1.861 . . . . 0.0 112.074 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 133.82 -48.71 0.94 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.69 -60.77 2.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.822 0.344 . . . . 0.0 110.762 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.92 -5.82 14.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.52 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -72.96 -62.22 1.54 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.924 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.68 92.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.183 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.493 ' C ' ' H ' ' A' ' 46' ' ' GLY . 4.5 m-85 -63.1 -83.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.349 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -53.65 -8.76 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.699 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 44' ' ' PHE . . . -65.85 -52.58 36.8 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.7 m -135.7 11.09 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.871 0.367 . . . . 0.0 110.675 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.525 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 13.1 t90 -61.64 -51.76 74.22 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 48' ' ' TRP . 11.1 Cg_endo -51.85 -16.4 4.09 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.807 1.672 . . . . 0.0 112.288 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.8 tp -76.06 -33.6 59.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.979 0.418 . . . . 0.0 110.1 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 72.6 mt -78.18 2.49 17.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.507 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.4 tt -85.21 -32.14 22.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.9 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.436 ' N ' ' CD1' ' A' ' 53' ' ' LEU . 10.2 mp -63.6 -32.43 73.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.389 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.3 tp -54.91 -46.0 74.82 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 tt -62.78 -40.08 96.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.855 0.359 . . . . 0.0 110.257 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.02 -11.44 59.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.698 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.7 mt -134.58 66.94 71.03 Favored Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.361 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.543 ' O ' ' N ' ' A' ' 60' ' ' ARG . 59.6 Cg_endo -77.74 163.63 28.78 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.709 2.273 . . . . 0.0 112.335 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -43.67 -11.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.698 2.265 . . . . 0.0 112.588 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.621 ' NH1' ' N ' ' A' ' 1' ' ' ALA . 9.3 tmm_? -70.68 -60.22 2.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.373 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.28 166.5 14.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.291 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -153.68 136.99 15.73 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.034 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.405 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.543 179.941 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.519 ' H2 ' ' H ' ' A' ' 62' ' ' TYR . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' A' ' 2' ' ' LEU . 9.3 mp -75.8 169.53 17.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.405 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -41.13 108.03 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.58 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -105.9 38.12 2.09 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.872 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.3 tp -112.52 -70.86 0.78 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.381 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.432 ' CG1' ' N ' ' A' ' 7' ' ' VAL . 11.5 p -60.34 -47.33 92.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.428 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.432 ' N ' ' CG1' ' A' ' 6' ' ' VAL . 12.7 p -64.64 -40.96 90.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.462 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.5 tp -61.71 -44.74 96.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.409 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -63.95 -45.67 88.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.95 0.405 . . . . 0.0 110.577 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.94 -26.49 64.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.343 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.64 -17.81 59.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.554 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.6 t -64.38 -50.97 65.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.318 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.5 p -91.79 -21.0 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.181 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.16 -77.84 0.44 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.592 0.234 . . . . 0.0 110.995 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.04 -164.5 0.74 Allowed Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.245 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 18' ' ' GLY . . . -90.94 -1.78 57.79 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -41.66 -19.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.139 -0.225 . . . . 0.0 111.299 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -67.37 -49.6 50.53 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 15.1 tt -49.24 -28.26 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.83 0.348 . . . . 0.0 110.679 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.442 ' C ' ' CD1' ' A' ' 20' ' ' LEU . 3.2 tm? -65.97 -45.02 83.21 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.496 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.8 m -59.65 -43.76 93.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.779 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -61.69 -39.82 92.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.666 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.32 -39.23 89.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.816 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.1 t -68.18 -42.85 85.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.007 0.432 . . . . 0.0 110.036 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -63.12 -44.24 96.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.59 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.62 -41.8 99.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.182 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.0 m -54.35 -41.47 69.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.343 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.69 -43.06 39.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.494 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.5 -38.39 89.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.411 ' C ' ' N ' ' A' ' 32' ' ' ILE . 58.0 t-105 -59.89 -30.39 68.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.148 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -52.03 -15.04 0.48 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.138 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.411 ' N ' ' C ' ' A' ' 30' ' ' TRP . 3.5 tp -67.65 -19.28 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.504 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.664 ' C ' ' H ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -42.15 -58.01 2.29 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 58.47 -14.75 0.02 OUTLIER Glycine 0 CA--C 1.534 1.274 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.021 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.664 ' H ' ' C ' ' A' ' 33' ' ' LYS . 85.0 mtm-85 -128.36 70.35 1.37 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.038 0.419 . . . . 0.0 111.097 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.61 118.97 5.57 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.91 158.13 73.11 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-O 120.766 0.317 . . . . 0.0 110.484 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -63.88 -177.89 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.533 2.155 . . . . 0.0 111.783 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.91 -72.42 0.35 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.537 ' C ' ' H ' ' A' ' 42' ' ' TYR . . . -56.72 -34.94 67.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.766 0.317 . . . . 0.0 110.665 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.47 21.19 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.82 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.537 ' H ' ' C ' ' A' ' 40' ' ' ALA . 81.3 t80 -56.52 -42.96 79.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.443 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.14 -42.2 90.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.325 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -55.67 -47.62 76.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.792 0.329 . . . . 0.0 110.338 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.432 ' O ' ' O ' ' A' ' 46' ' ' GLY . 31.4 m-85 -75.98 -35.64 59.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.28 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 45' ' ' TYR . . . -42.26 -97.99 0.01 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -144.46 36.24 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.702 0.287 . . . . 0.0 111.074 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.536 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 20.2 t-105 -60.95 -46.59 96.74 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.877 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 48' ' ' TRP . 30.4 Cg_endo -61.99 -13.65 32.57 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 121.765 1.643 . . . . 0.0 112.522 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.7 tp -77.33 -38.8 49.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.752 0.311 . . . . 0.0 110.922 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.461 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 4.0 mm? -62.44 -40.18 95.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.579 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.0 mt -49.06 -19.04 0.37 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.442 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.0 tt -66.44 -43.43 85.65 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.299 0.571 . . . . 0.0 110.062 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.5 mt -74.05 -19.15 60.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.403 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.2 mp -93.99 -41.94 9.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.937 0.399 . . . . 0.0 110.233 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.3 -34.06 75.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.79 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.3 mp -110.79 95.27 22.96 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -47.08 175.37 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.457 2.105 . . . . 0.0 112.266 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.77 -38.85 78.23 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.399 2.066 . . . . 0.0 112.392 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -50.67 72.06 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.0 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.08 159.23 15.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.639 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.519 ' H ' ' H2 ' ' A' ' 1' ' ' ALA . 69.9 t80 -169.3 154.04 5.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.391 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.047 -0.977 . . . . 0.0 110.396 179.741 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.502 ' C ' ' H ' ' A' ' 4' ' ' ASN . 0.3 OUTLIER -102.21 15.75 28.19 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.511 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.542 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 8.5 pm0 -74.48 25.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.835 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.502 ' H ' ' C ' ' A' ' 2' ' ' LEU . 0.4 OUTLIER -111.23 -46.42 3.3 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.861 -179.544 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.5 mt -78.3 -48.61 15.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.148 0.499 . . . . 0.0 110.633 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.415 ' CG1' ' N ' ' A' ' 7' ' ' VAL . 13.1 p -64.23 -44.08 97.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.552 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.415 ' N ' ' CG1' ' A' ' 6' ' ' VAL . 55.9 t -62.06 -50.02 81.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.825 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.437 ' O ' ' OG ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -65.97 -42.67 89.57 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.035 -179.528 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -60.92 -44.2 97.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.401 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 12' ' ' SER . . . -78.5 -68.31 0.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -41.22 -25.84 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.109 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 8' ' ' LEU . 3.1 m -60.85 -43.83 97.79 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.538 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.3 t -96.18 -34.64 5.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.852 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.73 -46.81 67.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.253 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.73 -11.04 23.29 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.89 -43.06 94.99 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.049 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -101.07 10.41 41.03 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.902 0.382 . . . . 0.0 110.336 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.29 -52.58 45.95 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.5 tp -66.28 -31.55 54.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.782 0.325 . . . . 0.0 110.774 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.6 mt -70.37 -39.11 74.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.231 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.1 t -62.26 -43.06 99.68 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.795 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -64.46 -35.45 80.97 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.474 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.8 tp -58.8 -36.53 74.61 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.396 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.441 ' O ' ' OG ' ' A' ' 27' ' ' SER . 38.8 t -76.82 -45.16 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.023 0.439 . . . . 0.0 110.413 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -66.41 -43.28 86.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.949 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -67.02 -24.55 66.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.971 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 24' ' ' VAL . 53.5 p -57.22 -32.77 66.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.915 0.388 . . . . 0.0 110.151 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.04 -28.91 70.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.42 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.96 -47.91 70.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.716 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -56.37 -37.8 70.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.831 0.348 . . . . 0.0 110.626 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -68.37 -44.38 75.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.534 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.77 -44.25 99.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.728 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -62.53 -43.92 97.62 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.467 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.55 74.57 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.86 -5.02 48.97 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.991 0.424 . . . . 0.0 110.175 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.01 158.45 28.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.636 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -167.82 174.46 2.35 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.481 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.86 139.45 90.37 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.198 1.932 . . . . 0.0 111.682 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.93 -99.27 0.29 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.46 -39.16 88.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.657 0.265 . . . . 0.0 110.95 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 44' ' ' PHE . . . -47.79 -85.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.723 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.438 ' C ' ' O ' ' A' ' 41' ' ' ALA . 72.3 m-85 -30.05 -44.06 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.749 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.13 -47.07 69.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.838 0.351 . . . . 0.0 110.824 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 41' ' ' ALA . 84.1 t80 -87.99 -70.47 0.63 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.27 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.47 ' O ' ' N ' ' A' ' 47' ' ' VAL . 3.5 m-85 -48.94 -39.95 28.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.7 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -41.12 -24.58 0.1 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 45' ' ' TYR . 42.8 t -81.45 76.11 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.923 0.392 . . . . 0.0 110.38 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.596 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -98.67 -39.32 0.24 Allowed Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.707 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 51.5 Cg_exo -53.19 -55.51 3.6 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.088 1.859 . . . . 0.0 112.213 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.445 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 10.1 mp -67.44 -29.54 69.04 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.998 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -44.69 95.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.92 0.39 . . . . 0.0 110.421 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.74 -33.03 53.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.202 0.525 . . . . 0.0 110.406 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.453 ' C ' ' H ' ' A' ' 55' ' ' LEU . 12.5 tp -66.54 -64.17 0.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.388 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.7 tp -53.9 -9.99 0.28 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.592 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -75.73 -73.3 0.27 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.791 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.95 3.15 52.2 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.627 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -127.45 81.12 70.71 Favored Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -75.99 165.07 30.51 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.378 2.052 . . . . 0.0 112.055 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -43.33 -35.81 5.83 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.361 2.04 . . . . 0.0 111.875 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.9 mtt-85 -49.03 -42.52 38.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.359 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.81 170.23 8.29 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.756 0.312 . . . . 0.0 110.432 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -83.11 -89.57 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.608 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.461 179.922 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.463 ' C ' ' H ' ' A' ' 4' ' ' ASN . 39.3 mt -65.25 -28.17 69.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.061 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -60.6 -3.49 0.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.522 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.463 ' H ' ' C ' ' A' ' 2' ' ' LEU . 9.8 m120 -115.04 -3.38 12.62 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.763 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.8 mp -106.82 -73.53 0.68 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.633 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.3 p -46.48 -33.89 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.907 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 11' ' ' ALA . 13.0 m -67.04 -41.11 86.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.759 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.99 -53.42 57.43 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.671 -0.412 . . . . 0.0 109.916 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -63.24 -45.11 93.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.311 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.75 -34.03 77.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.262 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -64.21 -37.44 87.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.454 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.9 t -49.56 -30.72 9.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.267 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.7 t -89.73 -50.16 13.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.454 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.1 -50.66 67.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.748 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 116.42 -2.74 20.35 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.959 -0.857 . . . . 0.0 110.959 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.548 ' C ' ' H ' ' A' ' 18' ' ' GLY . . . -61.1 -110.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.336 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.587 ' HE2' ' CA ' ' A' ' 58' ' ' PRO . 46.8 m80 -44.79 -13.12 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.813 0.34 . . . . 0.0 111.031 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.548 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -68.33 -45.51 69.09 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.1 tt -47.1 -24.22 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.371 . . . . 0.0 110.448 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.446 ' C ' ' CD1' ' A' ' 20' ' ' LEU . 3.0 tm? -64.73 -44.53 89.85 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.043 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.9 t -51.79 -42.86 62.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.439 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -64.17 -47.0 81.52 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.315 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.83 -46.07 74.56 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -177.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.1 p -69.21 -40.26 80.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.67 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -65.65 -38.58 89.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.34 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -75.79 -48.83 20.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.721 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.4 m -56.75 -42.07 78.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.389 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.66 -39.6 80.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.178 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.62 -40.07 90.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.565 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 9.7 t-105 -49.84 -32.34 14.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.968 0.413 . . . . 0.0 110.105 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -58.93 -26.22 64.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.198 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.2 tt -64.43 -33.78 65.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.938 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -68.92 -54.7 14.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.469 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.96 11.44 18.71 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 50.3 ttm-85 -76.88 -15.25 59.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.848 0.356 . . . . 0.0 110.575 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.4 tp -70.32 49.67 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.437 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.32 162.22 73.77 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.186 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.29 171.09 13.34 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.793 2.328 . . . . 0.0 111.796 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.83 -88.33 0.5 Allowed Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.23 -47.17 11.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 110.819 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.36 3.21 11.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.62 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -89.41 -45.59 9.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.607 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 45' ' ' TYR . . . -64.82 -74.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.174 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 46' ' ' GLY . 17.3 m-85 -65.34 6.1 0.33 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.686 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.519 ' H ' ' C ' ' A' ' 43' ' ' ALA . 58.5 t80 -40.95 -24.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.925 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 44' ' ' PHE . . . -92.36 31.26 6.16 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.433 ' N ' ' O ' ' A' ' 44' ' ' PHE . 7.4 p -110.93 -24.94 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 120.895 0.379 . . . . 0.0 110.581 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.639 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 19.0 p-90 -83.2 -29.5 0.45 Allowed Pre-proline 0 CA--C 1.549 0.92 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.702 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 60.4 Cg_endo -87.38 -19.32 2.41 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.951 2.434 . . . . 0.0 112.682 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.5 tp -77.1 -48.97 16.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.98 0.419 . . . . 0.0 110.663 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.6 mt -67.73 -2.21 6.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.323 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.9 tt -65.75 -39.01 90.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.8 mt -94.58 -48.2 6.2 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.805 0.336 . . . . 0.0 111.071 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.8 tp -41.8 -59.61 1.63 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.077 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.495 ' C ' ' H ' ' A' ' 57' ' ' LEU . 10.5 mp -62.01 -41.4 98.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.52 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.82 1.0 0.45 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.429 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.495 ' H ' ' C ' ' A' ' 55' ' ' LEU . 64.5 mt -130.79 146.65 62.89 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.656 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.587 ' CA ' ' HE2' ' A' ' 17' ' ' HIS . 38.9 Cg_endo -67.86 138.65 45.23 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.456 2.104 . . . . 0.0 112.45 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -45.06 -20.68 0.44 Allowed 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.351 2.034 . . . . 0.0 112.021 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 72.8 ttt-85 -63.63 -44.1 94.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.273 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.98 -169.31 1.75 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.569 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -168.46 155.83 7.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.489 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.522 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.92 179.884 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.511 ' N ' ' CD2' ' A' ' 2' ' ' LEU . 3.7 mm? -76.06 145.88 39.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.204 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.413 ' HA ' HH22 ' A' ' 60' ' ' ARG . 33.8 tt0 -67.58 -12.93 61.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.573 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -100.59 -64.88 1.01 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.431 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 53.8 mt -49.12 -33.41 11.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.681 0.277 . . . . 0.0 111.284 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' A' ' 7' ' ' VAL . 14.8 p -62.22 -48.42 88.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.739 0.304 . . . . 0.0 110.806 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.463 ' N ' ' CG1' ' A' ' 6' ' ' VAL . 7.2 p -85.62 -29.86 6.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.99 0.424 . . . . 0.0 111.288 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.414 ' O ' ' OG ' ' A' ' 12' ' ' SER . 3.0 tt -58.32 -74.24 0.06 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.257 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.426 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 28.5 m120 -57.26 -26.62 61.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.498 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.41 -82.3 0.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.848 0.356 . . . . 0.0 111.294 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . -53.42 -62.45 1.65 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.024 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 8' ' ' LEU . 1.4 m -38.24 -48.46 1.29 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.743 0.306 . . . . 0.0 110.819 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 9' ' ' ASN . 78.3 t -65.3 -42.73 94.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.945 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . -63.43 -19.26 64.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.537 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 16' ' ' ALA . . . 106.27 -28.79 12.46 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.618 ' C ' ' H ' ' A' ' 18' ' ' GLY . . . -50.79 -98.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.427 ' H ' ' HB3' ' A' ' 11' ' ' ALA . 68.3 t60 -47.48 -5.12 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.618 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -66.49 -51.92 38.92 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.1 tt -68.84 -31.77 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.678 0.275 . . . . 0.0 111.245 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.49 -42.35 87.54 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.449 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.4 m -65.83 -35.96 82.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.128 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -76.44 -21.63 55.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.762 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.1 tp -63.28 -40.76 98.29 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.652 0.263 . . . . 0.0 111.326 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.406 ' O ' ' OG ' ' A' ' 27' ' ' SER . 2.0 p -70.19 -28.81 37.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.166 0.508 . . . . 0.0 109.965 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -71.34 -41.02 70.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.604 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.5 ' O ' ' N ' ' A' ' 29' ' ' ALA . 16.2 t80 -65.85 -38.34 88.61 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.554 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 24' ' ' VAL . 85.3 p -45.62 -39.1 7.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.18 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.83 -29.03 70.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.144 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . -57.49 -38.13 74.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.642 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.432 ' CD1' ' N ' ' A' ' 30' ' ' TRP . 40.3 m0 -57.2 -41.0 78.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.495 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -65.01 -44.02 90.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.42 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.1 mt -66.57 -43.5 90.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.935 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -70.7 -54.31 12.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.838 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.34 28.2 68.38 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -100.06 9.88 42.16 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.729 0.3 . . . . 0.0 110.65 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.7 mt -110.07 173.65 6.23 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.64 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.561 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -157.08 173.26 5.16 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.312 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.42 72.83 0.02 OUTLIER 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 122.71 2.273 . . . . 0.0 112.28 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . -112.86 -129.76 5.19 Favored Glycine 0 N--CA 1.466 0.695 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.0 -40.2 14.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.697 0.284 . . . . 0.0 110.76 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.69 -10.32 59.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.803 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.22 -51.53 6.22 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.804 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.2 -49.21 78.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.18 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.465 ' O ' ' N ' ' A' ' 46' ' ' GLY . 62.0 t80 -62.43 -44.67 95.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.155 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.446 ' CD1' ' C ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -40.82 -25.24 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.269 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 44' ' ' PHE . . . -62.65 -62.58 5.41 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.112 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.2 p -83.5 10.66 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.897 0.349 . . . . 0.0 111.63 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.554 ' C ' ' H ' ' A' ' 50' ' ' LEU . 1.3 t90 -44.08 -44.67 18.08 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.225 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 32.0 Cg_exo -57.98 13.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.509 2.383 0 C-N-CA 122.533 2.156 . . . . 0.0 113.336 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.554 ' H ' ' C ' ' A' ' 48' ' ' TRP . 3.9 tt -104.0 -50.47 3.37 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.082 0.468 . . . . 0.0 110.125 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.1 tp -60.41 -38.91 85.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.463 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.493 ' CD2' ' N ' ' A' ' 52' ' ' LEU . 3.9 mm? -59.33 -73.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.436 ' N ' ' CD1' ' A' ' 53' ' ' LEU . 9.7 mp -46.37 -33.04 3.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.783 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.1 tp -63.29 -69.56 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.876 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.3 mt -68.31 -39.37 82.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.717 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.94 -16.48 6.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.789 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 43.2 mt -123.99 90.36 50.77 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.474 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.63 -178.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.072 0 C-N-CA 123.069 2.513 . . . . 0.0 112.724 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.58 ' C ' ' H ' ' A' ' 61' ' ' ALA . 32.0 Cg_exo -57.32 -39.65 88.08 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.941 2.427 . . . . 0.0 112.501 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.413 HH22 ' HA ' ' A' ' 3' ' ' GLU . 4.7 ptm180 -63.79 8.42 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.58 ' H ' ' C ' ' A' ' 59' ' ' PRO . . . -77.34 95.62 4.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.257 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -92.87 -31.62 14.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.487 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.481 179.989 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.478 ' CD1' ' N ' ' A' ' 2' ' ' LEU . 9.4 mp -74.63 142.72 44.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.446 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.493 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 58.6 mp0 -72.73 -2.96 22.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.534 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -65.28 -144.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.74 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.498 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 3.8 mm? -82.91 -8.24 59.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.351 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 70.5 t -60.42 -46.27 95.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.093 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.407 HG23 ' H ' ' A' ' 8' ' ' LEU . 2.2 m -64.12 -47.56 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.293 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.407 ' H ' HG23 ' A' ' 7' ' ' VAL . 58.5 tp -61.52 -43.84 98.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.111 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.444 ' O ' ' OG ' ' A' ' 12' ' ' SER . 20.5 m120 -60.96 -46.39 90.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.285 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.95 -37.43 72.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.424 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.99 -36.18 83.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.974 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 9' ' ' ASN . 58.9 p -61.33 -34.13 74.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.969 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.5 m -100.25 -13.65 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.898 0.38 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.34 -57.64 5.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.481 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.93 -71.12 0.51 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.04 -50.07 71.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.663 0.268 . . . . 0.0 110.619 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -49.11 -19.1 0.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.619 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.86 -63.33 4.7 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.2 mm -54.16 -23.85 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.802 0.335 . . . . 0.0 110.414 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 mt -79.16 -31.87 44.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.21 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 m -71.4 -44.79 64.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.17 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -72.65 -14.49 61.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.547 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.411 ' CD2' ' HE1' ' A' ' 48' ' ' TRP . 4.6 tt -67.54 -31.42 71.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.952 0.406 . . . . 0.0 111.132 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.3 p -64.49 -21.55 29.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.925 0.393 . . . . 0.0 111.342 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -63.16 -38.72 92.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -60.78 -43.81 97.6 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.556 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.7 t -45.31 -46.65 12.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.129 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.51 -39.66 24.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.567 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.414 ' O ' ' CG ' ' A' ' 33' ' ' LYS . . . -55.35 -28.12 51.74 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.763 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -64.91 -28.37 69.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.788 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -77.6 -52.17 9.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.346 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.411 ' CG1' ' N ' ' A' ' 33' ' ' LYS . 3.1 pt -65.49 -39.35 84.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.527 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.414 ' CG ' ' O ' ' A' ' 29' ' ' ALA . 16.7 mmmt -59.28 -34.44 72.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.469 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.06 -5.36 71.79 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -87.42 63.13 7.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.736 0.303 . . . . 0.0 110.456 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.38 112.86 10.67 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.041 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.19 174.34 3.76 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.53 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.18 134.84 58.02 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.724 2.283 . . . . 0.0 111.909 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.69 -124.98 1.2 Allowed Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.53 ' C ' ' H ' ' A' ' 42' ' ' TYR . . . -97.31 -5.11 37.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.77 0.319 . . . . 0.0 110.657 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.81 -3.27 0.07 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.959 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.53 ' H ' ' C ' ' A' ' 40' ' ' ALA . 27.9 m-85 -65.94 -41.32 91.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.927 0.394 . . . . 0.0 110.552 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.79 -53.04 62.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.614 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -61.76 -69.65 0.23 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.439 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -59.22 -14.55 11.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.512 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -44.64 -79.87 0.05 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.3 m -123.19 48.09 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.721 0.296 . . . . 0.0 110.664 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.622 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 1.1 t90 -67.56 -41.94 33.78 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.269 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 30.7 Cg_exo -61.5 -27.66 82.44 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.901 2.401 . . . . 0.0 112.131 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 tt -74.61 -27.32 60.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.783 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 tp -95.85 10.05 38.47 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.807 0.337 . . . . 0.0 111.071 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.526 ' C ' ' H ' ' A' ' 54' ' ' LEU . 6.5 tt -78.72 -42.21 28.91 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.074 0.464 . . . . 0.0 111.897 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.55 ' N ' ' CD1' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -48.89 -9.23 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.119 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.526 ' H ' ' C ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -59.14 -54.33 48.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.769 0.319 . . . . 0.0 110.684 -178.075 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.5 tt -68.47 -52.04 36.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.837 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.34 -27.64 68.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.923 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 53' ' ' LEU . 2.8 mp -145.97 98.74 4.39 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.823 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.409 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 50.1 Cg_exo -48.29 -175.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 123.062 2.508 . . . . 0.0 112.554 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 61' ' ' ALA . 51.3 Cg_exo -54.42 -27.28 48.4 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.046 2.497 . . . . 0.0 111.995 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -42.98 -23.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.317 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 59' ' ' PRO . . . -107.02 176.44 5.17 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.33 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -161.19 30.76 0.14 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.496 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.586 -179.946 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 64.9 mt -98.34 126.45 43.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.977 0.418 . . . . 0.0 110.287 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.454 ' HG2' ' H ' ' A' ' 4' ' ' ASN . 23.4 tt0 -90.6 -141.43 0.16 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.454 ' H ' ' HG2' ' A' ' 3' ' ' GLU . 39.6 t30 -87.5 3.53 46.99 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.845 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.2 tp -69.2 -85.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.984 0.421 . . . . 0.0 111.039 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.474 ' O ' ' OD1' ' A' ' 9' ' ' ASN . 95.3 t -40.62 -50.99 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.981 0.42 . . . . 0.0 111.002 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.424 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 0.7 OUTLIER -40.36 -30.14 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.965 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.98 -70.45 0.12 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.121 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.474 ' OD1' ' O ' ' A' ' 6' ' ' VAL . 21.8 p-10 -69.8 -34.78 74.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.616 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.44 -50.24 72.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.396 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 7' ' ' VAL . . . -64.22 -39.4 93.9 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.925 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.0 t -62.66 -47.29 84.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.563 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.3 t -75.03 -45.33 42.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.95 -58.34 7.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.786 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.84 -5.85 84.2 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.79 -37.27 87.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.856 0.36 . . . . 0.0 110.734 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -86.01 14.78 5.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.188 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.68 -51.28 55.26 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.6 mm -67.43 -40.46 84.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.163 0.506 . . . . 0.0 110.178 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.9 mp -67.61 -42.53 82.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.08 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.1 p -64.39 -44.68 90.56 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.625 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -67.31 -25.59 66.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.529 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.2 tp -61.44 -40.49 94.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.479 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.27 -34.97 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.991 0.424 . . . . 0.0 110.097 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -67.52 -46.19 73.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.485 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -56.23 -29.12 60.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.279 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.0 m -57.72 -35.87 71.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.014 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.15 -39.71 86.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.408 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.42 -34.95 26.36 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-O 121.015 0.436 . . . . 0.0 110.355 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.485 ' N ' ' CD1' ' A' ' 30' ' ' TRP . 19.2 m0 -78.09 -35.08 49.82 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.098 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -63.58 -45.99 87.9 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.55 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.4 tt -69.72 -40.84 79.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.545 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -64.24 -46.91 81.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.23 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.25 7.91 63.37 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.603 ' C ' ' H ' ' A' ' 37' ' ' ALA . 10.2 tpt85 -74.19 -19.67 60.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 110.224 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 37' ' ' ALA . 1.9 pp -52.82 -1.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.172 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.603 ' H ' ' C ' ' A' ' 35' ' ' ARG . . . -39.74 164.87 0.06 OUTLIER Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 120.694 0.283 . . . . 0.0 110.459 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -40.95 125.95 2.36 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.407 2.071 . . . . 0.0 111.702 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 168.0 -120.5 0.9 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.58 -13.45 24.38 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.701 0.286 . . . . 0.0 110.726 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.63 -10.09 24.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.619 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -62.97 -37.66 87.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.651 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.5 -43.34 84.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.848 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.407 ' C ' ' N ' ' A' ' 46' ' ' GLY . 71.1 m-85 -63.17 -69.04 0.29 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.648 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -47.21 -20.19 0.17 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.281 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' A' ' 44' ' ' PHE . . . -65.33 -32.6 84.19 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 t -146.56 78.77 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 120.588 0.232 . . . . 0.0 110.677 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.63 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -82.98 -39.9 0.81 Allowed Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.548 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 38.4 Cg_exo -59.58 2.85 0.24 Allowed 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.836 2.357 . . . . 0.0 112.119 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.512 ' H ' ' C ' ' A' ' 48' ' ' TRP . 54.5 tp -69.99 -43.15 72.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.575 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.531 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 3.7 mm? -85.0 -20.75 30.02 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.527 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.9 tt -67.61 -55.36 13.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.704 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.411 HD21 ' H ' ' A' ' 54' ' ' LEU . 0.9 OUTLIER -73.11 -37.74 66.6 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.964 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.411 ' H ' HD21 ' A' ' 53' ' ' LEU . 50.0 tp -64.57 -45.26 87.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.087 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.88 -34.28 66.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.714 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -46.1 -34.57 4.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.556 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.42 153.92 26.01 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.825 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.35 163.97 32.44 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.59 2.193 . . . . 0.0 112.283 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -47.03 -27.17 5.71 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.706 2.271 . . . . 0.0 112.086 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 83.2 mtt85 -56.9 -72.44 0.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.882 0.372 . . . . 0.0 110.443 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.03 -175.94 1.04 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.31 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -161.61 129.14 4.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.533 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.657 179.964 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 . . . . . 0 N--CA 1.457 -0.075 0 CA-C-O 120.834 0.35 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.511 ' C ' ' H ' ' A' ' 6' ' ' VAL . 6.1 m-20 -69.03 -56.64 7.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.558 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.585 ' N ' HD22 ' A' ' 5' ' ' LEU . 4.0 mm? -53.0 -6.41 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.561 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 4' ' ' ASN . 40.1 t -91.44 -51.92 10.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.567 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 13.6 p -81.45 -23.36 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.529 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.614 ' O ' HD13 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -61.98 -46.66 88.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.556 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.4 ' ND2' ' O ' ' A' ' 5' ' ' LEU . 23.8 m-80 -64.02 -46.7 83.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.567 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.82 -36.87 73.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.566 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 7' ' ' VAL . . . -55.45 -44.06 76.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.563 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.5 p -62.21 -41.75 98.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.556 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.9 t -68.94 -43.37 82.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.55 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.87 -52.47 63.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.575 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.27 -81.63 0.35 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.65 -67.48 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.822 0.344 . . . . 0.0 110.578 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -51.9 -19.42 1.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.632 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.33 -54.01 6.45 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 21.2 pt -68.84 -22.82 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 0.0 110.547 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.451 ' HA ' HD13 ' A' ' 20' ' ' LEU . 1.7 mm? -69.48 -41.91 75.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.54 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.3 m -63.74 -28.77 70.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.557 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.44 ' O ' ' N ' ' A' ' 25' ' ' PHE . 5.1 m-85 -64.31 -11.47 32.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.572 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.619 HD11 ' CZ3' ' A' ' 48' ' ' TRP . 61.4 tp -41.31 -39.64 1.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.545 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.557 HG22 HD21 ' A' ' 52' ' ' LEU . 8.8 t -71.03 -39.68 75.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.568 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.44 ' N ' ' O ' ' A' ' 22' ' ' PHE . 84.9 t80 -74.82 -27.78 60.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.625 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.58 -42.78 77.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.55 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.0 m -46.2 -42.74 14.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.568 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.69 -36.24 57.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.538 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.584 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -58.01 -39.68 78.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.561 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -69.34 -33.7 73.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.553 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -60.81 -22.12 63.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.608 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.674 HG23 ' N ' ' A' ' 33' ' ' LYS . 10.6 tp -48.04 -50.06 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.563 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.674 ' N ' HG23 ' A' ' 32' ' ' ILE . 4.7 tppt? -64.52 -50.56 66.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.515 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.9 43.13 6.87 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.762 ' O ' ' N ' ' A' ' 37' ' ' ALA . 15.4 ptm180 -145.5 -5.06 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.744 0.306 . . . . 0.0 110.523 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.699 ' C ' ' O ' ' A' ' 35' ' ' ARG . 32.2 tp -6.33 71.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.563 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.762 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -21.1 91.9 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.625 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.532 ' N ' ' O ' ' A' ' 36' ' ' LEU . 48.0 Cg_exo -53.62 150.74 27.11 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.843 2.362 . . . . 0.0 112.169 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.17 -75.51 0.42 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.48 ' C ' ' N ' ' A' ' 42' ' ' TYR . . . -87.77 -72.51 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.763 0.316 . . . . 0.0 110.575 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.12 -13.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.59 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.48 ' N ' ' C ' ' A' ' 40' ' ' ALA . 30.7 t80 -86.62 -49.39 7.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.551 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.35 -36.22 82.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.622 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.5 ' C ' ' H ' ' A' ' 46' ' ' GLY . 4.3 m-85 -44.61 -39.59 5.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.589 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -49.01 -10.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.62 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 44' ' ' PHE . . . -62.78 -35.47 91.99 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.0 m -148.62 23.91 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.85 0.357 . . . . 0.0 110.581 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.627 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -80.79 -42.99 1.25 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.513 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 15.1 Cg_exo -68.01 -15.09 42.77 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.806 2.337 . . . . 0.0 112.181 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.461 ' O ' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -62.16 -33.96 75.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.521 -179.038 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 tp -61.71 -7.56 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.611 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.702 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 55.1 mt -62.81 -49.55 74.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.609 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -85.2 -14.33 47.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.577 -178.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.525 ' O ' HD13 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -76.96 -58.31 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.578 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.613 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -75.84 -38.72 57.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.616 -178.798 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.755 ' HB3' HD13 ' A' ' 57' ' ' LEU . . . -34.11 -52.47 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.572 -177.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.046 HD13 ' N ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -111.57 155.7 42.56 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.548 178.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -78.27 163.44 27.61 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.843 2.362 . . . . 0.0 112.126 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.506 ' C ' ' H ' ' A' ' 61' ' ' ALA . 54.5 Cg_exo -47.93 -42.23 31.72 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.744 2.296 . . . . 0.0 112.121 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -68.16 42.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.621 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 59' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.602 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.551 ' O ' HG21 ' A' ' 7' ' ' VAL . 17.4 tp10 . . . . . 0 CA--C 1.528 0.099 0 CA-C-O 120.745 0.307 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.439 ' O ' ' O ' ' A' ' 5' ' ' LEU . 75.0 m-20 -112.08 -35.05 5.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.568 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 5' ' ' LEU . 4.1 mm? -48.27 -104.73 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.773 0.32 . . . . 0.0 111.446 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.0 t -44.03 -31.05 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.883 0.373 . . . . 0.0 110.72 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.551 HG21 ' O ' ' A' ' 3' ' ' GLU . 94.8 t -62.32 -42.52 95.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.717 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.5 tp -62.21 -43.28 99.18 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.051 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -75.64 -34.88 60.54 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.048 0.451 . . . . 0.0 110.797 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 12' ' ' SER . . . -72.24 -77.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.787 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -43.16 -15.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.342 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -57.74 -38.8 75.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.363 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.3 p -94.85 -37.57 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.562 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.63 -37.78 8.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.609 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.38 -21.6 28.33 Favored Glycine 0 N--CA 1.465 0.588 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.41 -50.59 71.18 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.522 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -101.15 12.41 37.64 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.961 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.78 -48.48 55.14 Favored Glycine 0 N--CA 1.462 0.425 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.642 HG23 ' CD2' ' A' ' 20' ' ' LEU . 8.6 tt -67.49 -34.02 65.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.841 0.353 . . . . 0.0 110.495 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.656 HD12 HD13 ' A' ' 54' ' ' LEU . 4.5 mm? -78.13 -25.87 47.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.69 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.507 ' O ' HG12 ' A' ' 24' ' ' VAL . 48.0 t -59.04 -43.16 91.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.913 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -62.22 -31.27 71.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.916 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.577 HD23 ' O ' ' A' ' 23' ' ' LEU . 1.1 tt -48.76 -39.38 24.81 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.391 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 21' ' ' SER . 1.8 p -63.21 -33.24 59.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.91 0.386 . . . . 0.0 110.255 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -63.94 -37.37 87.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.011 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -56.35 -43.85 79.53 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.754 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -44.59 -45.26 9.4 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.506 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.53 -39.24 22.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.843 0.354 . . . . 0.0 110.96 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.7 -36.07 24.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.253 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -59.22 -33.45 71.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.129 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -66.37 -44.9 81.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.542 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.5 mt -59.78 -44.42 93.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.949 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.646 ' C ' ' H ' ' A' ' 35' ' ' ARG . 84.7 tttt -69.32 -60.45 2.33 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.284 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 36' ' ' LEU . . . 56.47 -12.22 0.01 OUTLIER Glycine 0 CA--C 1.536 1.361 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.646 ' H ' ' C ' ' A' ' 33' ' ' LYS . 2.0 mmp_? -72.19 20.75 0.06 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.026 0.441 . . . . 0.0 110.922 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.505 ' H ' ' C ' ' A' ' 34' ' ' GLY . 46.8 tp -130.97 123.68 29.36 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.067 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.465 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -65.79 159.76 66.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.81 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.587 ' O ' ' N ' ' A' ' 40' ' ' ALA . 36.7 Cg_endo -65.4 -91.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.502 2.135 . . . . 0.0 111.47 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 49.88 -79.31 0.01 OUTLIER Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' A' ' 38' ' ' PRO . . . -68.1 -25.22 65.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.37 . . . . 0.0 110.39 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.43 -10.51 59.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.406 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -64.45 -71.23 0.18 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.367 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -79.18 -77.7 0.17 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.838 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.806 ' O ' HG22 ' A' ' 47' ' ' VAL . 80.6 t80 -23.17 -89.7 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.622 0.576 . . . . 0.0 111.94 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -52.87 -29.34 27.57 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.257 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -45.29 -14.51 0.06 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.806 HG22 ' O ' ' A' ' 44' ' ' PHE . 10.5 m -102.25 59.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.976 0.417 . . . . 0.0 110.648 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -66.79 -56.41 14.41 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.748 179.295 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 48' ' ' TRP . 27.6 Cg_endo -61.44 -16.74 49.34 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.61 2.206 . . . . 0.0 112.36 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.424 HD23 ' O ' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -95.32 -45.51 7.11 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.819 0.342 . . . . 0.0 110.412 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.9 tp -60.66 -24.34 65.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.467 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -69.36 4.13 1.91 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.557 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.616 ' C ' HD12 ' A' ' 53' ' ' LEU . 3.2 pp -68.24 -35.69 78.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.041 0.448 . . . . 0.0 110.678 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.656 HD13 HD12 ' A' ' 20' ' ' LEU . 2.2 pp -70.06 -1.26 9.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.871 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.4 -56.5 1.31 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.336 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.02 -19.88 50.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.191 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.0 tp -119.93 65.9 10.4 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.467 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.68 164.11 22.3 Favored 'Trans proline' 0 N--CA 1.501 1.915 0 C-N-CA 122.734 2.289 . . . . 0.0 111.872 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.51 -60.91 0.34 Allowed 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.764 2.309 . . . . 0.0 112.119 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.27 -75.56 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.673 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.276 -179.781 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.423 ' O ' ' CB ' ' A' ' 4' ' ' ASN . 18.6 pt-20 . . . . . 0 N--CA 1.466 0.343 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.57 ' C ' ' H ' ' A' ' 6' ' ' VAL . 55.4 t30 82.16 -123.02 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.612 0.57 . . . . 0.0 110.988 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tp -56.31 7.95 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.57 ' H ' ' C ' ' A' ' 4' ' ' ASN . 5.6 p -67.61 -46.49 82.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.974 0.416 . . . . 0.0 111.068 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.521 ' N ' HG13 ' A' ' 6' ' ' VAL . 13.5 p -64.84 -41.12 91.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.965 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.483 ' N ' HG13 ' A' ' 7' ' ' VAL . 31.9 tp -46.07 -70.74 0.09 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.191 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -66.43 -46.94 74.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.519 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.51 -47.79 69.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.704 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.37 -42.84 92.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.82 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.4 m -63.44 -44.33 94.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.009 0.433 . . . . 0.0 110.534 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.1 t -68.95 -42.72 82.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.678 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -44.34 -57.04 3.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.594 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.71 -90.45 0.34 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 18' ' ' GLY . . . -59.87 -40.77 89.81 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.709 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -55.14 -3.82 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.75 0.309 . . . . 0.0 110.777 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -75.15 -51.05 7.85 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.435 HG22 ' O ' ' A' ' 16' ' ' ALA . 17.4 tt -45.75 -17.64 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.761 0.315 . . . . 0.0 110.636 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -64.74 -42.79 94.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.857 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.408 ' O ' HG22 ' A' ' 24' ' ' VAL . 77.9 p -70.6 -41.54 72.16 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.385 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -65.66 -16.59 63.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.684 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.6 tp -50.74 -36.19 35.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.514 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' ' 25' ' ' PHE . 3.3 m -72.78 -39.82 60.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.914 0.388 . . . . 0.0 110.501 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.418 ' N ' HG23 ' A' ' 24' ' ' VAL . 28.5 m-85 -63.57 -45.41 90.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.718 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -67.04 -42.72 84.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 0.0 110.607 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.6 m -53.8 -43.8 69.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.502 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.34 -40.57 62.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.424 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.472 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -60.91 -51.48 69.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -52.64 -27.23 16.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.603 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.493 ' CZ ' HD23 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -72.74 -16.83 61.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.662 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.587 HG23 ' N ' ' A' ' 33' ' ' LYS . 18.8 tt -53.06 -50.05 47.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.703 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.587 ' N ' HG23 ' A' ' 32' ' ' ILE . 3.0 ptpp? -62.54 -46.87 86.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.295 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.96 11.14 47.22 Favored Glycine 0 N--CA 1.464 0.519 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.455 ' C ' ' H ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -79.06 -15.1 58.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.889 0.376 . . . . 0.0 110.312 179.378 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.493 HD23 ' CZ ' ' A' ' 31' ' ' TYR . 3.4 tp -73.63 13.36 0.49 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.225 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.663 ' HB1' ' CD ' ' A' ' 38' ' ' PRO . . . -47.43 -179.8 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.4 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.663 ' CD ' ' HB1' ' A' ' 37' ' ' ALA . 37.2 Cg_exo -59.95 148.17 89.86 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.089 1.859 . . . . 0.0 111.634 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.31 -128.81 2.68 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.2 -10.18 28.71 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.727 0.299 . . . . 0.0 110.941 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.406 ' C ' ' N ' ' A' ' 43' ' ' ALA . . . -82.96 -72.47 0.45 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.057 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -47.1 -20.75 0.18 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.286 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.406 ' N ' ' C ' ' A' ' 41' ' ' ALA . . . -57.67 -88.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.779 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -64.62 -45.35 87.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.206 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.509 ' C ' ' H ' ' A' ' 47' ' ' VAL . 14.3 t80 -59.13 -16.08 17.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.528 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.08 20.36 0.92 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.723 ' O ' HG13 ' A' ' 47' ' ' VAL . 12.7 p -99.05 71.79 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.104 0.478 . . . . 0.0 110.649 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.608 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 3.0 m0 -100.78 -34.04 0.23 Allowed Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.638 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 57.9 Cg_endo -77.59 -24.8 8.6 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.662 1.574 . . . . 0.0 112.575 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.503 ' O ' HD13 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -74.7 -46.31 38.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.934 0.397 . . . . 0.0 110.441 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.07 -47.14 72.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.3 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.8 mt -52.75 -30.15 31.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.142 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.4 tp -67.21 -44.04 80.55 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' LEU . 55.8 tp -62.45 -44.96 95.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.758 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.0 tp -69.99 -37.76 75.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.811 0.339 . . . . 0.0 110.662 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.07 -30.9 60.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.137 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -155.28 148.03 17.95 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.626 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.458 ' HG3' ' H ' ' A' ' 4' ' ' ASN . 35.1 Cg_endo -65.53 171.66 9.12 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.346 2.031 . . . . 0.0 112.534 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' A' ' 61' ' ' ALA . 31.2 Cg_exo -59.47 -17.12 39.24 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 122.329 2.02 . . . . 0.0 112.163 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.491 ' O ' ' C ' ' A' ' 61' ' ' ALA . 58.6 mtm180 44.85 -91.15 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.422 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 59' ' ' PRO . . . . . . . . 0 N--CA 1.476 0.83 0 O-C-N 123.764 0.665 . . . . 0.0 111.961 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 110.386 -0.228 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.1 m120 72.82 -60.75 0.52 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.43 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.3 pp -70.66 -29.83 66.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.488 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.515 HG23 ' N ' ' A' ' 7' ' ' VAL . 28.7 m -56.79 -46.22 83.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.64 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.515 ' N ' HG23 ' A' ' 6' ' ' VAL . 19.9 t -46.25 -29.69 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.829 0.347 . . . . 0.0 110.541 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.8 tp -94.23 -56.41 2.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.591 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -66.43 -55.61 14.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.434 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 6' ' ' VAL . . . -55.74 -54.26 46.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 110.644 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.15 -41.45 68.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.58 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 t -63.57 -45.49 90.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.542 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.5 t -74.15 -58.03 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.195 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.49 -58.03 9.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.774 0.321 . . . . 0.0 110.91 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.9 -32.45 6.82 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' A' ' 18' ' ' GLY . . . -69.91 -57.85 4.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.926 0.393 . . . . 0.0 110.322 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -50.75 -8.03 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.773 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.501 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -66.13 -58.06 9.53 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.2 pt -56.0 -24.05 16.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.424 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -72.67 -40.73 66.08 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.3 t -64.8 -43.46 93.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.631 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -78.91 -18.19 54.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.993 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.2 tp -48.9 -34.03 11.93 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.4 t -77.86 -36.64 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.693 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -61.0 -47.36 86.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.169 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -59.52 -26.82 65.64 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.515 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.7 t -51.12 -42.01 60.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.044 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.12 -37.89 53.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.383 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.475 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -59.08 -54.12 50.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.081 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 9.1 m0 -57.01 -23.79 48.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.702 0.287 . . . . 0.0 110.956 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.45 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 41.0 t80 -73.02 -14.99 61.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.688 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.506 HG23 ' N ' ' A' ' 33' ' ' LYS . 15.3 tt -62.09 -44.7 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.216 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.506 ' N ' HG23 ' A' ' 32' ' ' ILE . 1.5 tptm -70.84 -56.99 5.08 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.376 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.97 24.63 3.55 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -80.49 60.92 4.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.769 0.318 . . . . 0.0 110.283 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.9 mt -134.41 124.88 26.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.258 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -164.15 168.5 9.28 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.194 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.613 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 65.5 Cg_exo -47.63 106.4 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.092 1.861 . . . . 0.0 112.074 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 133.82 -48.71 0.94 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.69 -60.77 2.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.822 0.344 . . . . 0.0 110.762 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.92 -5.82 14.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.52 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -72.96 -62.22 1.54 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.924 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.68 92.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.183 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.442 ' C ' ' H ' ' A' ' 46' ' ' GLY . 4.5 m-85 -63.1 -83.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.349 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -53.65 -8.76 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.699 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 44' ' ' PHE . . . -65.85 -52.58 36.8 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.7 m -135.7 11.09 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.871 0.367 . . . . 0.0 110.675 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.551 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 13.1 t90 -61.64 -51.76 74.22 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 48' ' ' TRP . 11.1 Cg_endo -51.85 -16.4 4.09 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.807 1.672 . . . . 0.0 112.288 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.8 tp -76.06 -33.6 59.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.979 0.418 . . . . 0.0 110.1 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 72.6 mt -78.18 2.49 17.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.507 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.4 tt -85.21 -32.14 22.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.9 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 53' ' ' LEU . 10.2 mp -63.6 -32.43 73.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.389 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.3 tp -54.91 -46.0 74.82 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 tt -62.78 -40.08 96.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.855 0.359 . . . . 0.0 110.257 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.02 -11.44 59.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.698 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.7 mt -134.58 66.94 71.03 Favored Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.361 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.543 ' O ' ' N ' ' A' ' 60' ' ' ARG . 59.6 Cg_endo -77.74 163.63 28.78 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.709 2.273 . . . . 0.0 112.335 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -43.67 -11.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.698 2.265 . . . . 0.0 112.588 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 58' ' ' PRO . 9.3 tmm_? -70.68 -60.22 2.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.373 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.291 179.863 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.704 0.288 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -105.9 38.12 2.09 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.872 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.3 tp -112.52 -70.86 0.78 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.381 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.595 HG13 ' N ' ' A' ' 7' ' ' VAL . 11.5 p -60.34 -47.33 92.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.428 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.595 ' N ' HG13 ' A' ' 6' ' ' VAL . 12.7 p -64.64 -40.96 90.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.462 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.648 HD11 ' CE1' ' A' ' 17' ' ' HIS . 35.5 tp -61.71 -44.74 96.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.409 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -63.95 -45.67 88.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.95 0.405 . . . . 0.0 110.577 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 14' ' ' ALA . . . -69.94 -26.49 64.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.343 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.416 ' HA ' ' H ' ' A' ' 15' ' ' GLY . . . -75.64 -17.81 59.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.554 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.6 t -64.38 -50.97 65.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.318 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.5 p -91.79 -21.0 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.181 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 10' ' ' ALA . . . -93.16 -77.84 0.44 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.592 0.234 . . . . 0.0 110.995 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.416 ' H ' ' HA ' ' A' ' 11' ' ' ALA . . . -64.04 -164.5 0.74 Allowed Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.245 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 18' ' ' GLY . . . -90.94 -1.78 57.79 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.648 ' CE1' HD11 ' A' ' 8' ' ' LEU . 42.2 t60 -41.66 -19.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.139 -0.225 . . . . 0.0 111.299 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -67.37 -49.6 50.53 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.433 HG22 ' O ' ' A' ' 16' ' ' ALA . 15.1 tt -49.24 -28.26 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.83 0.348 . . . . 0.0 110.679 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.703 ' C ' HD13 ' A' ' 20' ' ' LEU . 3.2 tm? -65.97 -45.02 83.21 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.496 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.8 m -59.65 -43.76 93.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.779 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -61.69 -39.82 92.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.666 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.32 -39.23 89.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.816 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.1 t -68.18 -42.85 85.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.007 0.432 . . . . 0.0 110.036 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -63.12 -44.24 96.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.59 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.62 -41.8 99.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.182 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.0 m -54.35 -41.47 69.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.343 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.69 -43.06 39.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.494 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.5 -38.39 89.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.411 ' C ' ' N ' ' A' ' 32' ' ' ILE . 58.0 t-105 -59.89 -30.39 68.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.148 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -52.03 -15.04 0.48 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.138 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.411 ' N ' ' C ' ' A' ' 30' ' ' TRP . 3.5 tp -67.65 -19.28 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.504 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.632 ' C ' ' H ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -42.15 -58.01 2.29 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.823 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 58.47 -14.75 0.02 OUTLIER Glycine 0 CA--C 1.534 1.274 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.021 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.632 ' H ' ' C ' ' A' ' 33' ' ' LYS . 85.0 mtm-85 -128.36 70.35 1.37 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.038 0.419 . . . . 0.0 111.097 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.512 HD13 ' N ' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -152.61 118.97 5.57 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 179.358 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.512 ' N ' HD13 ' A' ' 36' ' ' LEU . . . -79.91 158.13 73.11 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-O 120.766 0.317 . . . . 0.0 110.484 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 35.0 Cg_endo -63.88 -177.89 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.533 2.155 . . . . 0.0 111.783 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.91 -72.42 0.35 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' A' ' 42' ' ' TYR . . . -56.72 -34.94 67.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.766 0.317 . . . . 0.0 110.665 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.47 21.19 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.82 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.525 ' H ' ' C ' ' A' ' 40' ' ' ALA . 81.3 t80 -56.52 -42.96 79.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.443 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.14 -42.2 90.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.325 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -55.67 -47.62 76.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.792 0.329 . . . . 0.0 110.338 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.432 ' O ' ' O ' ' A' ' 46' ' ' GLY . 31.4 m-85 -75.98 -35.64 59.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.28 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 45' ' ' TYR . . . -42.26 -97.99 0.01 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -144.46 36.24 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.702 0.287 . . . . 0.0 111.074 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.567 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 20.2 t-105 -60.95 -46.59 96.74 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.877 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 48' ' ' TRP . 30.4 Cg_endo -61.99 -13.65 32.57 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 121.765 1.643 . . . . 0.0 112.522 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.7 tp -77.33 -38.8 49.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.752 0.311 . . . . 0.0 110.922 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.499 HD22 ' N ' ' A' ' 51' ' ' LEU . 4.0 mm? -62.44 -40.18 95.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.579 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.0 mt -49.06 -19.04 0.37 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.442 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.675 HD23 ' O ' ' A' ' 53' ' ' LEU . 3.0 tt -66.44 -43.43 85.65 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.299 0.571 . . . . 0.0 110.062 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.5 mt -74.05 -19.15 60.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.403 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 55' ' ' LEU . 11.2 mp -93.99 -41.94 9.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.937 0.399 . . . . 0.0 110.233 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.465 ' C ' HD12 ' A' ' 57' ' ' LEU . . . -62.3 -34.06 75.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.79 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.465 HD12 ' C ' ' A' ' 56' ' ' ALA . 9.3 mp -110.79 95.27 22.96 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -47.08 175.37 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.457 2.105 . . . . 0.0 112.266 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.77 -38.85 78.23 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.399 2.066 . . . . 0.0 112.392 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -50.67 72.06 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.0 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.639 179.629 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.713 0.292 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.401 ' ND2' ' HB1' ' A' ' 56' ' ' ALA . 20.0 t-20 -111.23 -46.42 3.3 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.861 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.5 mt -78.3 -48.61 15.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.148 0.499 . . . . 0.0 110.633 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.539 HG13 ' N ' ' A' ' 7' ' ' VAL . 13.1 p -64.23 -44.08 97.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.552 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.539 ' N ' HG13 ' A' ' 6' ' ' VAL . 55.9 t -62.06 -50.02 81.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.825 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.534 ' O ' HD13 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -65.97 -42.67 89.57 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.035 -179.528 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -60.92 -44.2 97.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.401 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 12' ' ' SER . . . -78.5 -68.31 0.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.406 ' HB1' ' CG ' ' A' ' 17' ' ' HIS . . . -41.22 -25.84 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.109 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 8' ' ' LEU . 3.1 m -60.85 -43.83 97.79 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.538 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.3 t -96.18 -34.64 5.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.852 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.73 -46.81 67.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.253 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.73 -11.04 23.29 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.89 -43.06 94.99 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.049 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.406 ' CG ' ' HB1' ' A' ' 11' ' ' ALA . 1.4 m80 -101.07 10.41 41.03 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.902 0.382 . . . . 0.0 110.336 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.29 -52.58 45.95 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.5 tp -66.28 -31.55 54.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.782 0.325 . . . . 0.0 110.774 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.6 mt -70.37 -39.11 74.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.231 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.1 t -62.26 -43.06 99.68 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.795 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -64.46 -35.45 80.97 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.474 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.8 tp -58.8 -36.53 74.61 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.396 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.8 t -76.82 -45.16 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.023 0.439 . . . . 0.0 110.413 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -66.41 -43.28 86.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.949 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -67.02 -24.55 66.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.971 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.5 p -57.22 -32.77 66.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.915 0.388 . . . . 0.0 110.151 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.04 -28.91 70.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.42 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.96 -47.91 70.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.716 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -56.37 -37.8 70.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.831 0.348 . . . . 0.0 110.626 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -68.37 -44.38 75.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.534 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.77 -44.25 99.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.728 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -62.53 -43.92 97.62 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.467 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.55 74.57 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.411 ' HE ' ' HA ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -93.86 -5.02 48.97 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.991 0.424 . . . . 0.0 110.175 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.544 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -66.01 158.45 28.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.636 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.594 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -167.82 174.46 2.35 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.481 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.594 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 31.7 Cg_exo -57.86 139.45 90.37 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.198 1.932 . . . . 0.0 111.682 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.93 -99.27 0.29 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.46 -39.16 88.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.657 0.265 . . . . 0.0 110.95 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 44' ' ' PHE . . . -47.79 -85.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.723 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.438 ' C ' ' O ' ' A' ' 41' ' ' ALA . 72.3 m-85 -30.05 -44.06 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.749 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.13 -47.07 69.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.838 0.351 . . . . 0.0 110.824 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 41' ' ' ALA . 84.1 t80 -87.99 -70.47 0.63 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.27 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.47 ' O ' ' N ' ' A' ' 47' ' ' VAL . 3.5 m-85 -48.94 -39.95 28.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.7 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -41.12 -24.58 0.1 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 45' ' ' TYR . 42.8 t -81.45 76.11 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.923 0.392 . . . . 0.0 110.38 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.596 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -98.67 -39.32 0.24 Allowed Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.707 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 51.5 Cg_exo -53.19 -55.51 3.6 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.088 1.859 . . . . 0.0 112.213 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.537 ' N ' HD12 ' A' ' 50' ' ' LEU . 10.1 mp -67.44 -29.54 69.04 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.998 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.505 ' O ' HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -60.5 -44.69 95.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.92 0.39 . . . . 0.0 110.421 -178.434 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.559 HD23 ' O ' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -77.74 -33.03 53.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.202 0.525 . . . . 0.0 110.406 179.351 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.42 ' C ' ' H ' ' A' ' 55' ' ' LEU . 12.5 tp -66.54 -64.17 0.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.388 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.7 tp -53.9 -9.99 0.28 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.592 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.42 ' H ' ' C ' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -75.73 -73.3 0.27 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.791 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.601 ' O ' HD22 ' A' ' 57' ' ' LEU . . . -96.95 3.15 52.2 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.627 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.601 HD22 ' O ' ' A' ' 56' ' ' ALA . 1.6 mm? -127.45 81.12 70.71 Favored Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -75.99 165.07 30.51 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.378 2.052 . . . . 0.0 112.055 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -43.33 -35.81 5.83 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.361 2.04 . . . . 0.0 111.875 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.9 mtt-85 -49.03 -42.52 38.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.359 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.427 ' HB3' HD13 ' A' ' 57' ' ' LEU . . . . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 120.756 0.312 . . . . 0.0 110.432 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.588 0.232 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.483 ' C ' HD12 ' A' ' 5' ' ' LEU . 90.2 m-20 -115.04 -3.38 12.62 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.763 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.483 HD12 ' C ' ' A' ' 4' ' ' ASN . 10.8 mp -106.82 -73.53 0.68 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.633 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.3 p -46.48 -33.89 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.907 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.499 HG23 ' N ' ' A' ' 8' ' ' LEU . 13.0 m -67.04 -41.11 86.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.759 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.499 ' N ' HG23 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -60.99 -53.42 57.43 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.671 -0.412 . . . . 0.0 109.916 -179.148 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -63.24 -45.11 93.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.311 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.75 -34.03 77.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.262 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 7' ' ' VAL . . . -64.21 -37.44 87.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.454 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.9 t -49.56 -30.72 9.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.267 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.7 t -89.73 -50.16 13.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.454 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.1 -50.66 67.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.748 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.42 -2.74 20.35 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.959 -0.857 . . . . 0.0 110.959 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 18' ' ' GLY . . . -61.1 -110.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.336 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.46 ' H ' ' HD1' ' A' ' 17' ' ' HIS . 46.8 m80 -44.79 -13.12 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.813 0.34 . . . . 0.0 111.031 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -68.33 -45.51 69.09 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.447 HG22 ' O ' ' A' ' 16' ' ' ALA . 19.1 tt -47.1 -24.22 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.371 . . . . 0.0 110.448 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.704 ' C ' HD13 ' A' ' 20' ' ' LEU . 3.0 tm? -64.73 -44.53 89.85 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.043 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.9 t -51.79 -42.86 62.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.439 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -64.17 -47.0 81.52 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.315 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 23' ' ' LEU . 1.0 OUTLIER -54.83 -46.07 74.56 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -177.742 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.1 p -69.21 -40.26 80.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.67 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -65.65 -38.58 89.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.34 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -75.79 -48.83 20.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.721 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.4 m -56.75 -42.07 78.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.389 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.66 -39.6 80.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.178 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.471 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -60.62 -40.07 90.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.565 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 9.7 t-105 -49.84 -32.34 14.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.968 0.413 . . . . 0.0 110.105 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -58.93 -26.22 64.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.198 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 29' ' ' ALA . 7.2 tt -64.43 -33.78 65.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.938 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -68.92 -54.7 14.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.469 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.96 11.44 18.71 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 50.3 ttm-85 -76.88 -15.25 59.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.848 0.356 . . . . 0.0 110.575 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.4 tp -70.32 49.67 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.437 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.559 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -75.32 162.22 73.77 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.186 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.559 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 43.5 Cg_endo -68.29 171.09 13.34 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.793 2.328 . . . . 0.0 111.796 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.83 -88.33 0.5 Allowed Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.23 -47.17 11.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 110.819 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.36 3.21 11.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.62 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -89.41 -45.59 9.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.607 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.488 ' C ' ' H ' ' A' ' 45' ' ' TYR . . . -64.82 -74.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.174 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 46' ' ' GLY . 17.3 m-85 -65.34 6.1 0.33 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.686 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.488 ' H ' ' C ' ' A' ' 43' ' ' ALA . 58.5 t80 -40.95 -24.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.925 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 44' ' ' PHE . . . -92.36 31.26 6.16 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.433 ' N ' ' O ' ' A' ' 44' ' ' PHE . 7.4 p -110.93 -24.94 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 120.895 0.379 . . . . 0.0 110.581 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.639 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 19.0 p-90 -83.2 -29.5 0.45 Allowed Pre-proline 0 CA--C 1.549 0.92 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.702 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 60.4 Cg_endo -87.38 -19.32 2.41 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.951 2.434 . . . . 0.0 112.682 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.5 tp -77.1 -48.97 16.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.98 0.419 . . . . 0.0 110.663 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.6 mt -67.73 -2.21 6.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.323 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.9 tt -65.75 -39.01 90.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.8 mt -94.58 -48.2 6.2 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.805 0.336 . . . . 0.0 111.071 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.8 tp -41.8 -59.61 1.63 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.077 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 55' ' ' LEU . 10.5 mp -62.01 -41.4 98.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.52 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.82 1.0 0.45 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.429 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.469 ' H ' ' C ' ' A' ' 55' ' ' LEU . 64.5 mt -130.79 146.65 62.89 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.656 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.86 138.65 45.23 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.456 2.104 . . . . 0.0 112.45 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -45.06 -20.68 0.44 Allowed 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.351 2.034 . . . . 0.0 112.021 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 72.8 ttt-85 -63.63 -44.1 94.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.273 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.248 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.569 -179.959 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.434 ' HA ' HH22 ' A' ' 60' ' ' ARG . 33.8 tt0 . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.874 0.368 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -100.59 -64.88 1.01 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.431 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 5' ' ' LEU . 53.8 mt -49.12 -33.41 11.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.681 0.277 . . . . 0.0 111.284 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.632 HG13 ' N ' ' A' ' 7' ' ' VAL . 14.8 p -62.22 -48.42 88.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.739 0.304 . . . . 0.0 110.806 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.632 ' N ' HG13 ' A' ' 6' ' ' VAL . 7.2 p -85.62 -29.86 6.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.99 0.424 . . . . 0.0 111.288 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.531 HD23 ' C ' ' A' ' 8' ' ' LEU . 3.0 tt -58.32 -74.24 0.06 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.257 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.426 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 28.5 m120 -57.26 -26.62 61.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.498 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.41 -82.3 0.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.848 0.356 . . . . 0.0 111.294 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.467 ' HB1' ' H ' ' A' ' 17' ' ' HIS . . . -53.42 -62.45 1.65 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.024 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 8' ' ' LEU . 1.4 m -38.24 -48.46 1.29 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.743 0.306 . . . . 0.0 110.819 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 9' ' ' ASN . 78.3 t -65.3 -42.73 94.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.945 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . -63.43 -19.26 64.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.537 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 16' ' ' ALA . . . 106.27 -28.79 12.46 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.568 ' C ' ' H ' ' A' ' 18' ' ' GLY . . . -50.79 -98.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.467 ' H ' ' HB1' ' A' ' 11' ' ' ALA . 68.3 t60 -47.48 -5.12 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.568 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -66.49 -51.92 38.92 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.442 HG23 HD22 ' A' ' 20' ' ' LEU . 20.1 tt -68.84 -31.77 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.678 0.275 . . . . 0.0 111.245 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.442 HD22 HG23 ' A' ' 19' ' ' ILE . 3.8 mm? -66.49 -42.35 87.54 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.449 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.406 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.4 m -65.83 -35.96 82.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.128 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -76.44 -21.63 55.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.762 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.1 tp -63.28 -40.76 98.29 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.652 0.263 . . . . 0.0 111.326 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 21' ' ' SER . 2.0 p -70.19 -28.81 37.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.166 0.508 . . . . 0.0 109.965 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -71.34 -41.02 70.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.604 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.5 ' O ' ' N ' ' A' ' 29' ' ' ALA . 16.2 t80 -65.85 -38.34 88.61 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.554 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 85.3 p -45.62 -39.1 7.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.18 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.83 -29.03 70.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.144 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . -57.49 -38.13 74.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.642 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.432 ' CD1' ' N ' ' A' ' 30' ' ' TRP . 40.3 m0 -57.2 -41.0 78.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.495 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -65.01 -44.02 90.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.42 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.1 mt -66.57 -43.5 90.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.935 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -70.7 -54.31 12.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.838 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.34 28.2 68.38 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -100.06 9.88 42.16 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.729 0.3 . . . . 0.0 110.65 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.7 mt -110.07 173.65 6.23 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.64 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.656 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -157.08 173.26 5.16 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.312 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.656 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 51.3 Cg_exo -52.42 72.83 0.02 OUTLIER 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 122.71 2.273 . . . . 0.0 112.28 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . -112.86 -129.76 5.19 Favored Glycine 0 N--CA 1.466 0.695 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.0 -40.2 14.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.697 0.284 . . . . 0.0 110.76 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.69 -10.32 59.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.803 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.22 -51.53 6.22 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.804 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.2 -49.21 78.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.18 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.465 ' O ' ' N ' ' A' ' 46' ' ' GLY . 62.0 t80 -62.43 -44.67 95.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.155 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.446 ' CD1' ' C ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -40.82 -25.24 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.269 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 44' ' ' PHE . . . -62.65 -62.58 5.41 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.112 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.2 p -83.5 10.66 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.897 0.349 . . . . 0.0 111.63 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.538 ' C ' ' H ' ' A' ' 50' ' ' LEU . 1.3 t90 -44.08 -44.67 18.08 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.225 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 32.0 Cg_exo -57.98 13.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.509 2.383 0 C-N-CA 122.533 2.156 . . . . 0.0 113.336 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.592 HD23 ' O ' ' A' ' 50' ' ' LEU . 3.9 tt -104.0 -50.47 3.37 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.082 0.468 . . . . 0.0 110.125 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.1 tp -60.41 -38.91 85.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.463 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 52' ' ' LEU . 3.9 mm? -59.33 -73.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 53' ' ' LEU . 9.7 mp -46.37 -33.04 3.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.783 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.1 tp -63.29 -69.56 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.876 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.3 mt -68.31 -39.37 82.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.717 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.94 -16.48 6.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.789 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 43.2 mt -123.99 90.36 50.77 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.474 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.63 -178.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.072 0 C-N-CA 123.069 2.513 . . . . 0.0 112.724 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.548 ' C ' ' H ' ' A' ' 61' ' ' ALA . 32.0 Cg_exo -57.32 -39.65 88.08 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.941 2.427 . . . . 0.0 112.501 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.471 ' CZ ' HG11 ' A' ' 6' ' ' VAL . 4.7 ptm180 -63.79 8.42 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.548 ' H ' ' C ' ' A' ' 59' ' ' PRO . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.257 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 58.6 mp0 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.838 0.352 . . . . 0.0 110.534 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -65.28 -144.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.74 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.541 ' N ' HD22 ' A' ' 5' ' ' LEU . 3.8 mm? -82.91 -8.24 59.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.351 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 70.5 t -60.42 -46.27 95.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.093 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.455 HG22 ' H ' ' A' ' 7' ' ' VAL . 2.2 m -64.12 -47.56 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.293 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.5 tp -61.52 -43.84 98.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.111 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.444 ' O ' ' OG ' ' A' ' 12' ' ' SER . 20.5 m120 -60.96 -46.39 90.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.285 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.95 -37.43 72.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.424 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.99 -36.18 83.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.974 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 9' ' ' ASN . 58.9 p -61.33 -34.13 74.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.969 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.5 m -100.25 -13.65 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.898 0.38 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.34 -57.64 5.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.481 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.93 -71.12 0.51 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.04 -50.07 71.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.663 0.268 . . . . 0.0 110.619 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -49.11 -19.1 0.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.619 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.86 -63.33 4.7 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.2 mm -54.16 -23.85 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.802 0.335 . . . . 0.0 110.414 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 mt -79.16 -31.87 44.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.21 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.508 ' O ' HG12 ' A' ' 24' ' ' VAL . 1.6 m -71.4 -44.79 64.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.17 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -72.65 -14.49 61.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.547 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.82 HD21 ' HE1' ' A' ' 48' ' ' TRP . 4.6 tt -67.54 -31.42 71.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.952 0.406 . . . . 0.0 111.132 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.508 HG12 ' O ' ' A' ' 21' ' ' SER . 4.3 p -64.49 -21.55 29.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.925 0.393 . . . . 0.0 111.342 -178.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -63.16 -38.72 92.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.449 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 52.4 m-85 -60.78 -43.81 97.6 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.556 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.7 t -45.31 -46.65 12.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.129 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.51 -39.66 24.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.567 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.449 ' HB3' ' HA ' ' A' ' 26' ' ' PHE . . . -55.35 -28.12 51.74 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.763 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.606 ' HB3' HD23 ' A' ' 36' ' ' LEU . 43.7 m95 -64.91 -28.37 69.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.788 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -77.6 -52.17 9.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.346 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.411 ' CG1' ' N ' ' A' ' 33' ' ' LYS . 3.1 pt -65.49 -39.35 84.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.527 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.414 ' CG ' ' O ' ' A' ' 29' ' ' ALA . 16.7 mmmt -59.28 -34.44 72.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.469 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.06 -5.36 71.79 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -87.42 63.13 7.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.736 0.303 . . . . 0.0 110.456 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.606 HD23 ' HB3' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -135.38 112.86 10.67 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.041 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.71 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -162.19 174.34 3.76 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.53 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.71 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 52.7 Cg_exo -53.18 134.84 58.02 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.724 2.283 . . . . 0.0 111.909 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.69 -124.98 1.2 Allowed Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.506 ' C ' ' H ' ' A' ' 42' ' ' TYR . . . -97.31 -5.11 37.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.77 0.319 . . . . 0.0 110.657 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.81 -3.27 0.07 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.959 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.506 ' H ' ' C ' ' A' ' 40' ' ' ALA . 27.9 m-85 -65.94 -41.32 91.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.927 0.394 . . . . 0.0 110.552 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.79 -53.04 62.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.614 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -61.76 -69.65 0.23 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.439 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -59.22 -14.55 11.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.512 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -44.64 -79.87 0.05 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.3 m -123.19 48.09 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.721 0.296 . . . . 0.0 110.664 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.82 ' HE1' HD21 ' A' ' 23' ' ' LEU . 1.1 t90 -67.56 -41.94 33.78 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.269 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 30.7 Cg_exo -61.5 -27.66 82.44 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.901 2.401 . . . . 0.0 112.131 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.506 ' O ' HD12 ' A' ' 53' ' ' LEU . 5.6 tt -74.61 -27.32 60.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.783 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 tp -95.85 10.05 38.47 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.807 0.337 . . . . 0.0 111.071 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.507 ' C ' ' H ' ' A' ' 54' ' ' LEU . 6.5 tt -78.72 -42.21 28.91 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.074 0.464 . . . . 0.0 111.897 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.7 ' C ' HD22 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -48.89 -9.23 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.119 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.507 ' H ' ' C ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -59.14 -54.33 48.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.769 0.319 . . . . 0.0 110.684 -178.075 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.5 tt -68.47 -52.04 36.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.837 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.34 -27.64 68.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.923 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 53' ' ' LEU . 2.8 mp -145.97 98.74 4.39 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.823 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.409 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 50.1 Cg_exo -48.29 -175.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 123.062 2.508 . . . . 0.0 112.554 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 61' ' ' ALA . 51.3 Cg_exo -54.42 -27.28 48.4 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.046 2.497 . . . . 0.0 111.995 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -42.98 -23.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.317 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 59' ' ' PRO . . . . . . . . 0 N--CA 1.463 0.184 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.33 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 4' ' ' ASN . 23.4 tt0 . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.411 ' H ' ' HG2' ' A' ' 3' ' ' GLU . 11.0 t-20 -87.5 3.53 46.99 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.845 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.2 tp -69.2 -85.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.984 0.421 . . . . 0.0 111.039 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.474 ' O ' ' OD1' ' A' ' 9' ' ' ASN . 95.3 t -40.62 -50.99 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.981 0.42 . . . . 0.0 111.002 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.424 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 0.7 OUTLIER -40.36 -30.14 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.965 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.436 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -56.98 -70.45 0.12 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.121 -178.177 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.474 ' OD1' ' O ' ' A' ' 6' ' ' VAL . 21.8 p-10 -69.8 -34.78 74.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.616 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.44 -50.24 72.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.396 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 7' ' ' VAL . . . -64.22 -39.4 93.9 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.925 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.0 t -62.66 -47.29 84.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.563 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.3 t -75.03 -45.33 42.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.95 -58.34 7.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.786 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.84 -5.85 84.2 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.79 -37.27 87.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.856 0.36 . . . . 0.0 110.734 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -86.01 14.78 5.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.188 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.68 -51.28 55.26 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.6 mm -67.43 -40.46 84.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.163 0.506 . . . . 0.0 110.178 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 20' ' ' LEU . 10.9 mp -67.61 -42.53 82.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.08 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.449 ' O ' HG12 ' A' ' 24' ' ' VAL . 78.1 p -64.39 -44.68 90.56 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.625 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -67.31 -25.59 66.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.529 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.2 tp -61.44 -40.49 94.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.479 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 21' ' ' SER . 1.0 OUTLIER -72.27 -34.97 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.991 0.424 . . . . 0.0 110.097 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -67.52 -46.19 73.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.485 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -56.23 -29.12 60.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.279 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.0 m -57.72 -35.87 71.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.014 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.15 -39.71 86.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.408 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.42 -34.95 26.36 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-O 121.015 0.436 . . . . 0.0 110.355 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.485 ' CD1' ' N ' ' A' ' 30' ' ' TRP . 19.2 m0 -78.09 -35.08 49.82 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.098 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -63.58 -45.99 87.9 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.55 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 33' ' ' LYS . 14.4 tt -69.72 -40.84 79.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.545 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.461 ' N ' HG23 ' A' ' 32' ' ' ILE . 19.5 tptm -64.24 -46.91 81.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.23 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.25 7.91 63.37 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.575 ' C ' ' H ' ' A' ' 37' ' ' ALA . 10.2 tpt85 -74.19 -19.67 60.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 110.224 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 37' ' ' ALA . 1.9 pp -52.82 -1.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.172 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.596 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -39.74 164.87 0.06 OUTLIER Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 120.694 0.283 . . . . 0.0 110.459 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.596 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 70.9 Cg_exo -40.95 125.95 2.36 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.407 2.071 . . . . 0.0 111.702 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 168.0 -120.5 0.9 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.58 -13.45 24.38 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.701 0.286 . . . . 0.0 110.726 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.63 -10.09 24.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.619 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -62.97 -37.66 87.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.651 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.5 -43.34 84.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.848 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.407 ' C ' ' N ' ' A' ' 46' ' ' GLY . 71.1 m-85 -63.17 -69.04 0.29 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.648 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -47.21 -20.19 0.17 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.281 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' A' ' 44' ' ' PHE . . . -65.33 -32.6 84.19 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 t -146.56 78.77 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 120.588 0.232 . . . . 0.0 110.677 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.63 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -82.98 -39.9 0.81 Allowed Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.548 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 38.4 Cg_exo -59.58 2.85 0.24 Allowed 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.836 2.357 . . . . 0.0 112.119 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.479 ' H ' ' C ' ' A' ' 48' ' ' TRP . 54.5 tp -69.99 -43.15 72.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.575 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.611 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.7 mm? -85.0 -20.75 30.02 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.527 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 52' ' ' LEU . 2.9 tt -67.61 -55.36 13.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.704 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.744 HD23 ' H ' ' A' ' 54' ' ' LEU . 0.9 OUTLIER -73.11 -37.74 66.6 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.964 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.744 ' H ' HD23 ' A' ' 53' ' ' LEU . 50.0 tp -64.57 -45.26 87.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.087 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.88 -34.28 66.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.714 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -46.1 -34.57 4.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.556 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.564 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -156.42 153.92 26.01 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.825 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.35 163.97 32.44 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.59 2.193 . . . . 0.0 112.283 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -47.03 -27.17 5.71 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.706 2.271 . . . . 0.0 112.086 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 83.2 mtt85 -56.9 -72.44 0.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.882 0.372 . . . . 0.0 110.443 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.31 179.822 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.6 mt -72.77 146.3 46.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.536 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.474 ' H ' HG21 ' A' ' 6' ' ' VAL . 80.6 mm-40 -108.4 -166.49 1.13 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.528 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.511 ' C ' ' H ' ' A' ' 6' ' ' VAL . 6.1 m-20 -69.03 -56.64 7.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.558 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.585 ' N ' HD22 ' A' ' 5' ' ' LEU . 4.0 mm? -53.0 -6.41 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.561 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 4' ' ' ASN . 40.1 t -91.44 -51.92 10.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.567 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 13.6 p -81.45 -23.36 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.529 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.614 ' O ' HD13 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -61.98 -46.66 88.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.556 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.4 ' ND2' ' O ' ' A' ' 5' ' ' LEU . 23.8 m-80 -64.02 -46.7 83.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.567 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.82 -36.87 73.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.566 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 7' ' ' VAL . . . -55.45 -44.06 76.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.563 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.5 p -62.21 -41.75 98.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.556 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.9 t -68.94 -43.37 82.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.55 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.87 -52.47 63.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.575 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.27 -81.63 0.35 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.65 -67.48 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.822 0.344 . . . . 0.0 110.578 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -51.9 -19.42 1.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.632 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.33 -54.01 6.45 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 21.2 pt -68.84 -22.82 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 0.0 110.547 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.451 ' HA ' HD13 ' A' ' 20' ' ' LEU . 1.7 mm? -69.48 -41.91 75.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.54 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.3 m -63.74 -28.77 70.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.557 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.44 ' O ' ' N ' ' A' ' 25' ' ' PHE . 5.1 m-85 -64.31 -11.47 32.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.572 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.619 HD11 ' CZ3' ' A' ' 48' ' ' TRP . 61.4 tp -41.31 -39.64 1.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.545 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.557 HG22 HD21 ' A' ' 52' ' ' LEU . 8.8 t -71.03 -39.68 75.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.568 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.44 ' N ' ' O ' ' A' ' 22' ' ' PHE . 84.9 t80 -74.82 -27.78 60.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.625 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.58 -42.78 77.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.55 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.0 m -46.2 -42.74 14.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.568 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.69 -36.24 57.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.538 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.584 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -58.01 -39.68 78.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.561 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -69.34 -33.7 73.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.553 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -60.81 -22.12 63.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.608 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.674 HG23 ' N ' ' A' ' 33' ' ' LYS . 10.6 tp -48.04 -50.06 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.563 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.674 ' N ' HG23 ' A' ' 32' ' ' ILE . 4.7 tppt? -64.52 -50.56 66.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.515 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.9 43.13 6.87 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.762 ' O ' ' N ' ' A' ' 37' ' ' ALA . 15.4 ptm180 -145.5 -5.06 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.744 0.306 . . . . 0.0 110.523 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.699 ' C ' ' O ' ' A' ' 35' ' ' ARG . 32.2 tp -6.33 71.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.563 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.762 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -21.1 91.9 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.625 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.532 ' N ' ' O ' ' A' ' 36' ' ' LEU . 48.0 Cg_exo -53.62 150.74 27.11 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.843 2.362 . . . . 0.0 112.169 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.17 -75.51 0.42 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.48 ' C ' ' N ' ' A' ' 42' ' ' TYR . . . -87.77 -72.51 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.763 0.316 . . . . 0.0 110.575 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.12 -13.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.59 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.48 ' N ' ' C ' ' A' ' 40' ' ' ALA . 30.7 t80 -86.62 -49.39 7.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.551 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.35 -36.22 82.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.622 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.5 ' C ' ' H ' ' A' ' 46' ' ' GLY . 4.3 m-85 -44.61 -39.59 5.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.589 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -49.01 -10.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.62 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 44' ' ' PHE . . . -62.78 -35.47 91.99 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.0 m -148.62 23.91 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.85 0.357 . . . . 0.0 110.581 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.627 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -80.79 -42.99 1.25 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.513 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 15.1 Cg_exo -68.01 -15.09 42.77 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.806 2.337 . . . . 0.0 112.181 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.461 ' O ' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -62.16 -33.96 75.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.521 -179.038 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 tp -61.71 -7.56 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.611 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.702 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 55.1 mt -62.81 -49.55 74.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.609 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -85.2 -14.33 47.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.577 -178.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.525 ' O ' HD13 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -76.96 -58.31 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.578 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.613 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -75.84 -38.72 57.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.616 -178.798 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.755 ' HB3' HD13 ' A' ' 57' ' ' LEU . . . -34.11 -52.47 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.572 -177.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.046 HD13 ' N ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -111.57 155.7 42.56 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.548 178.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -78.27 163.44 27.61 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.843 2.362 . . . . 0.0 112.126 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.506 ' C ' ' H ' ' A' ' 61' ' ' ALA . 54.5 Cg_exo -47.93 -42.23 31.72 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.744 2.296 . . . . 0.0 112.121 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -68.16 42.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.621 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 59' ' ' PRO . . . -124.08 130.75 53.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.602 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -68.63 -3.46 11.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.581 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.551 179.959 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 61' ' ' ALA . 5.5 mp -86.39 -99.6 0.07 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.551 ' O ' HG21 ' A' ' 7' ' ' VAL . 17.4 tp10 -76.99 -138.18 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.745 0.307 . . . . 0.0 110.513 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.439 ' O ' ' O ' ' A' ' 5' ' ' LEU . 75.0 m-20 -112.08 -35.05 5.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.568 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 5' ' ' LEU . 4.1 mm? -48.27 -104.73 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.773 0.32 . . . . 0.0 111.446 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.0 t -44.03 -31.05 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.883 0.373 . . . . 0.0 110.72 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.551 HG21 ' O ' ' A' ' 3' ' ' GLU . 94.8 t -62.32 -42.52 95.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.717 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.5 tp -62.21 -43.28 99.18 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.051 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -75.64 -34.88 60.54 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.048 0.451 . . . . 0.0 110.797 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 12' ' ' SER . . . -72.24 -77.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.787 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -43.16 -15.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.342 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -57.74 -38.8 75.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.363 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.3 p -94.85 -37.57 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.562 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.63 -37.78 8.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.609 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.38 -21.6 28.33 Favored Glycine 0 N--CA 1.465 0.588 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.41 -50.59 71.18 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.522 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -101.15 12.41 37.64 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.961 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.78 -48.48 55.14 Favored Glycine 0 N--CA 1.462 0.425 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.642 HG23 ' CD2' ' A' ' 20' ' ' LEU . 8.6 tt -67.49 -34.02 65.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.841 0.353 . . . . 0.0 110.495 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.656 HD12 HD13 ' A' ' 54' ' ' LEU . 4.5 mm? -78.13 -25.87 47.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.69 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.507 ' O ' HG12 ' A' ' 24' ' ' VAL . 48.0 t -59.04 -43.16 91.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.913 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -62.22 -31.27 71.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.916 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.577 HD23 ' O ' ' A' ' 23' ' ' LEU . 1.1 tt -48.76 -39.38 24.81 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.391 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 21' ' ' SER . 1.8 p -63.21 -33.24 59.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.91 0.386 . . . . 0.0 110.255 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -63.94 -37.37 87.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.011 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -56.35 -43.85 79.53 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.754 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -44.59 -45.26 9.4 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.506 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.53 -39.24 22.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.843 0.354 . . . . 0.0 110.96 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.7 -36.07 24.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.253 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -59.22 -33.45 71.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.129 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -66.37 -44.9 81.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.542 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.5 mt -59.78 -44.42 93.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.949 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.646 ' C ' ' H ' ' A' ' 35' ' ' ARG . 84.7 tttt -69.32 -60.45 2.33 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.284 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 36' ' ' LEU . . . 56.47 -12.22 0.01 OUTLIER Glycine 0 CA--C 1.536 1.361 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.646 ' H ' ' C ' ' A' ' 33' ' ' LYS . 2.0 mmp_? -72.19 20.75 0.06 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.026 0.441 . . . . 0.0 110.922 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.505 ' H ' ' C ' ' A' ' 34' ' ' GLY . 46.8 tp -130.97 123.68 29.36 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.067 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.465 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -65.79 159.76 66.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.81 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.587 ' O ' ' N ' ' A' ' 40' ' ' ALA . 36.7 Cg_endo -65.4 -91.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.502 2.135 . . . . 0.0 111.47 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 49.88 -79.31 0.01 OUTLIER Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' A' ' 38' ' ' PRO . . . -68.1 -25.22 65.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.37 . . . . 0.0 110.39 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.43 -10.51 59.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.406 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -64.45 -71.23 0.18 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.367 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -79.18 -77.7 0.17 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.838 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.806 ' O ' HG22 ' A' ' 47' ' ' VAL . 80.6 t80 -23.17 -89.7 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.622 0.576 . . . . 0.0 111.94 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -52.87 -29.34 27.57 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.257 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -45.29 -14.51 0.06 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.806 HG22 ' O ' ' A' ' 44' ' ' PHE . 10.5 m -102.25 59.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.976 0.417 . . . . 0.0 110.648 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -66.79 -56.41 14.41 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.748 179.295 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 48' ' ' TRP . 27.6 Cg_endo -61.44 -16.74 49.34 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.61 2.206 . . . . 0.0 112.36 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.424 HD23 ' O ' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -95.32 -45.51 7.11 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.819 0.342 . . . . 0.0 110.412 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.9 tp -60.66 -24.34 65.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.467 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -69.36 4.13 1.91 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.557 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.616 ' C ' HD12 ' A' ' 53' ' ' LEU . 3.2 pp -68.24 -35.69 78.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.041 0.448 . . . . 0.0 110.678 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.656 HD13 HD12 ' A' ' 20' ' ' LEU . 2.2 pp -70.06 -1.26 9.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.871 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.4 -56.5 1.31 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.336 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.02 -19.88 50.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.191 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.0 tp -119.93 65.9 10.4 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.467 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.68 164.11 22.3 Favored 'Trans proline' 0 N--CA 1.501 1.915 0 C-N-CA 122.734 2.289 . . . . 0.0 111.872 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.51 -60.91 0.34 Allowed 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.764 2.309 . . . . 0.0 112.119 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.27 -75.56 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.673 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' A' ' 2' ' ' LEU . . . -75.75 -177.25 3.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.276 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 62' ' ' TYR . 48.3 p90 -162.91 122.97 2.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.459 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.462 179.996 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.6 ' N ' HD22 ' A' ' 2' ' ' LEU . 3.7 mm? -88.09 98.91 11.8 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.361 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.423 ' O ' ' CB ' ' A' ' 4' ' ' ASN . 18.6 pt-20 -124.24 168.9 12.33 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.14 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.57 ' C ' ' H ' ' A' ' 6' ' ' VAL . 55.4 t30 82.16 -123.02 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.612 0.57 . . . . 0.0 110.988 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tp -56.31 7.95 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.57 ' H ' ' C ' ' A' ' 4' ' ' ASN . 5.6 p -67.61 -46.49 82.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.974 0.416 . . . . 0.0 111.068 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.521 ' N ' HG13 ' A' ' 6' ' ' VAL . 13.5 p -64.84 -41.12 91.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.965 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.483 ' N ' HG13 ' A' ' 7' ' ' VAL . 31.9 tp -46.07 -70.74 0.09 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.191 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -66.43 -46.94 74.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.519 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.51 -47.79 69.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.704 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.37 -42.84 92.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.82 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.4 m -63.44 -44.33 94.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.009 0.433 . . . . 0.0 110.534 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.1 t -68.95 -42.72 82.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.678 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -44.34 -57.04 3.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.594 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.71 -90.45 0.34 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 18' ' ' GLY . . . -59.87 -40.77 89.81 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.709 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -55.14 -3.82 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.75 0.309 . . . . 0.0 110.777 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -75.15 -51.05 7.85 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.435 HG22 ' O ' ' A' ' 16' ' ' ALA . 17.4 tt -45.75 -17.64 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.761 0.315 . . . . 0.0 110.636 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -64.74 -42.79 94.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.857 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.408 ' O ' HG22 ' A' ' 24' ' ' VAL . 77.9 p -70.6 -41.54 72.16 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.385 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -65.66 -16.59 63.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.684 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.6 tp -50.74 -36.19 35.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.514 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' ' 25' ' ' PHE . 3.3 m -72.78 -39.82 60.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.914 0.388 . . . . 0.0 110.501 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.418 ' N ' HG23 ' A' ' 24' ' ' VAL . 28.5 m-85 -63.57 -45.41 90.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.718 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -67.04 -42.72 84.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 0.0 110.607 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.6 m -53.8 -43.8 69.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.502 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.34 -40.57 62.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.424 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.472 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -60.91 -51.48 69.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -52.64 -27.23 16.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.603 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.493 ' CZ ' HD23 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -72.74 -16.83 61.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.662 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.587 HG23 ' N ' ' A' ' 33' ' ' LYS . 18.8 tt -53.06 -50.05 47.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.703 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.587 ' N ' HG23 ' A' ' 32' ' ' ILE . 3.0 ptpp? -62.54 -46.87 86.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.295 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.96 11.14 47.22 Favored Glycine 0 N--CA 1.464 0.519 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.455 ' C ' ' H ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -79.06 -15.1 58.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.889 0.376 . . . . 0.0 110.312 179.378 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.493 HD23 ' CZ ' ' A' ' 31' ' ' TYR . 3.4 tp -73.63 13.36 0.49 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.225 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.663 ' HB1' ' CD ' ' A' ' 38' ' ' PRO . . . -47.43 -179.8 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.4 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.663 ' CD ' ' HB1' ' A' ' 37' ' ' ALA . 37.2 Cg_exo -59.95 148.17 89.86 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.089 1.859 . . . . 0.0 111.634 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.31 -128.81 2.68 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.2 -10.18 28.71 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.727 0.299 . . . . 0.0 110.941 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.406 ' C ' ' N ' ' A' ' 43' ' ' ALA . . . -82.96 -72.47 0.45 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.057 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -47.1 -20.75 0.18 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.286 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.406 ' N ' ' C ' ' A' ' 41' ' ' ALA . . . -57.67 -88.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.779 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -64.62 -45.35 87.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.206 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.509 ' C ' ' H ' ' A' ' 47' ' ' VAL . 14.3 t80 -59.13 -16.08 17.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.528 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.08 20.36 0.92 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.723 ' O ' HG13 ' A' ' 47' ' ' VAL . 12.7 p -99.05 71.79 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.104 0.478 . . . . 0.0 110.649 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.608 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 3.0 m0 -100.78 -34.04 0.23 Allowed Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.638 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 57.9 Cg_endo -77.59 -24.8 8.6 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.662 1.574 . . . . 0.0 112.575 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.503 ' O ' HD13 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -74.7 -46.31 38.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.934 0.397 . . . . 0.0 110.441 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.07 -47.14 72.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.3 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.8 mt -52.75 -30.15 31.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.142 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.4 tp -67.21 -44.04 80.55 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' LEU . 55.8 tp -62.45 -44.96 95.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.758 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.0 tp -69.99 -37.76 75.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.811 0.339 . . . . 0.0 110.662 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.07 -30.9 60.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.137 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -155.28 148.03 17.95 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.626 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.458 ' HG3' ' H ' ' A' ' 4' ' ' ASN . 35.1 Cg_endo -65.53 171.66 9.12 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.346 2.031 . . . . 0.0 112.534 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' A' ' 61' ' ' ALA . 31.2 Cg_exo -59.47 -17.12 39.24 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 122.329 2.02 . . . . 0.0 112.163 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.534 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 58.6 mtm180 44.85 -91.15 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.422 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 59' ' ' PRO . . . -19.7 91.06 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.764 0.665 . . . . 0.0 111.961 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.534 ' CD2' ' O ' ' A' ' 60' ' ' ARG . 46.9 m-85 -92.17 85.72 5.55 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.812 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.536 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.348 179.475 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.621 ' N ' ' NH1' ' A' ' 60' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.453 ' C ' ' NH2' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -107.61 86.48 2.31 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.127 -179.656 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -102.24 -165.89 1.23 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.386 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.1 m120 72.82 -60.75 0.52 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.43 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.3 pp -70.66 -29.83 66.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.488 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.515 HG23 ' N ' ' A' ' 7' ' ' VAL . 28.7 m -56.79 -46.22 83.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.64 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.515 ' N ' HG23 ' A' ' 6' ' ' VAL . 19.9 t -46.25 -29.69 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.829 0.347 . . . . 0.0 110.541 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.8 tp -94.23 -56.41 2.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.591 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -66.43 -55.61 14.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.434 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 6' ' ' VAL . . . -55.74 -54.26 46.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 110.644 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.15 -41.45 68.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.58 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 t -63.57 -45.49 90.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.542 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.5 t -74.15 -58.03 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.195 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.49 -58.03 9.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.774 0.321 . . . . 0.0 110.91 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.9 -32.45 6.82 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' A' ' 18' ' ' GLY . . . -69.91 -57.85 4.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.926 0.393 . . . . 0.0 110.322 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -50.75 -8.03 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.773 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.501 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -66.13 -58.06 9.53 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.2 pt -56.0 -24.05 16.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.424 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -72.67 -40.73 66.08 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.3 t -64.8 -43.46 93.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.631 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -78.91 -18.19 54.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.993 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.2 tp -48.9 -34.03 11.93 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.4 t -77.86 -36.64 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.693 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -61.0 -47.36 86.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.169 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -59.52 -26.82 65.64 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.515 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.7 t -51.12 -42.01 60.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.044 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.12 -37.89 53.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.383 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.475 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -59.08 -54.12 50.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.081 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 9.1 m0 -57.01 -23.79 48.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.702 0.287 . . . . 0.0 110.956 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.45 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 41.0 t80 -73.02 -14.99 61.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.688 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.506 HG23 ' N ' ' A' ' 33' ' ' LYS . 15.3 tt -62.09 -44.7 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.216 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.506 ' N ' HG23 ' A' ' 32' ' ' ILE . 1.5 tptm -70.84 -56.99 5.08 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.376 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.97 24.63 3.55 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -80.49 60.92 4.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.769 0.318 . . . . 0.0 110.283 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.9 mt -134.41 124.88 26.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.258 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -164.15 168.5 9.28 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.194 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.613 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 65.5 Cg_exo -47.63 106.4 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.092 1.861 . . . . 0.0 112.074 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 133.82 -48.71 0.94 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.69 -60.77 2.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.822 0.344 . . . . 0.0 110.762 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.92 -5.82 14.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.52 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -72.96 -62.22 1.54 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.924 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.68 92.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.183 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.442 ' C ' ' H ' ' A' ' 46' ' ' GLY . 4.5 m-85 -63.1 -83.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.349 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -53.65 -8.76 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.699 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 44' ' ' PHE . . . -65.85 -52.58 36.8 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.7 m -135.7 11.09 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.871 0.367 . . . . 0.0 110.675 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.551 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 13.1 t90 -61.64 -51.76 74.22 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 48' ' ' TRP . 11.1 Cg_endo -51.85 -16.4 4.09 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.807 1.672 . . . . 0.0 112.288 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.8 tp -76.06 -33.6 59.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.979 0.418 . . . . 0.0 110.1 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 72.6 mt -78.18 2.49 17.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.507 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.4 tt -85.21 -32.14 22.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.9 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 53' ' ' LEU . 10.2 mp -63.6 -32.43 73.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.389 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.3 tp -54.91 -46.0 74.82 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 tt -62.78 -40.08 96.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.855 0.359 . . . . 0.0 110.257 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.02 -11.44 59.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.698 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.7 mt -134.58 66.94 71.03 Favored Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.361 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.543 ' O ' ' N ' ' A' ' 60' ' ' ARG . 59.6 Cg_endo -77.74 163.63 28.78 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.709 2.273 . . . . 0.0 112.335 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -43.67 -11.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.698 2.265 . . . . 0.0 112.588 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.621 ' NH1' ' N ' ' A' ' 1' ' ' ALA . 9.3 tmm_? -70.68 -60.22 2.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.373 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.28 166.5 14.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.291 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -153.68 136.99 15.73 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.034 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.405 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.543 179.941 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.595 ' N ' HD12 ' A' ' 2' ' ' LEU . 9.3 mp -75.8 169.53 17.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.405 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -41.13 108.03 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.58 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -105.9 38.12 2.09 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.872 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.3 tp -112.52 -70.86 0.78 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.381 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.595 HG13 ' N ' ' A' ' 7' ' ' VAL . 11.5 p -60.34 -47.33 92.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.428 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.595 ' N ' HG13 ' A' ' 6' ' ' VAL . 12.7 p -64.64 -40.96 90.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.462 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.648 HD11 ' CE1' ' A' ' 17' ' ' HIS . 35.5 tp -61.71 -44.74 96.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.409 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -63.95 -45.67 88.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.95 0.405 . . . . 0.0 110.577 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 14' ' ' ALA . . . -69.94 -26.49 64.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.343 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.416 ' HA ' ' H ' ' A' ' 15' ' ' GLY . . . -75.64 -17.81 59.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.554 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.6 t -64.38 -50.97 65.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.318 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.5 p -91.79 -21.0 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.181 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 10' ' ' ALA . . . -93.16 -77.84 0.44 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.592 0.234 . . . . 0.0 110.995 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.416 ' H ' ' HA ' ' A' ' 11' ' ' ALA . . . -64.04 -164.5 0.74 Allowed Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.245 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 18' ' ' GLY . . . -90.94 -1.78 57.79 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.648 ' CE1' HD11 ' A' ' 8' ' ' LEU . 42.2 t60 -41.66 -19.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.139 -0.225 . . . . 0.0 111.299 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -67.37 -49.6 50.53 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.433 HG22 ' O ' ' A' ' 16' ' ' ALA . 15.1 tt -49.24 -28.26 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.83 0.348 . . . . 0.0 110.679 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.703 ' C ' HD13 ' A' ' 20' ' ' LEU . 3.2 tm? -65.97 -45.02 83.21 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.496 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.8 m -59.65 -43.76 93.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.779 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -61.69 -39.82 92.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.666 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.32 -39.23 89.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.816 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.1 t -68.18 -42.85 85.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.007 0.432 . . . . 0.0 110.036 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -63.12 -44.24 96.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.59 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.62 -41.8 99.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.182 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.0 m -54.35 -41.47 69.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.343 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.69 -43.06 39.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.494 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.5 -38.39 89.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.411 ' C ' ' N ' ' A' ' 32' ' ' ILE . 58.0 t-105 -59.89 -30.39 68.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.148 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -52.03 -15.04 0.48 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.138 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.411 ' N ' ' C ' ' A' ' 30' ' ' TRP . 3.5 tp -67.65 -19.28 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.504 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.632 ' C ' ' H ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -42.15 -58.01 2.29 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.823 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 58.47 -14.75 0.02 OUTLIER Glycine 0 CA--C 1.534 1.274 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.021 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.632 ' H ' ' C ' ' A' ' 33' ' ' LYS . 85.0 mtm-85 -128.36 70.35 1.37 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.038 0.419 . . . . 0.0 111.097 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.512 HD13 ' N ' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -152.61 118.97 5.57 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 179.358 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.512 ' N ' HD13 ' A' ' 36' ' ' LEU . . . -79.91 158.13 73.11 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-O 120.766 0.317 . . . . 0.0 110.484 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 35.0 Cg_endo -63.88 -177.89 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.533 2.155 . . . . 0.0 111.783 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.91 -72.42 0.35 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' A' ' 42' ' ' TYR . . . -56.72 -34.94 67.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.766 0.317 . . . . 0.0 110.665 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.47 21.19 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.82 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.525 ' H ' ' C ' ' A' ' 40' ' ' ALA . 81.3 t80 -56.52 -42.96 79.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.443 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.14 -42.2 90.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.325 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -55.67 -47.62 76.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.792 0.329 . . . . 0.0 110.338 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.432 ' O ' ' O ' ' A' ' 46' ' ' GLY . 31.4 m-85 -75.98 -35.64 59.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.28 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 45' ' ' TYR . . . -42.26 -97.99 0.01 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -144.46 36.24 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.702 0.287 . . . . 0.0 111.074 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.567 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 20.2 t-105 -60.95 -46.59 96.74 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.877 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 48' ' ' TRP . 30.4 Cg_endo -61.99 -13.65 32.57 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 121.765 1.643 . . . . 0.0 112.522 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.7 tp -77.33 -38.8 49.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.752 0.311 . . . . 0.0 110.922 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.499 HD22 ' N ' ' A' ' 51' ' ' LEU . 4.0 mm? -62.44 -40.18 95.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.579 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.0 mt -49.06 -19.04 0.37 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.442 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.675 HD23 ' O ' ' A' ' 53' ' ' LEU . 3.0 tt -66.44 -43.43 85.65 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.299 0.571 . . . . 0.0 110.062 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.5 mt -74.05 -19.15 60.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.403 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 55' ' ' LEU . 11.2 mp -93.99 -41.94 9.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.937 0.399 . . . . 0.0 110.233 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.465 ' C ' HD12 ' A' ' 57' ' ' LEU . . . -62.3 -34.06 75.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.79 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.465 HD12 ' C ' ' A' ' 56' ' ' ALA . 9.3 mp -110.79 95.27 22.96 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -47.08 175.37 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.457 2.105 . . . . 0.0 112.266 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.77 -38.85 78.23 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.399 2.066 . . . . 0.0 112.392 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -50.67 72.06 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.0 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.08 159.23 15.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.639 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -169.3 154.04 5.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.391 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.047 -0.977 . . . . 0.0 110.396 179.741 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 4' ' ' ASN . 0.3 OUTLIER -102.21 15.75 28.19 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.511 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.632 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 8.5 pm0 -74.48 25.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.835 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.469 ' H ' ' C ' ' A' ' 2' ' ' LEU . 20.0 t-20 -111.23 -46.42 3.3 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.861 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.5 mt -78.3 -48.61 15.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.148 0.499 . . . . 0.0 110.633 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.539 HG13 ' N ' ' A' ' 7' ' ' VAL . 13.1 p -64.23 -44.08 97.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.552 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.539 ' N ' HG13 ' A' ' 6' ' ' VAL . 55.9 t -62.06 -50.02 81.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.825 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.534 ' O ' HD13 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -65.97 -42.67 89.57 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.035 -179.528 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -60.92 -44.2 97.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.401 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 12' ' ' SER . . . -78.5 -68.31 0.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.406 ' HB1' ' CG ' ' A' ' 17' ' ' HIS . . . -41.22 -25.84 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.109 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 8' ' ' LEU . 3.1 m -60.85 -43.83 97.79 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.538 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.3 t -96.18 -34.64 5.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.852 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.73 -46.81 67.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.253 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.73 -11.04 23.29 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.89 -43.06 94.99 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.049 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.406 ' CG ' ' HB1' ' A' ' 11' ' ' ALA . 1.4 m80 -101.07 10.41 41.03 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.902 0.382 . . . . 0.0 110.336 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.29 -52.58 45.95 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.5 tp -66.28 -31.55 54.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.782 0.325 . . . . 0.0 110.774 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.6 mt -70.37 -39.11 74.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.231 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.1 t -62.26 -43.06 99.68 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.795 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -64.46 -35.45 80.97 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.474 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.8 tp -58.8 -36.53 74.61 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.396 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.8 t -76.82 -45.16 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.023 0.439 . . . . 0.0 110.413 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -66.41 -43.28 86.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.949 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -67.02 -24.55 66.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.971 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.5 p -57.22 -32.77 66.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.915 0.388 . . . . 0.0 110.151 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.04 -28.91 70.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.42 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.96 -47.91 70.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.716 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -56.37 -37.8 70.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.831 0.348 . . . . 0.0 110.626 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -68.37 -44.38 75.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.534 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.77 -44.25 99.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.728 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -62.53 -43.92 97.62 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.467 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.55 74.57 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.411 ' HE ' ' HA ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -93.86 -5.02 48.97 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.991 0.424 . . . . 0.0 110.175 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.544 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -66.01 158.45 28.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.636 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.594 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -167.82 174.46 2.35 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.481 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.594 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 31.7 Cg_exo -57.86 139.45 90.37 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.198 1.932 . . . . 0.0 111.682 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.93 -99.27 0.29 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.46 -39.16 88.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.657 0.265 . . . . 0.0 110.95 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 44' ' ' PHE . . . -47.79 -85.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.723 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.438 ' C ' ' O ' ' A' ' 41' ' ' ALA . 72.3 m-85 -30.05 -44.06 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.749 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.13 -47.07 69.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.838 0.351 . . . . 0.0 110.824 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 41' ' ' ALA . 84.1 t80 -87.99 -70.47 0.63 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.27 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.47 ' O ' ' N ' ' A' ' 47' ' ' VAL . 3.5 m-85 -48.94 -39.95 28.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.7 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -41.12 -24.58 0.1 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 45' ' ' TYR . 42.8 t -81.45 76.11 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.923 0.392 . . . . 0.0 110.38 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.596 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -98.67 -39.32 0.24 Allowed Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.707 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 51.5 Cg_exo -53.19 -55.51 3.6 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.088 1.859 . . . . 0.0 112.213 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.537 ' N ' HD12 ' A' ' 50' ' ' LEU . 10.1 mp -67.44 -29.54 69.04 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.998 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.505 ' O ' HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -60.5 -44.69 95.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.92 0.39 . . . . 0.0 110.421 -178.434 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.559 HD23 ' O ' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -77.74 -33.03 53.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.202 0.525 . . . . 0.0 110.406 179.351 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.42 ' C ' ' H ' ' A' ' 55' ' ' LEU . 12.5 tp -66.54 -64.17 0.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.388 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.7 tp -53.9 -9.99 0.28 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.592 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.42 ' H ' ' C ' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -75.73 -73.3 0.27 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.791 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.601 ' O ' HD22 ' A' ' 57' ' ' LEU . . . -96.95 3.15 52.2 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.627 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.601 HD22 ' O ' ' A' ' 56' ' ' ALA . 1.6 mm? -127.45 81.12 70.71 Favored Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -75.99 165.07 30.51 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.378 2.052 . . . . 0.0 112.055 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -43.33 -35.81 5.83 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.361 2.04 . . . . 0.0 111.875 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.9 mtt-85 -49.03 -42.52 38.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.359 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.427 ' HB3' HD13 ' A' ' 57' ' ' LEU . . . -101.81 170.23 8.29 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.756 0.312 . . . . 0.0 110.432 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -83.11 -89.57 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.608 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.461 179.922 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.427 ' C ' ' H ' ' A' ' 4' ' ' ASN . 39.3 mt -65.25 -28.17 69.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.061 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -60.6 -3.49 0.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.522 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.483 ' C ' HD12 ' A' ' 5' ' ' LEU . 90.2 m-20 -115.04 -3.38 12.62 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.763 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.483 HD12 ' C ' ' A' ' 4' ' ' ASN . 10.8 mp -106.82 -73.53 0.68 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.633 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.3 p -46.48 -33.89 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.907 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.499 HG23 ' N ' ' A' ' 8' ' ' LEU . 13.0 m -67.04 -41.11 86.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.759 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.499 ' N ' HG23 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -60.99 -53.42 57.43 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.671 -0.412 . . . . 0.0 109.916 -179.148 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -63.24 -45.11 93.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.311 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.75 -34.03 77.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.262 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 7' ' ' VAL . . . -64.21 -37.44 87.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.454 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.9 t -49.56 -30.72 9.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.267 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.7 t -89.73 -50.16 13.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.454 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.1 -50.66 67.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.748 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.42 -2.74 20.35 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.959 -0.857 . . . . 0.0 110.959 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 18' ' ' GLY . . . -61.1 -110.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.336 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.46 ' H ' ' HD1' ' A' ' 17' ' ' HIS . 46.8 m80 -44.79 -13.12 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.813 0.34 . . . . 0.0 111.031 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -68.33 -45.51 69.09 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.447 HG22 ' O ' ' A' ' 16' ' ' ALA . 19.1 tt -47.1 -24.22 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.371 . . . . 0.0 110.448 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.704 ' C ' HD13 ' A' ' 20' ' ' LEU . 3.0 tm? -64.73 -44.53 89.85 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.043 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.9 t -51.79 -42.86 62.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.439 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -64.17 -47.0 81.52 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.315 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 23' ' ' LEU . 1.0 OUTLIER -54.83 -46.07 74.56 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -177.742 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.1 p -69.21 -40.26 80.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.67 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -65.65 -38.58 89.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.34 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -75.79 -48.83 20.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.721 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.4 m -56.75 -42.07 78.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.389 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.66 -39.6 80.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.178 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.471 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -60.62 -40.07 90.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.565 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 9.7 t-105 -49.84 -32.34 14.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.968 0.413 . . . . 0.0 110.105 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -58.93 -26.22 64.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.198 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 29' ' ' ALA . 7.2 tt -64.43 -33.78 65.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.938 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -68.92 -54.7 14.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.469 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.96 11.44 18.71 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 50.3 ttm-85 -76.88 -15.25 59.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.848 0.356 . . . . 0.0 110.575 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.4 tp -70.32 49.67 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.437 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.559 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -75.32 162.22 73.77 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.186 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.559 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 43.5 Cg_endo -68.29 171.09 13.34 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.793 2.328 . . . . 0.0 111.796 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.83 -88.33 0.5 Allowed Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.23 -47.17 11.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 110.819 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.36 3.21 11.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.62 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -89.41 -45.59 9.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.607 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.488 ' C ' ' H ' ' A' ' 45' ' ' TYR . . . -64.82 -74.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.174 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 46' ' ' GLY . 17.3 m-85 -65.34 6.1 0.33 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.686 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.488 ' H ' ' C ' ' A' ' 43' ' ' ALA . 58.5 t80 -40.95 -24.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.925 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 44' ' ' PHE . . . -92.36 31.26 6.16 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.433 ' N ' ' O ' ' A' ' 44' ' ' PHE . 7.4 p -110.93 -24.94 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 120.895 0.379 . . . . 0.0 110.581 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.639 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 19.0 p-90 -83.2 -29.5 0.45 Allowed Pre-proline 0 CA--C 1.549 0.92 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.702 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 60.4 Cg_endo -87.38 -19.32 2.41 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.951 2.434 . . . . 0.0 112.682 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.5 tp -77.1 -48.97 16.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.98 0.419 . . . . 0.0 110.663 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.6 mt -67.73 -2.21 6.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.323 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.9 tt -65.75 -39.01 90.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.8 mt -94.58 -48.2 6.2 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.805 0.336 . . . . 0.0 111.071 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.8 tp -41.8 -59.61 1.63 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.077 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 55' ' ' LEU . 10.5 mp -62.01 -41.4 98.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.52 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.82 1.0 0.45 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.429 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.469 ' H ' ' C ' ' A' ' 55' ' ' LEU . 64.5 mt -130.79 146.65 62.89 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.656 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.86 138.65 45.23 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.456 2.104 . . . . 0.0 112.45 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -45.06 -20.68 0.44 Allowed 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.351 2.034 . . . . 0.0 112.021 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 72.8 ttt-85 -63.63 -44.1 94.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.273 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.98 -169.31 1.75 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.569 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -168.46 155.83 7.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.489 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.522 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.92 179.884 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.578 ' N ' HD22 ' A' ' 2' ' ' LEU . 3.7 mm? -76.06 145.88 39.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.204 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.434 ' HA ' HH22 ' A' ' 60' ' ' ARG . 33.8 tt0 -67.58 -12.93 61.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.573 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -100.59 -64.88 1.01 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.431 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 5' ' ' LEU . 53.8 mt -49.12 -33.41 11.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.681 0.277 . . . . 0.0 111.284 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.632 HG13 ' N ' ' A' ' 7' ' ' VAL . 14.8 p -62.22 -48.42 88.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.739 0.304 . . . . 0.0 110.806 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.632 ' N ' HG13 ' A' ' 6' ' ' VAL . 7.2 p -85.62 -29.86 6.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.99 0.424 . . . . 0.0 111.288 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.531 HD23 ' C ' ' A' ' 8' ' ' LEU . 3.0 tt -58.32 -74.24 0.06 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.257 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.426 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 28.5 m120 -57.26 -26.62 61.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.498 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.41 -82.3 0.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.848 0.356 . . . . 0.0 111.294 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.467 ' HB1' ' H ' ' A' ' 17' ' ' HIS . . . -53.42 -62.45 1.65 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.024 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 8' ' ' LEU . 1.4 m -38.24 -48.46 1.29 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.743 0.306 . . . . 0.0 110.819 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 9' ' ' ASN . 78.3 t -65.3 -42.73 94.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.945 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . -63.43 -19.26 64.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.537 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 16' ' ' ALA . . . 106.27 -28.79 12.46 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.568 ' C ' ' H ' ' A' ' 18' ' ' GLY . . . -50.79 -98.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.467 ' H ' ' HB1' ' A' ' 11' ' ' ALA . 68.3 t60 -47.48 -5.12 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.568 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -66.49 -51.92 38.92 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.442 HG23 HD22 ' A' ' 20' ' ' LEU . 20.1 tt -68.84 -31.77 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.678 0.275 . . . . 0.0 111.245 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.442 HD22 HG23 ' A' ' 19' ' ' ILE . 3.8 mm? -66.49 -42.35 87.54 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.449 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.406 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.4 m -65.83 -35.96 82.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.128 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -76.44 -21.63 55.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.762 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.1 tp -63.28 -40.76 98.29 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.652 0.263 . . . . 0.0 111.326 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 21' ' ' SER . 2.0 p -70.19 -28.81 37.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.166 0.508 . . . . 0.0 109.965 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -71.34 -41.02 70.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.604 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.5 ' O ' ' N ' ' A' ' 29' ' ' ALA . 16.2 t80 -65.85 -38.34 88.61 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.554 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 85.3 p -45.62 -39.1 7.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.18 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.83 -29.03 70.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.144 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . -57.49 -38.13 74.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.642 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.432 ' CD1' ' N ' ' A' ' 30' ' ' TRP . 40.3 m0 -57.2 -41.0 78.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.495 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -65.01 -44.02 90.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.42 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.1 mt -66.57 -43.5 90.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.935 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -70.7 -54.31 12.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.838 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.34 28.2 68.38 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -100.06 9.88 42.16 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.729 0.3 . . . . 0.0 110.65 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.7 mt -110.07 173.65 6.23 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.64 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.656 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -157.08 173.26 5.16 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.312 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.656 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 51.3 Cg_exo -52.42 72.83 0.02 OUTLIER 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 122.71 2.273 . . . . 0.0 112.28 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . -112.86 -129.76 5.19 Favored Glycine 0 N--CA 1.466 0.695 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.0 -40.2 14.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.697 0.284 . . . . 0.0 110.76 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.69 -10.32 59.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.803 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.22 -51.53 6.22 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.804 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.2 -49.21 78.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.18 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.465 ' O ' ' N ' ' A' ' 46' ' ' GLY . 62.0 t80 -62.43 -44.67 95.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.155 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.446 ' CD1' ' C ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -40.82 -25.24 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.269 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 44' ' ' PHE . . . -62.65 -62.58 5.41 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.112 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.2 p -83.5 10.66 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.897 0.349 . . . . 0.0 111.63 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.538 ' C ' ' H ' ' A' ' 50' ' ' LEU . 1.3 t90 -44.08 -44.67 18.08 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.225 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 32.0 Cg_exo -57.98 13.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.509 2.383 0 C-N-CA 122.533 2.156 . . . . 0.0 113.336 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.592 HD23 ' O ' ' A' ' 50' ' ' LEU . 3.9 tt -104.0 -50.47 3.37 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.082 0.468 . . . . 0.0 110.125 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.1 tp -60.41 -38.91 85.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.463 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 52' ' ' LEU . 3.9 mm? -59.33 -73.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 53' ' ' LEU . 9.7 mp -46.37 -33.04 3.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.783 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.1 tp -63.29 -69.56 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.876 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.3 mt -68.31 -39.37 82.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.717 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.94 -16.48 6.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.789 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 43.2 mt -123.99 90.36 50.77 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.474 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.63 -178.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.072 0 C-N-CA 123.069 2.513 . . . . 0.0 112.724 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.548 ' C ' ' H ' ' A' ' 61' ' ' ALA . 32.0 Cg_exo -57.32 -39.65 88.08 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.941 2.427 . . . . 0.0 112.501 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.471 ' CZ ' HG11 ' A' ' 6' ' ' VAL . 4.7 ptm180 -63.79 8.42 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.548 ' H ' ' C ' ' A' ' 59' ' ' PRO . . . -77.34 95.62 4.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.257 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -92.87 -31.62 14.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.487 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.481 179.989 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.623 ' O ' HG13 ' A' ' 7' ' ' VAL . 9.4 mp -74.63 142.72 44.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.446 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.493 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 58.6 mp0 -72.73 -2.96 22.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.534 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -65.28 -144.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.74 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.541 ' N ' HD22 ' A' ' 5' ' ' LEU . 3.8 mm? -82.91 -8.24 59.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.351 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 70.5 t -60.42 -46.27 95.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.093 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 2' ' ' LEU . 2.2 m -64.12 -47.56 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.293 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.5 tp -61.52 -43.84 98.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.111 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.444 ' O ' ' OG ' ' A' ' 12' ' ' SER . 20.5 m120 -60.96 -46.39 90.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.285 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.95 -37.43 72.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.424 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.99 -36.18 83.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.974 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 9' ' ' ASN . 58.9 p -61.33 -34.13 74.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.969 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.5 m -100.25 -13.65 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.898 0.38 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.34 -57.64 5.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.481 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.93 -71.12 0.51 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.04 -50.07 71.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.663 0.268 . . . . 0.0 110.619 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -49.11 -19.1 0.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.619 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.86 -63.33 4.7 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.2 mm -54.16 -23.85 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.802 0.335 . . . . 0.0 110.414 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 mt -79.16 -31.87 44.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.21 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.508 ' O ' HG12 ' A' ' 24' ' ' VAL . 1.6 m -71.4 -44.79 64.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.17 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -72.65 -14.49 61.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.547 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.82 HD21 ' HE1' ' A' ' 48' ' ' TRP . 4.6 tt -67.54 -31.42 71.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.952 0.406 . . . . 0.0 111.132 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.508 HG12 ' O ' ' A' ' 21' ' ' SER . 4.3 p -64.49 -21.55 29.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.925 0.393 . . . . 0.0 111.342 -178.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -63.16 -38.72 92.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.449 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 52.4 m-85 -60.78 -43.81 97.6 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.556 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.7 t -45.31 -46.65 12.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.129 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.51 -39.66 24.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.567 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.449 ' HB3' ' HA ' ' A' ' 26' ' ' PHE . . . -55.35 -28.12 51.74 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.763 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.606 ' HB3' HD23 ' A' ' 36' ' ' LEU . 43.7 m95 -64.91 -28.37 69.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.788 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -77.6 -52.17 9.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.346 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.411 ' CG1' ' N ' ' A' ' 33' ' ' LYS . 3.1 pt -65.49 -39.35 84.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.527 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.414 ' CG ' ' O ' ' A' ' 29' ' ' ALA . 16.7 mmmt -59.28 -34.44 72.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.469 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.06 -5.36 71.79 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -87.42 63.13 7.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.736 0.303 . . . . 0.0 110.456 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.606 HD23 ' HB3' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -135.38 112.86 10.67 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.041 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.71 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -162.19 174.34 3.76 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.53 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.71 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 52.7 Cg_exo -53.18 134.84 58.02 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.724 2.283 . . . . 0.0 111.909 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.69 -124.98 1.2 Allowed Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.506 ' C ' ' H ' ' A' ' 42' ' ' TYR . . . -97.31 -5.11 37.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.77 0.319 . . . . 0.0 110.657 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.81 -3.27 0.07 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.959 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.506 ' H ' ' C ' ' A' ' 40' ' ' ALA . 27.9 m-85 -65.94 -41.32 91.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.927 0.394 . . . . 0.0 110.552 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.79 -53.04 62.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.614 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -61.76 -69.65 0.23 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.439 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -59.22 -14.55 11.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.512 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -44.64 -79.87 0.05 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.3 m -123.19 48.09 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.721 0.296 . . . . 0.0 110.664 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.82 ' HE1' HD21 ' A' ' 23' ' ' LEU . 1.1 t90 -67.56 -41.94 33.78 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.269 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 30.7 Cg_exo -61.5 -27.66 82.44 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.901 2.401 . . . . 0.0 112.131 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.506 ' O ' HD12 ' A' ' 53' ' ' LEU . 5.6 tt -74.61 -27.32 60.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.783 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 tp -95.85 10.05 38.47 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.807 0.337 . . . . 0.0 111.071 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.507 ' C ' ' H ' ' A' ' 54' ' ' LEU . 6.5 tt -78.72 -42.21 28.91 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.074 0.464 . . . . 0.0 111.897 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.7 ' C ' HD22 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -48.89 -9.23 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.119 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.507 ' H ' ' C ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -59.14 -54.33 48.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.769 0.319 . . . . 0.0 110.684 -178.075 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.5 tt -68.47 -52.04 36.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.837 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.34 -27.64 68.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.923 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 53' ' ' LEU . 2.8 mp -145.97 98.74 4.39 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.823 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.409 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 50.1 Cg_exo -48.29 -175.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 123.062 2.508 . . . . 0.0 112.554 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 61' ' ' ALA . 51.3 Cg_exo -54.42 -27.28 48.4 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.046 2.497 . . . . 0.0 111.995 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -42.98 -23.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.317 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 59' ' ' PRO . . . -107.02 176.44 5.17 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.33 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -161.19 30.76 0.14 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.496 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.586 -179.946 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 64.9 mt -98.34 126.45 43.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.977 0.418 . . . . 0.0 110.287 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 4' ' ' ASN . 23.4 tt0 -90.6 -141.43 0.16 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.411 ' H ' ' HG2' ' A' ' 3' ' ' GLU . 11.0 t-20 -87.5 3.53 46.99 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.845 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.2 tp -69.2 -85.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.984 0.421 . . . . 0.0 111.039 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.474 ' O ' ' OD1' ' A' ' 9' ' ' ASN . 95.3 t -40.62 -50.99 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.981 0.42 . . . . 0.0 111.002 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.424 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 0.7 OUTLIER -40.36 -30.14 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.965 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.436 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -56.98 -70.45 0.12 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.121 -178.177 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.474 ' OD1' ' O ' ' A' ' 6' ' ' VAL . 21.8 p-10 -69.8 -34.78 74.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.616 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.44 -50.24 72.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.396 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 7' ' ' VAL . . . -64.22 -39.4 93.9 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.925 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.0 t -62.66 -47.29 84.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.563 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.3 t -75.03 -45.33 42.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.95 -58.34 7.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.786 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.84 -5.85 84.2 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.79 -37.27 87.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.856 0.36 . . . . 0.0 110.734 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -86.01 14.78 5.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.188 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.68 -51.28 55.26 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.6 mm -67.43 -40.46 84.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.163 0.506 . . . . 0.0 110.178 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 20' ' ' LEU . 10.9 mp -67.61 -42.53 82.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.08 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.449 ' O ' HG12 ' A' ' 24' ' ' VAL . 78.1 p -64.39 -44.68 90.56 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.625 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -67.31 -25.59 66.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.529 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.2 tp -61.44 -40.49 94.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.479 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 21' ' ' SER . 1.0 OUTLIER -72.27 -34.97 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.991 0.424 . . . . 0.0 110.097 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -67.52 -46.19 73.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.485 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -56.23 -29.12 60.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.279 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.0 m -57.72 -35.87 71.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.014 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.15 -39.71 86.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.408 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.42 -34.95 26.36 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-O 121.015 0.436 . . . . 0.0 110.355 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.485 ' CD1' ' N ' ' A' ' 30' ' ' TRP . 19.2 m0 -78.09 -35.08 49.82 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.098 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -63.58 -45.99 87.9 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.55 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 33' ' ' LYS . 14.4 tt -69.72 -40.84 79.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.545 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.461 ' N ' HG23 ' A' ' 32' ' ' ILE . 19.5 tptm -64.24 -46.91 81.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.23 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.25 7.91 63.37 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.575 ' C ' ' H ' ' A' ' 37' ' ' ALA . 10.2 tpt85 -74.19 -19.67 60.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 110.224 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 37' ' ' ALA . 1.9 pp -52.82 -1.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.172 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.596 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -39.74 164.87 0.06 OUTLIER Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 120.694 0.283 . . . . 0.0 110.459 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.596 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 70.9 Cg_exo -40.95 125.95 2.36 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.407 2.071 . . . . 0.0 111.702 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 168.0 -120.5 0.9 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.58 -13.45 24.38 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.701 0.286 . . . . 0.0 110.726 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.63 -10.09 24.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.619 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -62.97 -37.66 87.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.651 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.5 -43.34 84.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.848 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.407 ' C ' ' N ' ' A' ' 46' ' ' GLY . 71.1 m-85 -63.17 -69.04 0.29 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.648 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -47.21 -20.19 0.17 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.281 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' A' ' 44' ' ' PHE . . . -65.33 -32.6 84.19 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 t -146.56 78.77 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 120.588 0.232 . . . . 0.0 110.677 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.63 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -82.98 -39.9 0.81 Allowed Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.548 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 38.4 Cg_exo -59.58 2.85 0.24 Allowed 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.836 2.357 . . . . 0.0 112.119 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.479 ' H ' ' C ' ' A' ' 48' ' ' TRP . 54.5 tp -69.99 -43.15 72.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.575 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.611 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.7 mm? -85.0 -20.75 30.02 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.527 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 52' ' ' LEU . 2.9 tt -67.61 -55.36 13.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.704 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.744 HD23 ' H ' ' A' ' 54' ' ' LEU . 0.9 OUTLIER -73.11 -37.74 66.6 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.964 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.744 ' H ' HD23 ' A' ' 53' ' ' LEU . 50.0 tp -64.57 -45.26 87.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.087 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.88 -34.28 66.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.714 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -46.1 -34.57 4.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.556 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.564 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -156.42 153.92 26.01 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.825 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.35 163.97 32.44 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.59 2.193 . . . . 0.0 112.283 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -47.03 -27.17 5.71 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.706 2.271 . . . . 0.0 112.086 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 83.2 mtt85 -56.9 -72.44 0.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.882 0.372 . . . . 0.0 110.443 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.03 -175.94 1.04 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.31 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -161.61 129.14 4.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.533 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.657 179.964 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 . . . . . 0 N--CA 1.457 -0.075 0 CA-C-O 120.834 0.35 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.511 ' C ' ' H ' ' A' ' 6' ' ' VAL . 6.1 m-20 -69.03 -56.64 7.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.558 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.585 ' N ' HD22 ' A' ' 5' ' ' LEU . 4.0 mm? -53.0 -6.41 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.561 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 4' ' ' ASN . 40.1 t -91.44 -51.92 10.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.567 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 13.6 p -81.45 -23.36 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.529 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.614 ' O ' HD13 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -61.98 -46.66 88.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.556 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.4 ' ND2' ' O ' ' A' ' 5' ' ' LEU . 23.8 m-80 -64.02 -46.7 83.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.567 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.82 -36.87 73.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.566 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 7' ' ' VAL . . . -55.45 -44.06 76.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.563 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.5 p -62.21 -41.75 98.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.556 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.9 t -68.94 -43.37 82.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.55 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.87 -52.47 63.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.575 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.27 -81.63 0.35 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.65 -67.48 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.822 0.344 . . . . 0.0 110.578 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -51.9 -19.42 1.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.632 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.33 -54.01 6.45 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 21.2 pt -68.84 -22.82 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 0.0 110.547 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.451 ' HA ' HD13 ' A' ' 20' ' ' LEU . 1.7 mm? -69.48 -41.91 75.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.54 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.3 m -63.74 -28.77 70.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.557 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.44 ' O ' ' N ' ' A' ' 25' ' ' PHE . 5.1 m-85 -64.31 -11.47 32.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.572 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.619 HD11 ' CZ3' ' A' ' 48' ' ' TRP . 61.4 tp -41.31 -39.64 1.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.545 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.557 HG22 HD21 ' A' ' 52' ' ' LEU . 8.8 t -71.03 -39.68 75.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.568 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.44 ' N ' ' O ' ' A' ' 22' ' ' PHE . 84.9 t80 -74.82 -27.78 60.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.625 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.58 -42.78 77.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.55 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.0 m -46.2 -42.74 14.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.568 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.69 -36.24 57.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.538 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.584 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -58.01 -39.68 78.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.561 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -69.34 -33.7 73.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.553 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -60.81 -22.12 63.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.608 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.674 HG23 ' N ' ' A' ' 33' ' ' LYS . 10.6 tp -48.04 -50.06 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.563 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.674 ' N ' HG23 ' A' ' 32' ' ' ILE . 4.7 tppt? -64.52 -50.56 66.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.515 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.9 43.13 6.87 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.762 ' O ' ' N ' ' A' ' 37' ' ' ALA . 15.4 ptm180 -145.5 -5.06 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.744 0.306 . . . . 0.0 110.523 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.699 ' C ' ' O ' ' A' ' 35' ' ' ARG . 32.2 tp -6.33 71.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.563 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.762 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -21.1 91.9 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.625 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.532 ' N ' ' O ' ' A' ' 36' ' ' LEU . 48.0 Cg_exo -53.62 150.74 27.11 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.843 2.362 . . . . 0.0 112.169 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.17 -75.51 0.42 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.48 ' C ' ' N ' ' A' ' 42' ' ' TYR . . . -87.77 -72.51 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.763 0.316 . . . . 0.0 110.575 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.12 -13.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.59 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.48 ' N ' ' C ' ' A' ' 40' ' ' ALA . 30.7 t80 -86.62 -49.39 7.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.551 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.35 -36.22 82.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.622 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.5 ' C ' ' H ' ' A' ' 46' ' ' GLY . 4.3 m-85 -44.61 -39.59 5.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.589 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -49.01 -10.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.62 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 44' ' ' PHE . . . -62.78 -35.47 91.99 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.0 m -148.62 23.91 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.85 0.357 . . . . 0.0 110.581 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.627 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -80.79 -42.99 1.25 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.513 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 15.1 Cg_exo -68.01 -15.09 42.77 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.806 2.337 . . . . 0.0 112.181 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.461 ' O ' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -62.16 -33.96 75.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.521 -179.038 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 tp -61.71 -7.56 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.611 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.702 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 55.1 mt -62.81 -49.55 74.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.609 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -85.2 -14.33 47.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.577 -178.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.525 ' O ' HD13 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -76.96 -58.31 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.578 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.613 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -75.84 -38.72 57.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.616 -178.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.755 ' HB3' HD13 ' A' ' 57' ' ' LEU . . . -34.11 -52.47 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.572 -177.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.046 HD13 ' N ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -111.57 155.7 42.56 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.548 178.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -78.27 163.44 27.61 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.843 2.362 . . . . 0.0 112.126 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.506 ' C ' ' H ' ' A' ' 61' ' ' ALA . 54.5 Cg_exo -47.93 -42.23 31.72 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.744 2.296 . . . . 0.0 112.121 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -68.16 42.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.621 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 59' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.602 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.551 ' O ' HG21 ' A' ' 7' ' ' VAL . 17.4 tp10 . . . . . 0 CA--C 1.528 0.099 0 CA-C-O 120.745 0.307 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.439 ' O ' ' O ' ' A' ' 5' ' ' LEU . 75.0 m-20 -112.08 -35.05 5.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.568 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 5' ' ' LEU . 4.1 mm? -48.27 -104.73 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.773 0.32 . . . . 0.0 111.446 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.0 t -44.03 -31.05 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.883 0.373 . . . . 0.0 110.72 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.551 HG21 ' O ' ' A' ' 3' ' ' GLU . 94.8 t -62.32 -42.52 95.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.717 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.5 tp -62.21 -43.28 99.18 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.051 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -75.64 -34.88 60.54 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.048 0.451 . . . . 0.0 110.797 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 12' ' ' SER . . . -72.24 -77.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.787 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -43.16 -15.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.342 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -57.74 -38.8 75.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.363 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.3 p -94.85 -37.57 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.562 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.63 -37.78 8.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.609 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.38 -21.6 28.33 Favored Glycine 0 N--CA 1.465 0.588 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.41 -50.59 71.18 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.522 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -101.15 12.41 37.64 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.961 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.78 -48.48 55.14 Favored Glycine 0 N--CA 1.462 0.425 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.642 HG23 ' CD2' ' A' ' 20' ' ' LEU . 8.6 tt -67.49 -34.02 65.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.841 0.353 . . . . 0.0 110.495 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.656 HD12 HD13 ' A' ' 54' ' ' LEU . 4.5 mm? -78.13 -25.87 47.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.69 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.507 ' O ' HG12 ' A' ' 24' ' ' VAL . 48.0 t -59.04 -43.16 91.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.913 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -62.22 -31.27 71.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.916 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.577 HD23 ' O ' ' A' ' 23' ' ' LEU . 1.1 tt -48.76 -39.38 24.81 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.391 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 21' ' ' SER . 1.8 p -63.21 -33.24 59.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.91 0.386 . . . . 0.0 110.255 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -63.94 -37.37 87.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.011 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -56.35 -43.85 79.53 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.754 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -44.59 -45.26 9.4 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.506 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.53 -39.24 22.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.843 0.354 . . . . 0.0 110.96 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.7 -36.07 24.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.253 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -59.22 -33.45 71.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.129 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -66.37 -44.9 81.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.542 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.5 mt -59.78 -44.42 93.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.949 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.646 ' C ' ' H ' ' A' ' 35' ' ' ARG . 84.7 tttt -69.32 -60.45 2.33 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.284 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 36' ' ' LEU . . . 56.47 -12.22 0.01 OUTLIER Glycine 0 CA--C 1.536 1.361 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.646 ' H ' ' C ' ' A' ' 33' ' ' LYS . 2.0 mmp_? -72.19 20.75 0.06 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.026 0.441 . . . . 0.0 110.922 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.505 ' H ' ' C ' ' A' ' 34' ' ' GLY . 46.8 tp -130.97 123.68 29.36 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.067 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.465 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -65.79 159.76 66.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.81 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.587 ' O ' ' N ' ' A' ' 40' ' ' ALA . 36.7 Cg_endo -65.4 -91.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.502 2.135 . . . . 0.0 111.47 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 49.88 -79.31 0.01 OUTLIER Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' A' ' 38' ' ' PRO . . . -68.1 -25.22 65.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.37 . . . . 0.0 110.39 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.43 -10.51 59.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.406 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -64.45 -71.23 0.18 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.367 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -79.18 -77.7 0.17 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.838 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.806 ' O ' HG22 ' A' ' 47' ' ' VAL . 80.6 t80 -23.17 -89.7 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.622 0.576 . . . . 0.0 111.94 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -52.87 -29.34 27.57 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.257 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -45.29 -14.51 0.06 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.806 HG22 ' O ' ' A' ' 44' ' ' PHE . 10.5 m -102.25 59.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.976 0.417 . . . . 0.0 110.648 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -66.79 -56.41 14.41 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.748 179.295 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 48' ' ' TRP . 27.6 Cg_endo -61.44 -16.74 49.34 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.61 2.206 . . . . 0.0 112.36 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.424 HD23 ' O ' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -95.32 -45.51 7.11 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.819 0.342 . . . . 0.0 110.412 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.9 tp -60.66 -24.34 65.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.467 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -69.36 4.13 1.91 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.557 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.616 ' C ' HD12 ' A' ' 53' ' ' LEU . 3.2 pp -68.24 -35.69 78.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.041 0.448 . . . . 0.0 110.678 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.656 HD13 HD12 ' A' ' 20' ' ' LEU . 2.2 pp -70.06 -1.26 9.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.871 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.4 -56.5 1.31 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.336 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.02 -19.88 50.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.191 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.0 tp -119.93 65.9 10.4 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.467 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.68 164.11 22.3 Favored 'Trans proline' 0 N--CA 1.501 1.915 0 C-N-CA 122.734 2.289 . . . . 0.0 111.872 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.51 -60.91 0.34 Allowed 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.764 2.309 . . . . 0.0 112.119 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.27 -75.56 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.673 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.276 -179.781 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.423 ' O ' ' CB ' ' A' ' 4' ' ' ASN . 18.6 pt-20 . . . . . 0 N--CA 1.466 0.343 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.57 ' C ' ' H ' ' A' ' 6' ' ' VAL . 55.4 t30 82.16 -123.02 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.612 0.57 . . . . 0.0 110.988 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tp -56.31 7.95 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.57 ' H ' ' C ' ' A' ' 4' ' ' ASN . 5.6 p -67.61 -46.49 82.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.974 0.416 . . . . 0.0 111.068 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.521 ' N ' HG13 ' A' ' 6' ' ' VAL . 13.5 p -64.84 -41.12 91.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.965 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.483 ' N ' HG13 ' A' ' 7' ' ' VAL . 31.9 tp -46.07 -70.74 0.09 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.191 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -66.43 -46.94 74.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.519 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.51 -47.79 69.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.704 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.37 -42.84 92.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.82 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.4 m -63.44 -44.33 94.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.009 0.433 . . . . 0.0 110.534 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.1 t -68.95 -42.72 82.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.678 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -44.34 -57.04 3.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.594 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.71 -90.45 0.34 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 18' ' ' GLY . . . -59.87 -40.77 89.81 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.709 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -55.14 -3.82 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.75 0.309 . . . . 0.0 110.777 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -75.15 -51.05 7.85 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.435 HG22 ' O ' ' A' ' 16' ' ' ALA . 17.4 tt -45.75 -17.64 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.761 0.315 . . . . 0.0 110.636 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -64.74 -42.79 94.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.857 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.408 ' O ' HG22 ' A' ' 24' ' ' VAL . 77.9 p -70.6 -41.54 72.16 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.385 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -65.66 -16.59 63.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.684 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.6 tp -50.74 -36.19 35.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.514 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' ' 25' ' ' PHE . 3.3 m -72.78 -39.82 60.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.914 0.388 . . . . 0.0 110.501 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.418 ' N ' HG23 ' A' ' 24' ' ' VAL . 28.5 m-85 -63.57 -45.41 90.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.718 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -67.04 -42.72 84.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 0.0 110.607 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.6 m -53.8 -43.8 69.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.502 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.34 -40.57 62.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.424 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.472 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -60.91 -51.48 69.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -52.64 -27.23 16.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.603 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.493 ' CZ ' HD23 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -72.74 -16.83 61.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.662 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.587 HG23 ' N ' ' A' ' 33' ' ' LYS . 18.8 tt -53.06 -50.05 47.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.703 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.587 ' N ' HG23 ' A' ' 32' ' ' ILE . 3.0 ptpp? -62.54 -46.87 86.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.295 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.96 11.14 47.22 Favored Glycine 0 N--CA 1.464 0.519 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.455 ' C ' ' H ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -79.06 -15.1 58.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.889 0.376 . . . . 0.0 110.312 179.378 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.493 HD23 ' CZ ' ' A' ' 31' ' ' TYR . 3.4 tp -73.63 13.36 0.49 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.225 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.663 ' HB1' ' CD ' ' A' ' 38' ' ' PRO . . . -47.43 -179.8 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.4 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.663 ' CD ' ' HB1' ' A' ' 37' ' ' ALA . 37.2 Cg_exo -59.95 148.17 89.86 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.089 1.859 . . . . 0.0 111.634 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.31 -128.81 2.68 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.2 -10.18 28.71 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.727 0.299 . . . . 0.0 110.941 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.406 ' C ' ' N ' ' A' ' 43' ' ' ALA . . . -82.96 -72.47 0.45 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.057 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -47.1 -20.75 0.18 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.286 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.406 ' N ' ' C ' ' A' ' 41' ' ' ALA . . . -57.67 -88.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.779 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -64.62 -45.35 87.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.206 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.509 ' C ' ' H ' ' A' ' 47' ' ' VAL . 14.3 t80 -59.13 -16.08 17.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.528 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.08 20.36 0.92 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.723 ' O ' HG13 ' A' ' 47' ' ' VAL . 12.7 p -99.05 71.79 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.104 0.478 . . . . 0.0 110.649 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.608 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 3.0 m0 -100.78 -34.04 0.23 Allowed Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.638 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 57.9 Cg_endo -77.59 -24.8 8.6 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.662 1.574 . . . . 0.0 112.575 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.503 ' O ' HD13 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -74.7 -46.31 38.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.934 0.397 . . . . 0.0 110.441 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.07 -47.14 72.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.3 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.8 mt -52.75 -30.15 31.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.142 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.4 tp -67.21 -44.04 80.55 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' LEU . 55.8 tp -62.45 -44.96 95.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.758 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.0 tp -69.99 -37.76 75.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.811 0.339 . . . . 0.0 110.662 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.07 -30.9 60.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.137 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -155.28 148.03 17.95 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.626 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.458 ' HG3' ' H ' ' A' ' 4' ' ' ASN . 35.1 Cg_endo -65.53 171.66 9.12 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.346 2.031 . . . . 0.0 112.534 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' A' ' 61' ' ' ALA . 31.2 Cg_exo -59.47 -17.12 39.24 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 122.329 2.02 . . . . 0.0 112.163 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.491 ' O ' ' C ' ' A' ' 61' ' ' ALA . 58.6 mtm180 44.85 -91.15 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.422 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 59' ' ' PRO . . . . . . . . 0 N--CA 1.476 0.83 0 O-C-N 123.764 0.665 . . . . 0.0 111.961 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 110.386 -0.228 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.1 m120 72.82 -60.75 0.52 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.43 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.3 pp -70.66 -29.83 66.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.488 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.515 HG23 ' N ' ' A' ' 7' ' ' VAL . 28.7 m -56.79 -46.22 83.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.64 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.515 ' N ' HG23 ' A' ' 6' ' ' VAL . 19.9 t -46.25 -29.69 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.829 0.347 . . . . 0.0 110.541 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.8 tp -94.23 -56.41 2.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.591 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -66.43 -55.61 14.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.434 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 6' ' ' VAL . . . -55.74 -54.26 46.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 110.644 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.15 -41.45 68.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.58 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 t -63.57 -45.49 90.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.542 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.5 t -74.15 -58.03 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.195 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.49 -58.03 9.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.774 0.321 . . . . 0.0 110.91 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.9 -32.45 6.82 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' A' ' 18' ' ' GLY . . . -69.91 -57.85 4.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.926 0.393 . . . . 0.0 110.322 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -50.75 -8.03 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.773 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.501 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -66.13 -58.06 9.53 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.2 pt -56.0 -24.05 16.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.424 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -72.67 -40.73 66.08 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.3 t -64.8 -43.46 93.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.631 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -78.91 -18.19 54.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.993 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.2 tp -48.9 -34.03 11.93 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.4 t -77.86 -36.64 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.693 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -61.0 -47.36 86.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.169 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -59.52 -26.82 65.64 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.515 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.7 t -51.12 -42.01 60.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.044 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.12 -37.89 53.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.383 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.475 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -59.08 -54.12 50.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.081 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 9.1 m0 -57.01 -23.79 48.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.702 0.287 . . . . 0.0 110.956 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.45 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 41.0 t80 -73.02 -14.99 61.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.688 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.506 HG23 ' N ' ' A' ' 33' ' ' LYS . 15.3 tt -62.09 -44.7 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.216 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.506 ' N ' HG23 ' A' ' 32' ' ' ILE . 1.5 tptm -70.84 -56.99 5.08 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.376 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.97 24.63 3.55 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -80.49 60.92 4.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.769 0.318 . . . . 0.0 110.283 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.9 mt -134.41 124.88 26.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.258 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -164.15 168.5 9.28 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.194 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.613 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 65.5 Cg_exo -47.63 106.4 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.092 1.861 . . . . 0.0 112.074 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 133.82 -48.71 0.94 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.69 -60.77 2.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.822 0.344 . . . . 0.0 110.762 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.92 -5.82 14.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.52 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -72.96 -62.22 1.54 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.924 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.68 92.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.183 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.442 ' C ' ' H ' ' A' ' 46' ' ' GLY . 4.5 m-85 -63.1 -83.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.349 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -53.65 -8.76 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.699 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 44' ' ' PHE . . . -65.85 -52.58 36.8 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.7 m -135.7 11.09 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.871 0.367 . . . . 0.0 110.675 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.551 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 13.1 t90 -61.64 -51.76 74.22 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 48' ' ' TRP . 11.1 Cg_endo -51.85 -16.4 4.09 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.807 1.672 . . . . 0.0 112.288 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.8 tp -76.06 -33.6 59.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.979 0.418 . . . . 0.0 110.1 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 72.6 mt -78.18 2.49 17.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.507 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.4 tt -85.21 -32.14 22.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.9 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 53' ' ' LEU . 10.2 mp -63.6 -32.43 73.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.389 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.3 tp -54.91 -46.0 74.82 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 tt -62.78 -40.08 96.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.855 0.359 . . . . 0.0 110.257 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.02 -11.44 59.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.698 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.7 mt -134.58 66.94 71.03 Favored Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.361 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.543 ' O ' ' N ' ' A' ' 60' ' ' ARG . 59.6 Cg_endo -77.74 163.63 28.78 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.709 2.273 . . . . 0.0 112.335 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -43.67 -11.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.698 2.265 . . . . 0.0 112.588 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 58' ' ' PRO . 9.3 tmm_? -70.68 -60.22 2.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.373 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.291 179.863 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.704 0.288 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -105.9 38.12 2.09 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.872 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.3 tp -112.52 -70.86 0.78 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.381 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.595 HG13 ' N ' ' A' ' 7' ' ' VAL . 11.5 p -60.34 -47.33 92.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.428 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.595 ' N ' HG13 ' A' ' 6' ' ' VAL . 12.7 p -64.64 -40.96 90.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.462 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.648 HD11 ' CE1' ' A' ' 17' ' ' HIS . 35.5 tp -61.71 -44.74 96.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.409 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -63.95 -45.67 88.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.95 0.405 . . . . 0.0 110.577 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 14' ' ' ALA . . . -69.94 -26.49 64.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.343 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.416 ' HA ' ' H ' ' A' ' 15' ' ' GLY . . . -75.64 -17.81 59.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.554 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.6 t -64.38 -50.97 65.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.318 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.5 p -91.79 -21.0 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.181 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 10' ' ' ALA . . . -93.16 -77.84 0.44 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.592 0.234 . . . . 0.0 110.995 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.416 ' H ' ' HA ' ' A' ' 11' ' ' ALA . . . -64.04 -164.5 0.74 Allowed Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.245 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 18' ' ' GLY . . . -90.94 -1.78 57.79 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.648 ' CE1' HD11 ' A' ' 8' ' ' LEU . 42.2 t60 -41.66 -19.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.139 -0.225 . . . . 0.0 111.299 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -67.37 -49.6 50.53 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.433 HG22 ' O ' ' A' ' 16' ' ' ALA . 15.1 tt -49.24 -28.26 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.83 0.348 . . . . 0.0 110.679 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.703 ' C ' HD13 ' A' ' 20' ' ' LEU . 3.2 tm? -65.97 -45.02 83.21 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.496 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.8 m -59.65 -43.76 93.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.779 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -61.69 -39.82 92.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.666 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.32 -39.23 89.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.816 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.1 t -68.18 -42.85 85.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.007 0.432 . . . . 0.0 110.036 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -63.12 -44.24 96.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.59 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.62 -41.8 99.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.182 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.0 m -54.35 -41.47 69.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.343 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.69 -43.06 39.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.494 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.5 -38.39 89.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.411 ' C ' ' N ' ' A' ' 32' ' ' ILE . 58.0 t-105 -59.89 -30.39 68.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.148 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -52.03 -15.04 0.48 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.138 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.411 ' N ' ' C ' ' A' ' 30' ' ' TRP . 3.5 tp -67.65 -19.28 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.504 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.632 ' C ' ' H ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -42.15 -58.01 2.29 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 58.47 -14.75 0.02 OUTLIER Glycine 0 CA--C 1.534 1.274 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.021 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.632 ' H ' ' C ' ' A' ' 33' ' ' LYS . 85.0 mtm-85 -128.36 70.35 1.37 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.038 0.419 . . . . 0.0 111.097 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.512 HD13 ' N ' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -152.61 118.97 5.57 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 179.358 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.512 ' N ' HD13 ' A' ' 36' ' ' LEU . . . -79.91 158.13 73.11 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-O 120.766 0.317 . . . . 0.0 110.484 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 35.0 Cg_endo -63.88 -177.89 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.533 2.155 . . . . 0.0 111.783 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.91 -72.42 0.35 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' A' ' 42' ' ' TYR . . . -56.72 -34.94 67.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.766 0.317 . . . . 0.0 110.665 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.47 21.19 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.82 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.525 ' H ' ' C ' ' A' ' 40' ' ' ALA . 81.3 t80 -56.52 -42.96 79.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.443 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.14 -42.2 90.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.325 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -55.67 -47.62 76.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.792 0.329 . . . . 0.0 110.338 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.432 ' O ' ' O ' ' A' ' 46' ' ' GLY . 31.4 m-85 -75.98 -35.64 59.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.28 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 45' ' ' TYR . . . -42.26 -97.99 0.01 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -144.46 36.24 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.702 0.287 . . . . 0.0 111.074 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.567 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 20.2 t-105 -60.95 -46.59 96.74 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.877 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 48' ' ' TRP . 30.4 Cg_endo -61.99 -13.65 32.57 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 121.765 1.643 . . . . 0.0 112.522 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.7 tp -77.33 -38.8 49.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.752 0.311 . . . . 0.0 110.922 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.499 HD22 ' N ' ' A' ' 51' ' ' LEU . 4.0 mm? -62.44 -40.18 95.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.579 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.0 mt -49.06 -19.04 0.37 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.442 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.675 HD23 ' O ' ' A' ' 53' ' ' LEU . 3.0 tt -66.44 -43.43 85.65 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.299 0.571 . . . . 0.0 110.062 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.5 mt -74.05 -19.15 60.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.403 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 55' ' ' LEU . 11.2 mp -93.99 -41.94 9.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.937 0.399 . . . . 0.0 110.233 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.465 ' C ' HD12 ' A' ' 57' ' ' LEU . . . -62.3 -34.06 75.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.79 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.465 HD12 ' C ' ' A' ' 56' ' ' ALA . 9.3 mp -110.79 95.27 22.96 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -47.08 175.37 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.457 2.105 . . . . 0.0 112.266 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.77 -38.85 78.23 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.399 2.066 . . . . 0.0 112.392 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -50.67 72.06 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.0 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.639 179.629 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 pm0 . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.713 0.292 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.23 -46.42 3.3 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.861 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.5 mt -78.3 -48.61 15.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.148 0.499 . . . . 0.0 110.633 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.539 HG13 ' N ' ' A' ' 7' ' ' VAL . 13.1 p -64.23 -44.08 97.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.552 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.539 ' N ' HG13 ' A' ' 6' ' ' VAL . 55.9 t -62.06 -50.02 81.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.825 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.534 ' O ' HD13 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -65.97 -42.67 89.57 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.035 -179.528 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -60.92 -44.2 97.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.401 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 12' ' ' SER . . . -78.5 -68.31 0.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.406 ' HB1' ' CG ' ' A' ' 17' ' ' HIS . . . -41.22 -25.84 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.109 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 8' ' ' LEU . 3.1 m -60.85 -43.83 97.79 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.538 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.3 t -96.18 -34.64 5.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.852 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.73 -46.81 67.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.253 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.73 -11.04 23.29 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.89 -43.06 94.99 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.049 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.406 ' CG ' ' HB1' ' A' ' 11' ' ' ALA . 1.4 m80 -101.07 10.41 41.03 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.902 0.382 . . . . 0.0 110.336 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.29 -52.58 45.95 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.5 tp -66.28 -31.55 54.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.782 0.325 . . . . 0.0 110.774 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.6 mt -70.37 -39.11 74.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.231 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.1 t -62.26 -43.06 99.68 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.795 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -64.46 -35.45 80.97 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.474 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.8 tp -58.8 -36.53 74.61 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.396 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.8 t -76.82 -45.16 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.023 0.439 . . . . 0.0 110.413 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -66.41 -43.28 86.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.949 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -67.02 -24.55 66.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.971 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.5 p -57.22 -32.77 66.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.915 0.388 . . . . 0.0 110.151 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.04 -28.91 70.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.42 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.96 -47.91 70.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.716 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -56.37 -37.8 70.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.831 0.348 . . . . 0.0 110.626 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -68.37 -44.38 75.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.534 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.77 -44.25 99.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.728 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -62.53 -43.92 97.62 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.467 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.55 74.57 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.411 ' HE ' ' HA ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -93.86 -5.02 48.97 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.991 0.424 . . . . 0.0 110.175 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.544 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -66.01 158.45 28.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.636 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.594 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -167.82 174.46 2.35 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.481 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.594 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 31.7 Cg_exo -57.86 139.45 90.37 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.198 1.932 . . . . 0.0 111.682 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.93 -99.27 0.29 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.46 -39.16 88.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.657 0.265 . . . . 0.0 110.95 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 44' ' ' PHE . . . -47.79 -85.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.723 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.438 ' C ' ' O ' ' A' ' 41' ' ' ALA . 72.3 m-85 -30.05 -44.06 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.749 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.13 -47.07 69.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.838 0.351 . . . . 0.0 110.824 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 41' ' ' ALA . 84.1 t80 -87.99 -70.47 0.63 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.27 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.47 ' O ' ' N ' ' A' ' 47' ' ' VAL . 3.5 m-85 -48.94 -39.95 28.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.7 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -41.12 -24.58 0.1 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 45' ' ' TYR . 42.8 t -81.45 76.11 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.923 0.392 . . . . 0.0 110.38 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.596 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -98.67 -39.32 0.24 Allowed Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.707 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 51.5 Cg_exo -53.19 -55.51 3.6 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.088 1.859 . . . . 0.0 112.213 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.537 ' N ' HD12 ' A' ' 50' ' ' LEU . 10.1 mp -67.44 -29.54 69.04 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.998 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.505 ' O ' HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -60.5 -44.69 95.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.92 0.39 . . . . 0.0 110.421 -178.434 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.559 HD23 ' O ' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -77.74 -33.03 53.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.202 0.525 . . . . 0.0 110.406 179.351 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.42 ' C ' ' H ' ' A' ' 55' ' ' LEU . 12.5 tp -66.54 -64.17 0.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.388 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.7 tp -53.9 -9.99 0.28 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.592 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.42 ' H ' ' C ' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -75.73 -73.3 0.27 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.791 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.601 ' O ' HD22 ' A' ' 57' ' ' LEU . . . -96.95 3.15 52.2 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.627 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.601 HD22 ' O ' ' A' ' 56' ' ' ALA . 1.6 mm? -127.45 81.12 70.71 Favored Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -75.99 165.07 30.51 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.378 2.052 . . . . 0.0 112.055 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -43.33 -35.81 5.83 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.361 2.04 . . . . 0.0 111.875 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.9 mtt-85 -49.03 -42.52 38.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.359 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.427 ' HB3' HD13 ' A' ' 57' ' ' LEU . . . . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 120.756 0.312 . . . . 0.0 110.432 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.588 0.232 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.483 ' C ' HD12 ' A' ' 5' ' ' LEU . 9.8 m120 -115.04 -3.38 12.62 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.763 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.483 HD12 ' C ' ' A' ' 4' ' ' ASN . 10.8 mp -106.82 -73.53 0.68 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.633 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.3 p -46.48 -33.89 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.907 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.499 HG23 ' N ' ' A' ' 8' ' ' LEU . 13.0 m -67.04 -41.11 86.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.759 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.499 ' N ' HG23 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -60.99 -53.42 57.43 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.671 -0.412 . . . . 0.0 109.916 -179.148 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -63.24 -45.11 93.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.311 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.75 -34.03 77.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.262 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 7' ' ' VAL . . . -64.21 -37.44 87.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.454 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.9 t -49.56 -30.72 9.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.267 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.7 t -89.73 -50.16 13.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.454 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.1 -50.66 67.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.748 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.42 -2.74 20.35 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.959 -0.857 . . . . 0.0 110.959 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 18' ' ' GLY . . . -61.1 -110.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.336 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.46 ' H ' ' HD1' ' A' ' 17' ' ' HIS . 46.8 m80 -44.79 -13.12 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.813 0.34 . . . . 0.0 111.031 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -68.33 -45.51 69.09 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.447 HG22 ' O ' ' A' ' 16' ' ' ALA . 19.1 tt -47.1 -24.22 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.371 . . . . 0.0 110.448 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.704 ' C ' HD13 ' A' ' 20' ' ' LEU . 3.0 tm? -64.73 -44.53 89.85 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.043 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.9 t -51.79 -42.86 62.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.439 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -64.17 -47.0 81.52 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.315 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 23' ' ' LEU . 1.0 OUTLIER -54.83 -46.07 74.56 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -177.742 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.1 p -69.21 -40.26 80.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.67 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -65.65 -38.58 89.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.34 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -75.79 -48.83 20.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.721 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.4 m -56.75 -42.07 78.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.389 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.66 -39.6 80.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.178 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.471 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -60.62 -40.07 90.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.565 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 9.7 t-105 -49.84 -32.34 14.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.968 0.413 . . . . 0.0 110.105 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -58.93 -26.22 64.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.198 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 29' ' ' ALA . 7.2 tt -64.43 -33.78 65.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.938 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -68.92 -54.7 14.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.469 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.96 11.44 18.71 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 50.3 ttm-85 -76.88 -15.25 59.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.848 0.356 . . . . 0.0 110.575 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.4 tp -70.32 49.67 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.437 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.559 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -75.32 162.22 73.77 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.186 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.559 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 43.5 Cg_endo -68.29 171.09 13.34 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.793 2.328 . . . . 0.0 111.796 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.83 -88.33 0.5 Allowed Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.23 -47.17 11.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 110.819 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.36 3.21 11.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.62 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -89.41 -45.59 9.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.607 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.488 ' C ' ' H ' ' A' ' 45' ' ' TYR . . . -64.82 -74.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.174 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 46' ' ' GLY . 17.3 m-85 -65.34 6.1 0.33 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.686 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.488 ' H ' ' C ' ' A' ' 43' ' ' ALA . 58.5 t80 -40.95 -24.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.925 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 44' ' ' PHE . . . -92.36 31.26 6.16 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.433 ' N ' ' O ' ' A' ' 44' ' ' PHE . 7.4 p -110.93 -24.94 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 120.895 0.379 . . . . 0.0 110.581 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.639 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 19.0 p-90 -83.2 -29.5 0.45 Allowed Pre-proline 0 CA--C 1.549 0.92 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.702 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 60.4 Cg_endo -87.38 -19.32 2.41 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.951 2.434 . . . . 0.0 112.682 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.5 tp -77.1 -48.97 16.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.98 0.419 . . . . 0.0 110.663 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.6 mt -67.73 -2.21 6.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.323 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.9 tt -65.75 -39.01 90.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.8 mt -94.58 -48.2 6.2 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.805 0.336 . . . . 0.0 111.071 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.8 tp -41.8 -59.61 1.63 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.077 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 55' ' ' LEU . 10.5 mp -62.01 -41.4 98.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.52 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.82 1.0 0.45 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.429 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.469 ' H ' ' C ' ' A' ' 55' ' ' LEU . 64.5 mt -130.79 146.65 62.89 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.656 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.86 138.65 45.23 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.456 2.104 . . . . 0.0 112.45 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -45.06 -20.68 0.44 Allowed 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.351 2.034 . . . . 0.0 112.021 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 72.8 ttt-85 -63.63 -44.1 94.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.273 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.248 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.569 -179.959 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.434 ' HA ' HH22 ' A' ' 60' ' ' ARG . 33.8 tt0 . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.874 0.368 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -100.59 -64.88 1.01 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.431 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 5' ' ' LEU . 53.8 mt -49.12 -33.41 11.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.681 0.277 . . . . 0.0 111.284 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.632 HG13 ' N ' ' A' ' 7' ' ' VAL . 14.8 p -62.22 -48.42 88.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.739 0.304 . . . . 0.0 110.806 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.632 ' N ' HG13 ' A' ' 6' ' ' VAL . 7.2 p -85.62 -29.86 6.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.99 0.424 . . . . 0.0 111.288 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.531 HD23 ' C ' ' A' ' 8' ' ' LEU . 3.0 tt -58.32 -74.24 0.06 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.257 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.426 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 28.5 m120 -57.26 -26.62 61.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.498 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.41 -82.3 0.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.848 0.356 . . . . 0.0 111.294 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.467 ' HB1' ' H ' ' A' ' 17' ' ' HIS . . . -53.42 -62.45 1.65 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.024 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 8' ' ' LEU . 1.4 m -38.24 -48.46 1.29 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.743 0.306 . . . . 0.0 110.819 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 9' ' ' ASN . 78.3 t -65.3 -42.73 94.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.945 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . -63.43 -19.26 64.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.537 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 16' ' ' ALA . . . 106.27 -28.79 12.46 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.568 ' C ' ' H ' ' A' ' 18' ' ' GLY . . . -50.79 -98.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.467 ' H ' ' HB1' ' A' ' 11' ' ' ALA . 68.3 t60 -47.48 -5.12 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.568 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -66.49 -51.92 38.92 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.442 HG23 HD22 ' A' ' 20' ' ' LEU . 20.1 tt -68.84 -31.77 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.678 0.275 . . . . 0.0 111.245 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.442 HD22 HG23 ' A' ' 19' ' ' ILE . 3.8 mm? -66.49 -42.35 87.54 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.449 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.406 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.4 m -65.83 -35.96 82.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.128 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -76.44 -21.63 55.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.762 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.1 tp -63.28 -40.76 98.29 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.652 0.263 . . . . 0.0 111.326 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 21' ' ' SER . 2.0 p -70.19 -28.81 37.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.166 0.508 . . . . 0.0 109.965 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -71.34 -41.02 70.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.604 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.5 ' O ' ' N ' ' A' ' 29' ' ' ALA . 16.2 t80 -65.85 -38.34 88.61 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.554 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 85.3 p -45.62 -39.1 7.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.18 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.83 -29.03 70.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.144 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . -57.49 -38.13 74.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.642 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.432 ' CD1' ' N ' ' A' ' 30' ' ' TRP . 40.3 m0 -57.2 -41.0 78.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.495 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -65.01 -44.02 90.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.42 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.1 mt -66.57 -43.5 90.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.935 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -70.7 -54.31 12.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.838 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.34 28.2 68.38 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -100.06 9.88 42.16 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.729 0.3 . . . . 0.0 110.65 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.7 mt -110.07 173.65 6.23 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.64 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.656 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -157.08 173.26 5.16 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.312 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.656 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 51.3 Cg_exo -52.42 72.83 0.02 OUTLIER 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 122.71 2.273 . . . . 0.0 112.28 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . -112.86 -129.76 5.19 Favored Glycine 0 N--CA 1.466 0.695 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.0 -40.2 14.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.697 0.284 . . . . 0.0 110.76 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.69 -10.32 59.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.803 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.22 -51.53 6.22 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.804 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.2 -49.21 78.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.18 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.465 ' O ' ' N ' ' A' ' 46' ' ' GLY . 62.0 t80 -62.43 -44.67 95.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.155 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.446 ' CD1' ' C ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -40.82 -25.24 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.269 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 44' ' ' PHE . . . -62.65 -62.58 5.41 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.112 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.2 p -83.5 10.66 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.897 0.349 . . . . 0.0 111.63 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.538 ' C ' ' H ' ' A' ' 50' ' ' LEU . 1.3 t90 -44.08 -44.67 18.08 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.225 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 32.0 Cg_exo -57.98 13.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.509 2.383 0 C-N-CA 122.533 2.156 . . . . 0.0 113.336 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.592 HD23 ' O ' ' A' ' 50' ' ' LEU . 3.9 tt -104.0 -50.47 3.37 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.082 0.468 . . . . 0.0 110.125 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.1 tp -60.41 -38.91 85.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.463 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 52' ' ' LEU . 3.9 mm? -59.33 -73.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 53' ' ' LEU . 9.7 mp -46.37 -33.04 3.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.783 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.1 tp -63.29 -69.56 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.876 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.3 mt -68.31 -39.37 82.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.717 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.94 -16.48 6.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.789 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 43.2 mt -123.99 90.36 50.77 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.474 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.63 -178.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.072 0 C-N-CA 123.069 2.513 . . . . 0.0 112.724 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.548 ' C ' ' H ' ' A' ' 61' ' ' ALA . 32.0 Cg_exo -57.32 -39.65 88.08 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.941 2.427 . . . . 0.0 112.501 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.471 ' CZ ' HG11 ' A' ' 6' ' ' VAL . 4.7 ptm180 -63.79 8.42 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.548 ' H ' ' C ' ' A' ' 59' ' ' PRO . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.257 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 58.6 mp0 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.838 0.352 . . . . 0.0 110.534 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -65.28 -144.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.74 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.541 ' N ' HD22 ' A' ' 5' ' ' LEU . 3.8 mm? -82.91 -8.24 59.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.351 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 70.5 t -60.42 -46.27 95.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.093 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.455 HG22 ' H ' ' A' ' 7' ' ' VAL . 2.2 m -64.12 -47.56 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.293 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.5 tp -61.52 -43.84 98.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.111 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.444 ' O ' ' OG ' ' A' ' 12' ' ' SER . 20.5 m120 -60.96 -46.39 90.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.285 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.95 -37.43 72.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.424 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.99 -36.18 83.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.974 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 9' ' ' ASN . 58.9 p -61.33 -34.13 74.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.969 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.5 m -100.25 -13.65 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.898 0.38 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.34 -57.64 5.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.481 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.93 -71.12 0.51 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.04 -50.07 71.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.663 0.268 . . . . 0.0 110.619 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -49.11 -19.1 0.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.619 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.86 -63.33 4.7 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.2 mm -54.16 -23.85 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.802 0.335 . . . . 0.0 110.414 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 mt -79.16 -31.87 44.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.21 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.508 ' O ' HG12 ' A' ' 24' ' ' VAL . 1.6 m -71.4 -44.79 64.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.17 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -72.65 -14.49 61.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.547 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.82 HD21 ' HE1' ' A' ' 48' ' ' TRP . 4.6 tt -67.54 -31.42 71.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.952 0.406 . . . . 0.0 111.132 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.508 HG12 ' O ' ' A' ' 21' ' ' SER . 4.3 p -64.49 -21.55 29.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.925 0.393 . . . . 0.0 111.342 -178.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -63.16 -38.72 92.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.449 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 52.4 m-85 -60.78 -43.81 97.6 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.556 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.7 t -45.31 -46.65 12.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.129 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.51 -39.66 24.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.567 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.449 ' HB3' ' HA ' ' A' ' 26' ' ' PHE . . . -55.35 -28.12 51.74 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.763 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.606 ' HB3' HD23 ' A' ' 36' ' ' LEU . 43.7 m95 -64.91 -28.37 69.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.788 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -77.6 -52.17 9.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.346 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.411 ' CG1' ' N ' ' A' ' 33' ' ' LYS . 3.1 pt -65.49 -39.35 84.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.527 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.414 ' CG ' ' O ' ' A' ' 29' ' ' ALA . 16.7 mmmt -59.28 -34.44 72.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.469 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.06 -5.36 71.79 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -87.42 63.13 7.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.736 0.303 . . . . 0.0 110.456 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.606 HD23 ' HB3' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -135.38 112.86 10.67 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.041 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.71 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -162.19 174.34 3.76 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.53 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.71 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 52.7 Cg_exo -53.18 134.84 58.02 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.724 2.283 . . . . 0.0 111.909 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.69 -124.98 1.2 Allowed Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.506 ' C ' ' H ' ' A' ' 42' ' ' TYR . . . -97.31 -5.11 37.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.77 0.319 . . . . 0.0 110.657 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.81 -3.27 0.07 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.959 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.506 ' H ' ' C ' ' A' ' 40' ' ' ALA . 27.9 m-85 -65.94 -41.32 91.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.927 0.394 . . . . 0.0 110.552 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.79 -53.04 62.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.614 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -61.76 -69.65 0.23 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.439 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -59.22 -14.55 11.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.512 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -44.64 -79.87 0.05 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.3 m -123.19 48.09 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.721 0.296 . . . . 0.0 110.664 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.82 ' HE1' HD21 ' A' ' 23' ' ' LEU . 1.1 t90 -67.56 -41.94 33.78 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.269 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 30.7 Cg_exo -61.5 -27.66 82.44 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.901 2.401 . . . . 0.0 112.131 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.506 ' O ' HD12 ' A' ' 53' ' ' LEU . 5.6 tt -74.61 -27.32 60.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.783 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 tp -95.85 10.05 38.47 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.807 0.337 . . . . 0.0 111.071 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.507 ' C ' ' H ' ' A' ' 54' ' ' LEU . 6.5 tt -78.72 -42.21 28.91 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.074 0.464 . . . . 0.0 111.897 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.7 ' C ' HD22 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -48.89 -9.23 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.119 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.507 ' H ' ' C ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -59.14 -54.33 48.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.769 0.319 . . . . 0.0 110.684 -178.075 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.5 tt -68.47 -52.04 36.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.837 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.34 -27.64 68.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.923 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 53' ' ' LEU . 2.8 mp -145.97 98.74 4.39 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.823 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.409 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 50.1 Cg_exo -48.29 -175.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 123.062 2.508 . . . . 0.0 112.554 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 61' ' ' ALA . 51.3 Cg_exo -54.42 -27.28 48.4 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.046 2.497 . . . . 0.0 111.995 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -42.98 -23.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.317 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 59' ' ' PRO . . . . . . . . 0 N--CA 1.463 0.184 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.33 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 4' ' ' ASN . 23.4 tt0 . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.411 ' H ' ' HG2' ' A' ' 3' ' ' GLU . 39.6 t30 -87.5 3.53 46.99 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.845 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.2 tp -69.2 -85.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.984 0.421 . . . . 0.0 111.039 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.474 ' O ' ' OD1' ' A' ' 9' ' ' ASN . 95.3 t -40.62 -50.99 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.981 0.42 . . . . 0.0 111.002 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.424 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 0.7 OUTLIER -40.36 -30.14 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.965 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.436 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -56.98 -70.45 0.12 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.121 -178.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.474 ' OD1' ' O ' ' A' ' 6' ' ' VAL . 21.8 p-10 -69.8 -34.78 74.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.616 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.44 -50.24 72.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.396 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 7' ' ' VAL . . . -64.22 -39.4 93.9 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.925 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.0 t -62.66 -47.29 84.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.563 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.3 t -75.03 -45.33 42.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.95 -58.34 7.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.786 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.84 -5.85 84.2 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.79 -37.27 87.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.856 0.36 . . . . 0.0 110.734 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -86.01 14.78 5.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.188 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.68 -51.28 55.26 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.6 mm -67.43 -40.46 84.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.163 0.506 . . . . 0.0 110.178 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 20' ' ' LEU . 10.9 mp -67.61 -42.53 82.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.08 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.449 ' O ' HG12 ' A' ' 24' ' ' VAL . 78.1 p -64.39 -44.68 90.56 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.625 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -67.31 -25.59 66.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.529 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.2 tp -61.44 -40.49 94.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.479 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 21' ' ' SER . 1.0 OUTLIER -72.27 -34.97 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.991 0.424 . . . . 0.0 110.097 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -67.52 -46.19 73.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.485 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -56.23 -29.12 60.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.279 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.0 m -57.72 -35.87 71.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.014 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.15 -39.71 86.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.408 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.42 -34.95 26.36 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-O 121.015 0.436 . . . . 0.0 110.355 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.485 ' CD1' ' N ' ' A' ' 30' ' ' TRP . 19.2 m0 -78.09 -35.08 49.82 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.098 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -63.58 -45.99 87.9 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.55 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 33' ' ' LYS . 14.4 tt -69.72 -40.84 79.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.545 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.461 ' N ' HG23 ' A' ' 32' ' ' ILE . 19.5 tptm -64.24 -46.91 81.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.23 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.25 7.91 63.37 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.575 ' C ' ' H ' ' A' ' 37' ' ' ALA . 10.2 tpt85 -74.19 -19.67 60.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 110.224 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 37' ' ' ALA . 1.9 pp -52.82 -1.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.172 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.596 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -39.74 164.87 0.06 OUTLIER Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 120.694 0.283 . . . . 0.0 110.459 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.596 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 70.9 Cg_exo -40.95 125.95 2.36 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.407 2.071 . . . . 0.0 111.702 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 168.0 -120.5 0.9 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.58 -13.45 24.38 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.701 0.286 . . . . 0.0 110.726 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.63 -10.09 24.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.619 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -62.97 -37.66 87.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.651 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.5 -43.34 84.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.848 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.407 ' C ' ' N ' ' A' ' 46' ' ' GLY . 71.1 m-85 -63.17 -69.04 0.29 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.648 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -47.21 -20.19 0.17 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.281 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' A' ' 44' ' ' PHE . . . -65.33 -32.6 84.19 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 t -146.56 78.77 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 120.588 0.232 . . . . 0.0 110.677 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.63 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -82.98 -39.9 0.81 Allowed Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 38.4 Cg_exo -59.58 2.85 0.24 Allowed 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.836 2.357 . . . . 0.0 112.119 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.479 ' H ' ' C ' ' A' ' 48' ' ' TRP . 54.5 tp -69.99 -43.15 72.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.575 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.611 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.7 mm? -85.0 -20.75 30.02 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.527 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 52' ' ' LEU . 2.9 tt -67.61 -55.36 13.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.704 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.744 HD23 ' H ' ' A' ' 54' ' ' LEU . 0.9 OUTLIER -73.11 -37.74 66.6 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.964 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.744 ' H ' HD23 ' A' ' 53' ' ' LEU . 50.0 tp -64.57 -45.26 87.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.087 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.88 -34.28 66.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.714 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -46.1 -34.57 4.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.556 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.564 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -156.42 153.92 26.01 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.825 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.35 163.97 32.44 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.59 2.193 . . . . 0.0 112.283 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -47.03 -27.17 5.71 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.706 2.271 . . . . 0.0 112.086 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 83.2 mtt85 -56.9 -72.44 0.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.882 0.372 . . . . 0.0 110.443 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.31 179.822 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.6 mt -72.77 146.3 46.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.536 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.474 ' H ' HG21 ' A' ' 6' ' ' VAL . 80.6 mm-40 -108.4 -166.49 1.13 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.528 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.511 ' C ' ' H ' ' A' ' 6' ' ' VAL . 6.1 m-20 -69.03 -56.64 7.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.558 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.585 ' N ' HD22 ' A' ' 5' ' ' LEU . 4.0 mm? -53.0 -6.41 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.561 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 4' ' ' ASN . 40.1 t -91.44 -51.92 10.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.567 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 13.6 p -81.45 -23.36 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.529 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.614 ' O ' HD13 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -61.98 -46.66 88.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.556 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.4 ' ND2' ' O ' ' A' ' 5' ' ' LEU . 23.8 m-80 -64.02 -46.7 83.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.567 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.82 -36.87 73.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.566 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 7' ' ' VAL . . . -55.45 -44.06 76.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.563 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.5 p -62.21 -41.75 98.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.556 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.9 t -68.94 -43.37 82.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.55 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.87 -52.47 63.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.575 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.27 -81.63 0.35 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.65 -67.48 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.822 0.344 . . . . 0.0 110.578 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -51.9 -19.42 1.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.632 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.33 -54.01 6.45 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 21.2 pt -68.84 -22.82 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 0.0 110.547 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.451 ' HA ' HD13 ' A' ' 20' ' ' LEU . 1.7 mm? -69.48 -41.91 75.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.54 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.3 m -63.74 -28.77 70.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.557 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.44 ' O ' ' N ' ' A' ' 25' ' ' PHE . 5.1 m-85 -64.31 -11.47 32.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.572 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.619 HD11 ' CZ3' ' A' ' 48' ' ' TRP . 61.4 tp -41.31 -39.64 1.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.545 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.557 HG22 HD21 ' A' ' 52' ' ' LEU . 8.8 t -71.03 -39.68 75.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.568 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.44 ' N ' ' O ' ' A' ' 22' ' ' PHE . 84.9 t80 -74.82 -27.78 60.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.625 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.58 -42.78 77.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.55 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.0 m -46.2 -42.74 14.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.568 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.69 -36.24 57.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.538 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.584 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -58.01 -39.68 78.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.561 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -69.34 -33.7 73.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.553 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -60.81 -22.12 63.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.608 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.674 HG23 ' N ' ' A' ' 33' ' ' LYS . 10.6 tp -48.04 -50.06 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.563 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.674 ' N ' HG23 ' A' ' 32' ' ' ILE . 4.7 tppt? -64.52 -50.56 66.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.515 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.9 43.13 6.87 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.762 ' O ' ' N ' ' A' ' 37' ' ' ALA . 15.4 ptm180 -145.5 -5.06 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.744 0.306 . . . . 0.0 110.523 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.699 ' C ' ' O ' ' A' ' 35' ' ' ARG . 32.2 tp -6.33 71.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.563 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.762 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . -21.1 91.9 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.625 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.532 ' N ' ' O ' ' A' ' 36' ' ' LEU . 48.0 Cg_exo -53.62 150.74 27.11 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.843 2.362 . . . . 0.0 112.169 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.17 -75.51 0.42 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.48 ' C ' ' N ' ' A' ' 42' ' ' TYR . . . -87.77 -72.51 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.763 0.316 . . . . 0.0 110.575 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.12 -13.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.59 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.48 ' N ' ' C ' ' A' ' 40' ' ' ALA . 30.7 t80 -86.62 -49.39 7.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.551 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.35 -36.22 82.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.622 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.5 ' C ' ' H ' ' A' ' 46' ' ' GLY . 4.3 m-85 -44.61 -39.59 5.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.589 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -49.01 -10.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.62 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 44' ' ' PHE . . . -62.78 -35.47 91.99 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.0 m -148.62 23.91 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.85 0.357 . . . . 0.0 110.581 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.627 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -80.79 -42.99 1.25 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.513 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 15.1 Cg_exo -68.01 -15.09 42.77 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.806 2.337 . . . . 0.0 112.181 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.461 ' O ' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -62.16 -33.96 75.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.521 -179.038 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 tp -61.71 -7.56 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.611 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.702 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 55.1 mt -62.81 -49.55 74.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.609 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -85.2 -14.33 47.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.577 -178.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.525 ' O ' HD13 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -76.96 -58.31 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.578 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.613 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -75.84 -38.72 57.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.616 -178.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.755 ' HB3' HD13 ' A' ' 57' ' ' LEU . . . -34.11 -52.47 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.572 -177.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.046 HD13 ' N ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -111.57 155.7 42.56 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.548 178.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -78.27 163.44 27.61 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.843 2.362 . . . . 0.0 112.126 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.506 ' C ' ' H ' ' A' ' 61' ' ' ALA . 54.5 Cg_exo -47.93 -42.23 31.72 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.744 2.296 . . . . 0.0 112.121 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -68.16 42.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.621 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 59' ' ' PRO . . . -124.08 130.75 53.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.602 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -68.63 -3.46 11.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.581 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.551 179.959 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 61' ' ' ALA . 5.5 mp -86.39 -99.6 0.07 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.551 ' O ' HG21 ' A' ' 7' ' ' VAL . 17.4 tp10 -76.99 -138.18 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.745 0.307 . . . . 0.0 110.513 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.439 ' O ' ' O ' ' A' ' 5' ' ' LEU . 75.0 m-20 -112.08 -35.05 5.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.568 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 5' ' ' LEU . 4.1 mm? -48.27 -104.73 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.773 0.32 . . . . 0.0 111.446 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.0 t -44.03 -31.05 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.883 0.373 . . . . 0.0 110.72 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.551 HG21 ' O ' ' A' ' 3' ' ' GLU . 94.8 t -62.32 -42.52 95.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.717 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.5 tp -62.21 -43.28 99.18 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.051 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -75.64 -34.88 60.54 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.048 0.451 . . . . 0.0 110.797 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 12' ' ' SER . . . -72.24 -77.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.787 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -43.16 -15.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.342 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -57.74 -38.8 75.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.363 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.3 p -94.85 -37.57 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.562 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.63 -37.78 8.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.609 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.38 -21.6 28.33 Favored Glycine 0 N--CA 1.465 0.588 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.41 -50.59 71.18 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.522 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -101.15 12.41 37.64 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.961 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.78 -48.48 55.14 Favored Glycine 0 N--CA 1.462 0.425 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.642 HG23 ' CD2' ' A' ' 20' ' ' LEU . 8.6 tt -67.49 -34.02 65.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.841 0.353 . . . . 0.0 110.495 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.656 HD12 HD13 ' A' ' 54' ' ' LEU . 4.5 mm? -78.13 -25.87 47.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.69 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.507 ' O ' HG12 ' A' ' 24' ' ' VAL . 48.0 t -59.04 -43.16 91.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.913 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -62.22 -31.27 71.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.916 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.577 HD23 ' O ' ' A' ' 23' ' ' LEU . 1.1 tt -48.76 -39.38 24.81 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.391 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 21' ' ' SER . 1.8 p -63.21 -33.24 59.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.91 0.386 . . . . 0.0 110.255 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -63.94 -37.37 87.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.011 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -56.35 -43.85 79.53 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.754 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -44.59 -45.26 9.4 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.506 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.53 -39.24 22.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.843 0.354 . . . . 0.0 110.96 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.7 -36.07 24.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.253 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -59.22 -33.45 71.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.129 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -66.37 -44.9 81.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.542 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.5 mt -59.78 -44.42 93.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.949 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.646 ' C ' ' H ' ' A' ' 35' ' ' ARG . 84.7 tttt -69.32 -60.45 2.33 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.284 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 36' ' ' LEU . . . 56.47 -12.22 0.01 OUTLIER Glycine 0 CA--C 1.536 1.361 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.646 ' H ' ' C ' ' A' ' 33' ' ' LYS . 2.0 mmp_? -72.19 20.75 0.06 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.026 0.441 . . . . 0.0 110.922 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.505 ' H ' ' C ' ' A' ' 34' ' ' GLY . 46.8 tp -130.97 123.68 29.36 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.067 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.465 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -65.79 159.76 66.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.81 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.587 ' O ' ' N ' ' A' ' 40' ' ' ALA . 36.7 Cg_endo -65.4 -91.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.502 2.135 . . . . 0.0 111.47 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 49.88 -79.31 0.01 OUTLIER Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' A' ' 38' ' ' PRO . . . -68.1 -25.22 65.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.37 . . . . 0.0 110.39 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.43 -10.51 59.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.406 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -64.45 -71.23 0.18 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.367 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -79.18 -77.7 0.17 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.838 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.806 ' O ' HG22 ' A' ' 47' ' ' VAL . 80.6 t80 -23.17 -89.7 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.622 0.576 . . . . 0.0 111.94 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -52.87 -29.34 27.57 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.257 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -45.29 -14.51 0.06 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.806 HG22 ' O ' ' A' ' 44' ' ' PHE . 10.5 m -102.25 59.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.976 0.417 . . . . 0.0 110.648 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -66.79 -56.41 14.41 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.748 179.295 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 48' ' ' TRP . 27.6 Cg_endo -61.44 -16.74 49.34 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.61 2.206 . . . . 0.0 112.36 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.424 HD23 ' O ' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -95.32 -45.51 7.11 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.819 0.342 . . . . 0.0 110.412 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.9 tp -60.66 -24.34 65.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.467 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -69.36 4.13 1.91 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.557 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.616 ' C ' HD12 ' A' ' 53' ' ' LEU . 3.2 pp -68.24 -35.69 78.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.041 0.448 . . . . 0.0 110.678 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.656 HD13 HD12 ' A' ' 20' ' ' LEU . 2.2 pp -70.06 -1.26 9.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.871 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.4 -56.5 1.31 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.336 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.02 -19.88 50.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.191 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.0 tp -119.93 65.9 10.4 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.467 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.68 164.11 22.3 Favored 'Trans proline' 0 N--CA 1.501 1.915 0 C-N-CA 122.734 2.289 . . . . 0.0 111.872 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.51 -60.91 0.34 Allowed 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.764 2.309 . . . . 0.0 112.119 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.27 -75.56 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.673 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' A' ' 2' ' ' LEU . . . -75.75 -177.25 3.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.276 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 62' ' ' TYR . 48.3 p90 -162.91 122.97 2.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.459 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.462 179.996 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.6 ' N ' HD22 ' A' ' 2' ' ' LEU . 3.7 mm? -88.09 98.91 11.8 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.361 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.423 ' O ' ' CB ' ' A' ' 4' ' ' ASN . 18.6 pt-20 -124.24 168.9 12.33 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.14 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.57 ' C ' ' H ' ' A' ' 6' ' ' VAL . 55.4 t30 82.16 -123.02 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.612 0.57 . . . . 0.0 110.988 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tp -56.31 7.95 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.57 ' H ' ' C ' ' A' ' 4' ' ' ASN . 5.6 p -67.61 -46.49 82.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.974 0.416 . . . . 0.0 111.068 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.521 ' N ' HG13 ' A' ' 6' ' ' VAL . 13.5 p -64.84 -41.12 91.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.965 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.483 ' N ' HG13 ' A' ' 7' ' ' VAL . 31.9 tp -46.07 -70.74 0.09 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.191 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -66.43 -46.94 74.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.519 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.51 -47.79 69.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.704 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.37 -42.84 92.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.82 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.4 m -63.44 -44.33 94.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.009 0.433 . . . . 0.0 110.534 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.1 t -68.95 -42.72 82.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.678 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -44.34 -57.04 3.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.594 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.71 -90.45 0.34 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 18' ' ' GLY . . . -59.87 -40.77 89.81 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.709 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -55.14 -3.82 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.75 0.309 . . . . 0.0 110.777 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -75.15 -51.05 7.85 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.435 HG22 ' O ' ' A' ' 16' ' ' ALA . 17.4 tt -45.75 -17.64 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.761 0.315 . . . . 0.0 110.636 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -64.74 -42.79 94.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.857 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.408 ' O ' HG22 ' A' ' 24' ' ' VAL . 77.9 p -70.6 -41.54 72.16 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.385 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -65.66 -16.59 63.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.684 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.6 tp -50.74 -36.19 35.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.514 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' ' 25' ' ' PHE . 3.3 m -72.78 -39.82 60.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.914 0.388 . . . . 0.0 110.501 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.418 ' N ' HG23 ' A' ' 24' ' ' VAL . 28.5 m-85 -63.57 -45.41 90.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.718 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -67.04 -42.72 84.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 0.0 110.607 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.6 m -53.8 -43.8 69.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.502 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.34 -40.57 62.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.424 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.472 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -60.91 -51.48 69.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -52.64 -27.23 16.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.603 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.493 ' CZ ' HD23 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -72.74 -16.83 61.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.662 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.587 HG23 ' N ' ' A' ' 33' ' ' LYS . 18.8 tt -53.06 -50.05 47.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.703 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.587 ' N ' HG23 ' A' ' 32' ' ' ILE . 3.0 ptpp? -62.54 -46.87 86.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.295 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.96 11.14 47.22 Favored Glycine 0 N--CA 1.464 0.519 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.455 ' C ' ' H ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -79.06 -15.1 58.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.889 0.376 . . . . 0.0 110.312 179.378 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.493 HD23 ' CZ ' ' A' ' 31' ' ' TYR . 3.4 tp -73.63 13.36 0.49 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.225 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.663 ' HB1' ' CD ' ' A' ' 38' ' ' PRO . . . -47.43 -179.8 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.4 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.663 ' CD ' ' HB1' ' A' ' 37' ' ' ALA . 37.2 Cg_exo -59.95 148.17 89.86 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.089 1.859 . . . . 0.0 111.634 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.31 -128.81 2.68 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.2 -10.18 28.71 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.727 0.299 . . . . 0.0 110.941 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.406 ' C ' ' N ' ' A' ' 43' ' ' ALA . . . -82.96 -72.47 0.45 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.057 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -47.1 -20.75 0.18 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.286 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.406 ' N ' ' C ' ' A' ' 41' ' ' ALA . . . -57.67 -88.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.779 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -64.62 -45.35 87.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.206 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.509 ' C ' ' H ' ' A' ' 47' ' ' VAL . 14.3 t80 -59.13 -16.08 17.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.528 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.08 20.36 0.92 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.723 ' O ' HG13 ' A' ' 47' ' ' VAL . 12.7 p -99.05 71.79 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.104 0.478 . . . . 0.0 110.649 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.608 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 3.0 m0 -100.78 -34.04 0.23 Allowed Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.638 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 57.9 Cg_endo -77.59 -24.8 8.6 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.662 1.574 . . . . 0.0 112.575 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.503 ' O ' HD13 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -74.7 -46.31 38.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.934 0.397 . . . . 0.0 110.441 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.07 -47.14 72.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.3 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.8 mt -52.75 -30.15 31.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.142 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.4 tp -67.21 -44.04 80.55 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' LEU . 55.8 tp -62.45 -44.96 95.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.758 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.0 tp -69.99 -37.76 75.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.811 0.339 . . . . 0.0 110.662 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.07 -30.9 60.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.137 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -155.28 148.03 17.95 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.626 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.458 ' HG3' ' H ' ' A' ' 4' ' ' ASN . 35.1 Cg_endo -65.53 171.66 9.12 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.346 2.031 . . . . 0.0 112.534 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' A' ' 61' ' ' ALA . 31.2 Cg_exo -59.47 -17.12 39.24 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 122.329 2.02 . . . . 0.0 112.163 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.534 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 58.6 mtm180 44.85 -91.15 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.422 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 59' ' ' PRO . . . -19.7 91.06 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.764 0.665 . . . . 0.0 111.961 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.534 ' CD2' ' O ' ' A' ' 60' ' ' ARG . 46.9 m-85 -92.17 85.72 5.55 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.812 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.536 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.348 179.475 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.621 ' N ' ' NH1' ' A' ' 60' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.453 ' C ' ' NH2' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -107.61 86.48 2.31 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.127 -179.656 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -102.24 -165.89 1.23 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.386 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.1 m120 72.82 -60.75 0.52 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.43 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.3 pp -70.66 -29.83 66.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.488 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.515 HG23 ' N ' ' A' ' 7' ' ' VAL . 28.7 m -56.79 -46.22 83.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.64 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.515 ' N ' HG23 ' A' ' 6' ' ' VAL . 19.9 t -46.25 -29.69 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.829 0.347 . . . . 0.0 110.541 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.8 tp -94.23 -56.41 2.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.591 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -66.43 -55.61 14.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.434 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 6' ' ' VAL . . . -55.74 -54.26 46.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 110.644 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.15 -41.45 68.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.58 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 t -63.57 -45.49 90.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.542 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.5 t -74.15 -58.03 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.195 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.49 -58.03 9.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.774 0.321 . . . . 0.0 110.91 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.9 -32.45 6.82 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' A' ' 18' ' ' GLY . . . -69.91 -57.85 4.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.926 0.393 . . . . 0.0 110.322 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -50.75 -8.03 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.773 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.501 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -66.13 -58.06 9.53 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.2 pt -56.0 -24.05 16.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.424 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -72.67 -40.73 66.08 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.3 t -64.8 -43.46 93.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.631 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -78.91 -18.19 54.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.993 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.2 tp -48.9 -34.03 11.93 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.4 t -77.86 -36.64 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.693 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -61.0 -47.36 86.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.169 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -59.52 -26.82 65.64 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.515 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.7 t -51.12 -42.01 60.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.044 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.12 -37.89 53.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.383 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.475 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -59.08 -54.12 50.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.081 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 9.1 m0 -57.01 -23.79 48.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.702 0.287 . . . . 0.0 110.956 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.45 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 41.0 t80 -73.02 -14.99 61.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.688 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.506 HG23 ' N ' ' A' ' 33' ' ' LYS . 15.3 tt -62.09 -44.7 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.216 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.506 ' N ' HG23 ' A' ' 32' ' ' ILE . 1.5 tptm -70.84 -56.99 5.08 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.376 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.97 24.63 3.55 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -80.49 60.92 4.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.769 0.318 . . . . 0.0 110.283 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.9 mt -134.41 124.88 26.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.258 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -164.15 168.5 9.28 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.194 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.613 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 65.5 Cg_exo -47.63 106.4 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.092 1.861 . . . . 0.0 112.074 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 133.82 -48.71 0.94 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.69 -60.77 2.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.822 0.344 . . . . 0.0 110.762 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.92 -5.82 14.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.52 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -72.96 -62.22 1.54 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.924 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.68 92.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.183 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.442 ' C ' ' H ' ' A' ' 46' ' ' GLY . 4.5 m-85 -63.1 -83.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.349 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -53.65 -8.76 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.699 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 44' ' ' PHE . . . -65.85 -52.58 36.8 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.7 m -135.7 11.09 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.871 0.367 . . . . 0.0 110.675 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.551 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 13.1 t90 -61.64 -51.76 74.22 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 48' ' ' TRP . 11.1 Cg_endo -51.85 -16.4 4.09 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.807 1.672 . . . . 0.0 112.288 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.8 tp -76.06 -33.6 59.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.979 0.418 . . . . 0.0 110.1 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 72.6 mt -78.18 2.49 17.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.507 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.4 tt -85.21 -32.14 22.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.9 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 53' ' ' LEU . 10.2 mp -63.6 -32.43 73.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.389 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.3 tp -54.91 -46.0 74.82 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 tt -62.78 -40.08 96.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.855 0.359 . . . . 0.0 110.257 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.02 -11.44 59.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.698 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.7 mt -134.58 66.94 71.03 Favored Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.361 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.543 ' O ' ' N ' ' A' ' 60' ' ' ARG . 59.6 Cg_endo -77.74 163.63 28.78 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.709 2.273 . . . . 0.0 112.335 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -43.67 -11.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.698 2.265 . . . . 0.0 112.588 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.621 ' NH1' ' N ' ' A' ' 1' ' ' ALA . 9.3 tmm_? -70.68 -60.22 2.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.373 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.28 166.5 14.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.291 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -153.68 136.99 15.73 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.034 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.405 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.543 179.941 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.595 ' N ' HD12 ' A' ' 2' ' ' LEU . 9.3 mp -75.8 169.53 17.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.405 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -41.13 108.03 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.58 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -105.9 38.12 2.09 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.872 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.3 tp -112.52 -70.86 0.78 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.381 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.595 HG13 ' N ' ' A' ' 7' ' ' VAL . 11.5 p -60.34 -47.33 92.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.428 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.595 ' N ' HG13 ' A' ' 6' ' ' VAL . 12.7 p -64.64 -40.96 90.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.462 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.648 HD11 ' CE1' ' A' ' 17' ' ' HIS . 35.5 tp -61.71 -44.74 96.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.409 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -63.95 -45.67 88.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.95 0.405 . . . . 0.0 110.577 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 14' ' ' ALA . . . -69.94 -26.49 64.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.343 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.416 ' HA ' ' H ' ' A' ' 15' ' ' GLY . . . -75.64 -17.81 59.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.554 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.6 t -64.38 -50.97 65.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.318 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.5 p -91.79 -21.0 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.181 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 10' ' ' ALA . . . -93.16 -77.84 0.44 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.592 0.234 . . . . 0.0 110.995 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.416 ' H ' ' HA ' ' A' ' 11' ' ' ALA . . . -64.04 -164.5 0.74 Allowed Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.245 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 18' ' ' GLY . . . -90.94 -1.78 57.79 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.648 ' CE1' HD11 ' A' ' 8' ' ' LEU . 42.2 t60 -41.66 -19.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.139 -0.225 . . . . 0.0 111.299 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -67.37 -49.6 50.53 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.433 HG22 ' O ' ' A' ' 16' ' ' ALA . 15.1 tt -49.24 -28.26 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.83 0.348 . . . . 0.0 110.679 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.703 ' C ' HD13 ' A' ' 20' ' ' LEU . 3.2 tm? -65.97 -45.02 83.21 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.496 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.8 m -59.65 -43.76 93.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.779 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -61.69 -39.82 92.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.666 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.32 -39.23 89.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.816 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.1 t -68.18 -42.85 85.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.007 0.432 . . . . 0.0 110.036 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -63.12 -44.24 96.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.59 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.62 -41.8 99.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.182 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.0 m -54.35 -41.47 69.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.343 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.69 -43.06 39.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.494 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.5 -38.39 89.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.411 ' C ' ' N ' ' A' ' 32' ' ' ILE . 58.0 t-105 -59.89 -30.39 68.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.148 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -52.03 -15.04 0.48 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.138 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.411 ' N ' ' C ' ' A' ' 30' ' ' TRP . 3.5 tp -67.65 -19.28 24.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.504 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.632 ' C ' ' H ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -42.15 -58.01 2.29 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 58.47 -14.75 0.02 OUTLIER Glycine 0 CA--C 1.534 1.274 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.021 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.632 ' H ' ' C ' ' A' ' 33' ' ' LYS . 85.0 mtm-85 -128.36 70.35 1.37 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.038 0.419 . . . . 0.0 111.097 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.512 HD13 ' N ' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -152.61 118.97 5.57 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 179.358 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.512 ' N ' HD13 ' A' ' 36' ' ' LEU . . . -79.91 158.13 73.11 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-O 120.766 0.317 . . . . 0.0 110.484 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 35.0 Cg_endo -63.88 -177.89 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.533 2.155 . . . . 0.0 111.783 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.91 -72.42 0.35 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' A' ' 42' ' ' TYR . . . -56.72 -34.94 67.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.766 0.317 . . . . 0.0 110.665 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.47 21.19 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.82 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.525 ' H ' ' C ' ' A' ' 40' ' ' ALA . 81.3 t80 -56.52 -42.96 79.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.443 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.14 -42.2 90.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.325 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -55.67 -47.62 76.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.792 0.329 . . . . 0.0 110.338 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.432 ' O ' ' O ' ' A' ' 46' ' ' GLY . 31.4 m-85 -75.98 -35.64 59.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.28 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 45' ' ' TYR . . . -42.26 -97.99 0.01 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -144.46 36.24 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.702 0.287 . . . . 0.0 111.074 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.567 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 20.2 t-105 -60.95 -46.59 96.74 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.877 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 48' ' ' TRP . 30.4 Cg_endo -61.99 -13.65 32.57 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 121.765 1.643 . . . . 0.0 112.522 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.7 tp -77.33 -38.8 49.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.752 0.311 . . . . 0.0 110.922 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.499 HD22 ' N ' ' A' ' 51' ' ' LEU . 4.0 mm? -62.44 -40.18 95.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.579 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.0 mt -49.06 -19.04 0.37 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.442 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.675 HD23 ' O ' ' A' ' 53' ' ' LEU . 3.0 tt -66.44 -43.43 85.65 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.299 0.571 . . . . 0.0 110.062 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.5 mt -74.05 -19.15 60.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.403 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 55' ' ' LEU . 11.2 mp -93.99 -41.94 9.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.937 0.399 . . . . 0.0 110.233 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.465 ' C ' HD12 ' A' ' 57' ' ' LEU . . . -62.3 -34.06 75.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.79 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.465 HD12 ' C ' ' A' ' 56' ' ' ALA . 9.3 mp -110.79 95.27 22.96 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -47.08 175.37 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.457 2.105 . . . . 0.0 112.266 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.77 -38.85 78.23 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.399 2.066 . . . . 0.0 112.392 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -50.67 72.06 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.0 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.08 159.23 15.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.639 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -169.3 154.04 5.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.391 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.047 -0.977 . . . . 0.0 110.396 179.741 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 4' ' ' ASN . 0.3 OUTLIER -102.21 15.75 28.19 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.511 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.632 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 8.5 pm0 -74.48 25.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.835 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.469 ' H ' ' C ' ' A' ' 2' ' ' LEU . 0.4 OUTLIER -111.23 -46.42 3.3 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.861 -179.544 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.5 mt -78.3 -48.61 15.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.148 0.499 . . . . 0.0 110.633 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.539 HG13 ' N ' ' A' ' 7' ' ' VAL . 13.1 p -64.23 -44.08 97.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.552 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.539 ' N ' HG13 ' A' ' 6' ' ' VAL . 55.9 t -62.06 -50.02 81.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.825 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.534 ' O ' HD13 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -65.97 -42.67 89.57 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.035 -179.528 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -60.92 -44.2 97.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.401 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 12' ' ' SER . . . -78.5 -68.31 0.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.406 ' HB1' ' CG ' ' A' ' 17' ' ' HIS . . . -41.22 -25.84 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.109 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 8' ' ' LEU . 3.1 m -60.85 -43.83 97.79 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.538 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.3 t -96.18 -34.64 5.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.852 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.73 -46.81 67.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.253 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.73 -11.04 23.29 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.89 -43.06 94.99 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.049 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.406 ' CG ' ' HB1' ' A' ' 11' ' ' ALA . 1.4 m80 -101.07 10.41 41.03 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.902 0.382 . . . . 0.0 110.336 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.29 -52.58 45.95 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.5 tp -66.28 -31.55 54.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.782 0.325 . . . . 0.0 110.774 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.6 mt -70.37 -39.11 74.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.231 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.1 t -62.26 -43.06 99.68 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.795 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -64.46 -35.45 80.97 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.474 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.8 tp -58.8 -36.53 74.61 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.396 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.8 t -76.82 -45.16 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.023 0.439 . . . . 0.0 110.413 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -66.41 -43.28 86.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.949 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -67.02 -24.55 66.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.971 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.5 p -57.22 -32.77 66.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.915 0.388 . . . . 0.0 110.151 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.04 -28.91 70.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.42 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.96 -47.91 70.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.716 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -56.37 -37.8 70.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.831 0.348 . . . . 0.0 110.626 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -68.37 -44.38 75.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.534 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.77 -44.25 99.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.728 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -62.53 -43.92 97.62 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.467 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.55 74.57 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.411 ' HE ' ' HA ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -93.86 -5.02 48.97 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.991 0.424 . . . . 0.0 110.175 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.544 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -66.01 158.45 28.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.636 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.594 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -167.82 174.46 2.35 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.481 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.594 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 31.7 Cg_exo -57.86 139.45 90.37 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.198 1.932 . . . . 0.0 111.682 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.93 -99.27 0.29 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.46 -39.16 88.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.657 0.265 . . . . 0.0 110.95 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 44' ' ' PHE . . . -47.79 -85.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.723 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.438 ' C ' ' O ' ' A' ' 41' ' ' ALA . 72.3 m-85 -30.05 -44.06 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.749 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.13 -47.07 69.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.838 0.351 . . . . 0.0 110.824 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 41' ' ' ALA . 84.1 t80 -87.99 -70.47 0.63 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.27 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.47 ' O ' ' N ' ' A' ' 47' ' ' VAL . 3.5 m-85 -48.94 -39.95 28.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.7 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -41.12 -24.58 0.1 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 45' ' ' TYR . 42.8 t -81.45 76.11 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.923 0.392 . . . . 0.0 110.38 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.596 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -98.67 -39.32 0.24 Allowed Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.707 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 51.5 Cg_exo -53.19 -55.51 3.6 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.088 1.859 . . . . 0.0 112.213 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.537 ' N ' HD12 ' A' ' 50' ' ' LEU . 10.1 mp -67.44 -29.54 69.04 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.998 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.505 ' O ' HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -60.5 -44.69 95.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.92 0.39 . . . . 0.0 110.421 -178.434 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.559 HD23 ' O ' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -77.74 -33.03 53.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.202 0.525 . . . . 0.0 110.406 179.351 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.42 ' C ' ' H ' ' A' ' 55' ' ' LEU . 12.5 tp -66.54 -64.17 0.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.388 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.7 tp -53.9 -9.99 0.28 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.592 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.42 ' H ' ' C ' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -75.73 -73.3 0.27 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.791 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.601 ' O ' HD22 ' A' ' 57' ' ' LEU . . . -96.95 3.15 52.2 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.627 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.601 HD22 ' O ' ' A' ' 56' ' ' ALA . 1.6 mm? -127.45 81.12 70.71 Favored Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -75.99 165.07 30.51 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.378 2.052 . . . . 0.0 112.055 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -43.33 -35.81 5.83 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.361 2.04 . . . . 0.0 111.875 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.9 mtt-85 -49.03 -42.52 38.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.359 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.427 ' HB3' HD13 ' A' ' 57' ' ' LEU . . . -101.81 170.23 8.29 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.756 0.312 . . . . 0.0 110.432 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -83.11 -89.57 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.608 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.461 179.922 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.427 ' C ' ' H ' ' A' ' 4' ' ' ASN . 39.3 mt -65.25 -28.17 69.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.061 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -60.6 -3.49 0.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.522 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.483 ' C ' HD12 ' A' ' 5' ' ' LEU . 9.8 m120 -115.04 -3.38 12.62 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.763 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.483 HD12 ' C ' ' A' ' 4' ' ' ASN . 10.8 mp -106.82 -73.53 0.68 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.633 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.3 p -46.48 -33.89 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.907 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.499 HG23 ' N ' ' A' ' 8' ' ' LEU . 13.0 m -67.04 -41.11 86.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.759 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.499 ' N ' HG23 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -60.99 -53.42 57.43 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.671 -0.412 . . . . 0.0 109.916 -179.148 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -63.24 -45.11 93.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.311 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.75 -34.03 77.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.262 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 7' ' ' VAL . . . -64.21 -37.44 87.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.454 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.9 t -49.56 -30.72 9.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.267 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.7 t -89.73 -50.16 13.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.454 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.1 -50.66 67.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.748 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.42 -2.74 20.35 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.959 -0.857 . . . . 0.0 110.959 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 18' ' ' GLY . . . -61.1 -110.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.336 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.46 ' H ' ' HD1' ' A' ' 17' ' ' HIS . 46.8 m80 -44.79 -13.12 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.813 0.34 . . . . 0.0 111.031 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -68.33 -45.51 69.09 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.447 HG22 ' O ' ' A' ' 16' ' ' ALA . 19.1 tt -47.1 -24.22 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.371 . . . . 0.0 110.448 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.704 ' C ' HD13 ' A' ' 20' ' ' LEU . 3.0 tm? -64.73 -44.53 89.85 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.043 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.9 t -51.79 -42.86 62.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.439 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -64.17 -47.0 81.52 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.315 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 23' ' ' LEU . 1.0 OUTLIER -54.83 -46.07 74.56 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -177.742 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.1 p -69.21 -40.26 80.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.67 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -65.65 -38.58 89.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.34 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -75.79 -48.83 20.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.721 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.4 m -56.75 -42.07 78.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.389 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.66 -39.6 80.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.178 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.471 ' O ' HG22 ' A' ' 32' ' ' ILE . . . -60.62 -40.07 90.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.565 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 9.7 t-105 -49.84 -32.34 14.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.968 0.413 . . . . 0.0 110.105 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -58.93 -26.22 64.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.198 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 29' ' ' ALA . 7.2 tt -64.43 -33.78 65.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.938 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -68.92 -54.7 14.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.469 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.96 11.44 18.71 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 50.3 ttm-85 -76.88 -15.25 59.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.848 0.356 . . . . 0.0 110.575 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.4 tp -70.32 49.67 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.437 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.559 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -75.32 162.22 73.77 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.186 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.559 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 43.5 Cg_endo -68.29 171.09 13.34 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.793 2.328 . . . . 0.0 111.796 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.83 -88.33 0.5 Allowed Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.23 -47.17 11.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 110.819 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.36 3.21 11.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.62 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -89.41 -45.59 9.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.607 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.488 ' C ' ' H ' ' A' ' 45' ' ' TYR . . . -64.82 -74.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.174 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 46' ' ' GLY . 17.3 m-85 -65.34 6.1 0.33 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.686 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.488 ' H ' ' C ' ' A' ' 43' ' ' ALA . 58.5 t80 -40.95 -24.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.925 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 44' ' ' PHE . . . -92.36 31.26 6.16 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.433 ' N ' ' O ' ' A' ' 44' ' ' PHE . 7.4 p -110.93 -24.94 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 120.895 0.379 . . . . 0.0 110.581 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.639 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 19.0 p-90 -83.2 -29.5 0.45 Allowed Pre-proline 0 CA--C 1.549 0.92 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.702 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 60.4 Cg_endo -87.38 -19.32 2.41 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.951 2.434 . . . . 0.0 112.682 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.5 tp -77.1 -48.97 16.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.98 0.419 . . . . 0.0 110.663 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.6 mt -67.73 -2.21 6.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.323 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.9 tt -65.75 -39.01 90.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.8 mt -94.58 -48.2 6.2 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.805 0.336 . . . . 0.0 111.071 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.8 tp -41.8 -59.61 1.63 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.077 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 55' ' ' LEU . 10.5 mp -62.01 -41.4 98.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.52 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.82 1.0 0.45 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.429 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.469 ' H ' ' C ' ' A' ' 55' ' ' LEU . 64.5 mt -130.79 146.65 62.89 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.656 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.86 138.65 45.23 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.456 2.104 . . . . 0.0 112.45 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -45.06 -20.68 0.44 Allowed 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.351 2.034 . . . . 0.0 112.021 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 72.8 ttt-85 -63.63 -44.1 94.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.273 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.98 -169.31 1.75 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.569 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -168.46 155.83 7.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.489 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.522 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.92 179.884 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.578 ' N ' HD22 ' A' ' 2' ' ' LEU . 3.7 mm? -76.06 145.88 39.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.204 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.434 ' HA ' HH22 ' A' ' 60' ' ' ARG . 33.8 tt0 -67.58 -12.93 61.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.573 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -100.59 -64.88 1.01 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.431 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 5' ' ' LEU . 53.8 mt -49.12 -33.41 11.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.681 0.277 . . . . 0.0 111.284 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.632 HG13 ' N ' ' A' ' 7' ' ' VAL . 14.8 p -62.22 -48.42 88.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.739 0.304 . . . . 0.0 110.806 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.632 ' N ' HG13 ' A' ' 6' ' ' VAL . 7.2 p -85.62 -29.86 6.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.99 0.424 . . . . 0.0 111.288 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.531 HD23 ' C ' ' A' ' 8' ' ' LEU . 3.0 tt -58.32 -74.24 0.06 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.257 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.426 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 28.5 m120 -57.26 -26.62 61.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.498 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.41 -82.3 0.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.848 0.356 . . . . 0.0 111.294 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.467 ' HB1' ' H ' ' A' ' 17' ' ' HIS . . . -53.42 -62.45 1.65 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.024 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 8' ' ' LEU . 1.4 m -38.24 -48.46 1.29 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.743 0.306 . . . . 0.0 110.819 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 9' ' ' ASN . 78.3 t -65.3 -42.73 94.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.945 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . -63.43 -19.26 64.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.537 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 16' ' ' ALA . . . 106.27 -28.79 12.46 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.568 ' C ' ' H ' ' A' ' 18' ' ' GLY . . . -50.79 -98.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.467 ' H ' ' HB1' ' A' ' 11' ' ' ALA . 68.3 t60 -47.48 -5.12 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.568 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -66.49 -51.92 38.92 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.442 HG23 HD22 ' A' ' 20' ' ' LEU . 20.1 tt -68.84 -31.77 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.678 0.275 . . . . 0.0 111.245 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.442 HD22 HG23 ' A' ' 19' ' ' ILE . 3.8 mm? -66.49 -42.35 87.54 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.449 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.406 ' O ' HG12 ' A' ' 24' ' ' VAL . 15.4 m -65.83 -35.96 82.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.128 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -76.44 -21.63 55.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.762 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.1 tp -63.28 -40.76 98.29 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.652 0.263 . . . . 0.0 111.326 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 21' ' ' SER . 2.0 p -70.19 -28.81 37.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.166 0.508 . . . . 0.0 109.965 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -71.34 -41.02 70.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.604 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.5 ' O ' ' N ' ' A' ' 29' ' ' ALA . 16.2 t80 -65.85 -38.34 88.61 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.554 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 85.3 p -45.62 -39.1 7.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.18 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.83 -29.03 70.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.144 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . -57.49 -38.13 74.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.642 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.432 ' CD1' ' N ' ' A' ' 30' ' ' TRP . 40.3 m0 -57.2 -41.0 78.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.495 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -65.01 -44.02 90.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.42 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.1 mt -66.57 -43.5 90.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.935 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -70.7 -54.31 12.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.838 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.34 28.2 68.38 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -100.06 9.88 42.16 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.729 0.3 . . . . 0.0 110.65 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.7 mt -110.07 173.65 6.23 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.64 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.656 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -157.08 173.26 5.16 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.312 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.656 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 51.3 Cg_exo -52.42 72.83 0.02 OUTLIER 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 122.71 2.273 . . . . 0.0 112.28 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . -112.86 -129.76 5.19 Favored Glycine 0 N--CA 1.466 0.695 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.0 -40.2 14.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.697 0.284 . . . . 0.0 110.76 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.69 -10.32 59.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.803 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.22 -51.53 6.22 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.804 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.2 -49.21 78.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.18 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.465 ' O ' ' N ' ' A' ' 46' ' ' GLY . 62.0 t80 -62.43 -44.67 95.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.155 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.446 ' CD1' ' C ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -40.82 -25.24 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.269 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 44' ' ' PHE . . . -62.65 -62.58 5.41 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.112 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.2 p -83.5 10.66 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.897 0.349 . . . . 0.0 111.63 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.538 ' C ' ' H ' ' A' ' 50' ' ' LEU . 1.3 t90 -44.08 -44.67 18.08 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.225 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 32.0 Cg_exo -57.98 13.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.509 2.383 0 C-N-CA 122.533 2.156 . . . . 0.0 113.336 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.592 HD23 ' O ' ' A' ' 50' ' ' LEU . 3.9 tt -104.0 -50.47 3.37 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.082 0.468 . . . . 0.0 110.125 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.1 tp -60.41 -38.91 85.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.463 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 52' ' ' LEU . 3.9 mm? -59.33 -73.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 53' ' ' LEU . 9.7 mp -46.37 -33.04 3.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.783 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.1 tp -63.29 -69.56 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.876 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.3 mt -68.31 -39.37 82.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.717 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.94 -16.48 6.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.789 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 43.2 mt -123.99 90.36 50.77 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.474 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.63 -178.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.072 0 C-N-CA 123.069 2.513 . . . . 0.0 112.724 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.548 ' C ' ' H ' ' A' ' 61' ' ' ALA . 32.0 Cg_exo -57.32 -39.65 88.08 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.941 2.427 . . . . 0.0 112.501 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.471 ' CZ ' HG11 ' A' ' 6' ' ' VAL . 4.7 ptm180 -63.79 8.42 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.548 ' H ' ' C ' ' A' ' 59' ' ' PRO . . . -77.34 95.62 4.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.257 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -92.87 -31.62 14.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.487 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.481 179.989 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.623 ' O ' HG13 ' A' ' 7' ' ' VAL . 9.4 mp -74.63 142.72 44.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.446 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.493 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 58.6 mp0 -72.73 -2.96 22.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.534 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -65.28 -144.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.74 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.541 ' N ' HD22 ' A' ' 5' ' ' LEU . 3.8 mm? -82.91 -8.24 59.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.351 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 70.5 t -60.42 -46.27 95.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.093 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 2' ' ' LEU . 2.2 m -64.12 -47.56 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.293 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.5 tp -61.52 -43.84 98.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.111 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.444 ' O ' ' OG ' ' A' ' 12' ' ' SER . 20.5 m120 -60.96 -46.39 90.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.285 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.95 -37.43 72.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.424 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.99 -36.18 83.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.974 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 9' ' ' ASN . 58.9 p -61.33 -34.13 74.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.969 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.5 m -100.25 -13.65 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.898 0.38 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.34 -57.64 5.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.481 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.93 -71.12 0.51 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.04 -50.07 71.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.663 0.268 . . . . 0.0 110.619 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -49.11 -19.1 0.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.619 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.86 -63.33 4.7 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.2 mm -54.16 -23.85 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.802 0.335 . . . . 0.0 110.414 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 mt -79.16 -31.87 44.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.21 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.508 ' O ' HG12 ' A' ' 24' ' ' VAL . 1.6 m -71.4 -44.79 64.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.17 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -72.65 -14.49 61.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.547 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.82 HD21 ' HE1' ' A' ' 48' ' ' TRP . 4.6 tt -67.54 -31.42 71.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.952 0.406 . . . . 0.0 111.132 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.508 HG12 ' O ' ' A' ' 21' ' ' SER . 4.3 p -64.49 -21.55 29.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.925 0.393 . . . . 0.0 111.342 -178.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -63.16 -38.72 92.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.449 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 52.4 m-85 -60.78 -43.81 97.6 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.556 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.7 t -45.31 -46.65 12.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.129 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.51 -39.66 24.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.567 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.449 ' HB3' ' HA ' ' A' ' 26' ' ' PHE . . . -55.35 -28.12 51.74 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.763 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.606 ' HB3' HD23 ' A' ' 36' ' ' LEU . 43.7 m95 -64.91 -28.37 69.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.788 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -77.6 -52.17 9.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.346 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.411 ' CG1' ' N ' ' A' ' 33' ' ' LYS . 3.1 pt -65.49 -39.35 84.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.527 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.414 ' CG ' ' O ' ' A' ' 29' ' ' ALA . 16.7 mmmt -59.28 -34.44 72.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.469 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.06 -5.36 71.79 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -87.42 63.13 7.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.736 0.303 . . . . 0.0 110.456 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.606 HD23 ' HB3' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -135.38 112.86 10.67 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.041 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.71 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -162.19 174.34 3.76 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.53 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.71 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 52.7 Cg_exo -53.18 134.84 58.02 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.724 2.283 . . . . 0.0 111.909 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.69 -124.98 1.2 Allowed Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.506 ' C ' ' H ' ' A' ' 42' ' ' TYR . . . -97.31 -5.11 37.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.77 0.319 . . . . 0.0 110.657 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.81 -3.27 0.07 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.959 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.506 ' H ' ' C ' ' A' ' 40' ' ' ALA . 27.9 m-85 -65.94 -41.32 91.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.927 0.394 . . . . 0.0 110.552 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.79 -53.04 62.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.614 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -61.76 -69.65 0.23 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.439 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -59.22 -14.55 11.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.512 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 42' ' ' TYR . . . -44.64 -79.87 0.05 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.3 m -123.19 48.09 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.721 0.296 . . . . 0.0 110.664 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.82 ' HE1' HD21 ' A' ' 23' ' ' LEU . 1.1 t90 -67.56 -41.94 33.78 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.269 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 30.7 Cg_exo -61.5 -27.66 82.44 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.901 2.401 . . . . 0.0 112.131 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.506 ' O ' HD12 ' A' ' 53' ' ' LEU . 5.6 tt -74.61 -27.32 60.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.783 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 tp -95.85 10.05 38.47 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.807 0.337 . . . . 0.0 111.071 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.507 ' C ' ' H ' ' A' ' 54' ' ' LEU . 6.5 tt -78.72 -42.21 28.91 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.074 0.464 . . . . 0.0 111.897 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.7 ' C ' HD22 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -48.89 -9.23 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.119 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.507 ' H ' ' C ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -59.14 -54.33 48.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.769 0.319 . . . . 0.0 110.684 -178.075 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.5 tt -68.47 -52.04 36.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.837 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.34 -27.64 68.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.923 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 53' ' ' LEU . 2.8 mp -145.97 98.74 4.39 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.823 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.409 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 50.1 Cg_exo -48.29 -175.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 123.062 2.508 . . . . 0.0 112.554 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 61' ' ' ALA . 51.3 Cg_exo -54.42 -27.28 48.4 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.046 2.497 . . . . 0.0 111.995 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -42.98 -23.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.317 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 59' ' ' PRO . . . -107.02 176.44 5.17 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.33 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -161.19 30.76 0.14 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.496 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.586 -179.946 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 64.9 mt -98.34 126.45 43.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.977 0.418 . . . . 0.0 110.287 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 4' ' ' ASN . 23.4 tt0 -90.6 -141.43 0.16 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.411 ' H ' ' HG2' ' A' ' 3' ' ' GLU . 39.6 t30 -87.5 3.53 46.99 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.845 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.2 tp -69.2 -85.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.984 0.421 . . . . 0.0 111.039 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.474 ' O ' ' OD1' ' A' ' 9' ' ' ASN . 95.3 t -40.62 -50.99 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.981 0.42 . . . . 0.0 111.002 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.424 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 0.7 OUTLIER -40.36 -30.14 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.965 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.436 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -56.98 -70.45 0.12 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.121 -178.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.474 ' OD1' ' O ' ' A' ' 6' ' ' VAL . 21.8 p-10 -69.8 -34.78 74.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.616 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.44 -50.24 72.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.396 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 7' ' ' VAL . . . -64.22 -39.4 93.9 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.925 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.0 t -62.66 -47.29 84.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.563 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.3 t -75.03 -45.33 42.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.95 -58.34 7.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.786 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.84 -5.85 84.2 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.79 -37.27 87.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.856 0.36 . . . . 0.0 110.734 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -86.01 14.78 5.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.188 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.68 -51.28 55.26 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.6 mm -67.43 -40.46 84.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.163 0.506 . . . . 0.0 110.178 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 20' ' ' LEU . 10.9 mp -67.61 -42.53 82.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.08 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.449 ' O ' HG12 ' A' ' 24' ' ' VAL . 78.1 p -64.39 -44.68 90.56 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.625 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -67.31 -25.59 66.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.529 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.2 tp -61.44 -40.49 94.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.479 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 21' ' ' SER . 1.0 OUTLIER -72.27 -34.97 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.991 0.424 . . . . 0.0 110.097 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -67.52 -46.19 73.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.485 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -56.23 -29.12 60.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.279 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.0 m -57.72 -35.87 71.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.014 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.15 -39.71 86.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.408 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.42 -34.95 26.36 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-O 121.015 0.436 . . . . 0.0 110.355 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.485 ' CD1' ' N ' ' A' ' 30' ' ' TRP . 19.2 m0 -78.09 -35.08 49.82 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.098 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -63.58 -45.99 87.9 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.55 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 33' ' ' LYS . 14.4 tt -69.72 -40.84 79.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.545 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.461 ' N ' HG23 ' A' ' 32' ' ' ILE . 19.5 tptm -64.24 -46.91 81.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.23 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.25 7.91 63.37 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.575 ' C ' ' H ' ' A' ' 37' ' ' ALA . 10.2 tpt85 -74.19 -19.67 60.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 110.224 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 37' ' ' ALA . 1.9 pp -52.82 -1.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.172 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.596 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . -39.74 164.87 0.06 OUTLIER Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 120.694 0.283 . . . . 0.0 110.459 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.596 ' HD2' ' HB1' ' A' ' 37' ' ' ALA . 70.9 Cg_exo -40.95 125.95 2.36 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.407 2.071 . . . . 0.0 111.702 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 168.0 -120.5 0.9 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.58 -13.45 24.38 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.701 0.286 . . . . 0.0 110.726 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.63 -10.09 24.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.619 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -62.97 -37.66 87.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.651 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.5 -43.34 84.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.848 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.407 ' C ' ' N ' ' A' ' 46' ' ' GLY . 71.1 m-85 -63.17 -69.04 0.29 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.648 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -47.21 -20.19 0.17 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.281 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' A' ' 44' ' ' PHE . . . -65.33 -32.6 84.19 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 t -146.56 78.77 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 120.588 0.232 . . . . 0.0 110.677 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.63 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -82.98 -39.9 0.81 Allowed Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 38.4 Cg_exo -59.58 2.85 0.24 Allowed 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.836 2.357 . . . . 0.0 112.119 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.479 ' H ' ' C ' ' A' ' 48' ' ' TRP . 54.5 tp -69.99 -43.15 72.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.575 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.611 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.7 mm? -85.0 -20.75 30.02 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.527 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 52' ' ' LEU . 2.9 tt -67.61 -55.36 13.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.704 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.744 HD23 ' H ' ' A' ' 54' ' ' LEU . 0.9 OUTLIER -73.11 -37.74 66.6 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.964 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.744 ' H ' HD23 ' A' ' 53' ' ' LEU . 50.0 tp -64.57 -45.26 87.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.087 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.88 -34.28 66.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.714 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -46.1 -34.57 4.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.556 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.564 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -156.42 153.92 26.01 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.825 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.35 163.97 32.44 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.59 2.193 . . . . 0.0 112.283 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -47.03 -27.17 5.71 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.706 2.271 . . . . 0.0 112.086 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 83.2 mtt85 -56.9 -72.44 0.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.882 0.372 . . . . 0.0 110.443 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.03 -175.94 1.04 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.31 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -161.61 129.14 4.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.533 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.657 179.964 . . . . . . . . 0 0 . 1 stop_ save_